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ABSTRACT
 Innate immunity is the first line of defense against invading pathogens.  
Vertebrate innate immunity provides both initial protection, and activates adaptive 
immune responses, including memory.  As a result, the study of innate immune 
signaling is crucial for understanding the interactions between host and 
pathogen.  Unlike mammals, the insect Drosophila melanogaster lack classical 
adaptive immunity, relying on innate immune signaling via the Toll and IMD 
pathways to detect and respond to invading pathogens.  Once activated these 
pathways lead to the rapid and robust production of a variety of antimicrobial 
peptides.  These peptides are secreted directly into the hemolymph and assist in 
clearance of the infection. 
 The genetic and molecular tools available in the Drosophila system make 
it an excellent model system for studying immunity.  Furthermore, the innate 
immune signaling pathways used by Drosophila show strong homology to those 
of vertebrates making them ideal for the study of activation, regulation and 
mechanism.  Currently a number of questions remain regarding the activation 
and regulation of both vertebrate and insect innate immune signaling.  Over the 
past years many proteins have been implicated in mammalian and insect innate 
immune signaling pathways, however the mechanisms by which these proteins 
function remain largely undetermined.  
 My work has focused on understanding the molecular mechanisms of 
innate immune activation in Drosophila. In these studies I have identified a 
xii
number of novel protein/protein interactions which are vital for the activation and 
regulation of innate immune induction. This work shows that upon stimulation the 
Drosophila protein IMD is cleaved by the caspase-8 homologue DREDD. 
Cleaved IMD then binds the E3 ligase DIAP2 and promotes the K63-
polyubiquitination of IMD and activation of downstream signaling. Furthermore 
the Yersinia pestis effector protein YopJ is able to inhibit the critical IMD pathway 
MAP3 kinase TAK1 by serine/threonine-acetylation of its activation loop.  Lastly 
TAK1 signaling to the downstream Relish/NF-κB and JNK signaling pathways 
can be regulated by two isoforms of the TAB2 protein. This work elucidates the 
molecular mechanism of the IMD signaling pathway and suggests possible 
mechanisms of homologous mammalian systems, of which the molecular details 
remain unclear.
xiii
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CHAPTER I 
INTRODUCTION
2
A brief history of insects and immunity
In the last 200 years substantial focus has been placed on infection in 
insects for economic and public health reasons.  In 1865 Louis Pasteur 
established that microsporidia was the causative agent of pébrine disease in 
silkworms resulting in decrease in silk production causing a significant economic 
impact (Brey, 1998).  In the following decades Carlos Finlay showed that 
mosquitoes were vectors for yellow fever (Chaves-Carballo, 2005).  As a result 
during the early 20th century a great deal of interest was placed on characterizing 
the microbial flora associated with insects with a view to their potential impact on 
human society (Steinhaus, 1940). 
By the end of the 1960s, it had already been determined that pathogens 
such as fungi, protozoa, viruses and bacteria were capable of infecting insects.  
In response to these infections, insects activate cellular and humoral immune 
defenses including phagocytosis and the production of antimicrobial substances 
(Heimpel and Harshbarger, 1965).  A milestone in the field of insect immunity was  
the study from Hans Boman and colleagues on the inducible antibacterial 
defense mechanisms of Drosophila (Boman et al., 1972).  In subsequent years, a 
number of studies were undertaken to characterize insect specific antimicrobial 
peptides (AMPs) and the genes encoding them from various insect species 
including Drosophila (Hultmark et al., 1983; Kylsten et al., 1990; Samakovlis et 
al., 1990; Steiner et al., 1981; Sun et al., 1991).  
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Antimicrobial peptides are small, cationic molecules that are effective 
against specific classes of pathogens.  For example, Drosophila express 
peptides against Gram-positive bacteria (Defensin) (Dimarcq et al., 1994), Gram-
negative bacteria (Diptericin, Drosocin and Attacin) (Asling et al., 1995; Michaut 
et al., 1996; Wicker et al., 1990), fungi (Drosomycin) and both bacteria and fungi 
(Metchnikowin and Cecropin) (Ekengren and Hultmark, 1999; Levashina et al., 
1995; Samakovlis et al., 1992).  These antimicrobial peptides are critical for 
resistance to infection, such that transgenic expression of a single antimicrobial 
peptide can protect immunodeficient flies (Tzou et al., 2002).  Since these early 
studies on antimicrobial peptides, two major questions have shaped the field of 
insect immunology; how are microbes recognized and how is antimicrobial 
peptide gene expression regulated?  The powerful genetic and molecular tools 
available made Drosophila the preferred experimental system to address these 
issues.
While study in vertebrate systems is still essential, there are many 
advantages to using Drosophila as a model system.  Although evolutionarily 
separated from vertebrate organisms, many major Drosophila pathways including 
those involved in immunity, DNA damage repair, and neurodegeneration are 
reasonably conserved.  Moreover many vertebrate systems have developed 
multiple redundant proteins which can make analysis difficult. Drosophila often 
do not contain the same level of redundancy however.  With a generation time of 
only two weeks, Drosophila, are quicker, cheaper and easier to maintain than 
4
most mammals.  Drosophila also offer a number of well established genetic tools 
such as balancers and P-elements, which allow for expedient genome wide 
screening in adult animals.  Lastly, a number of well established Drosophila cell 
culture lines are also available for experimental use.  Overall Drosophila provide 
versatility and control ideal for scientific research. 
An Overview of the Drosophila immune response
Insects are exposed to a multitude of pathogens in their natural 
environment, and as a result they have developed sophisticated mechanisms to 
recognize and respond to infectious microorganisms.  Although they lack a fully 
evolved adaptive immune response, insects do have highly effective innate 
immune responses to a wide range of pathogens.  Moreover, the insect immune 
response has proven to be a useful and highly conserved model system for the 
study of innate immunity in general.  
Drosophila have a multi-layered immune system to facilitate pathogen 
defense, with an initial physical barrier provided by the chitin-based exoskeleton 
and internal structures.  If a pathogen breaches these barriers, several immune 
effector mechanisms respond, including cellular responses (i.e. phagocytosis, 
encapsulation and melanization) and humoral responses (i.e. antimicrobial 
peptides).  Of these mechanisms, antimicrobial peptide synthesis is perhaps the 
most critical for protection from microbial infections.  Antimicrobial peptides are 
produced both locally, at the site of infection, and systemically in the insect sera, 
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or hemolymph.  Local induction of antimicrobial peptide gene expression takes 
place in epithelial tissues such as the trachea and gut (Ferrandon et al., 1998; 
Liehl et al., 2006; Tzou et al., 2000).  Systemic humoral response is initiated in 
the fat body, the Drosophila liver-like organ, which is the major site of 
antimicrobial peptide production.  Other tissues also contribute, including the 
malphigian tubules and circulating blood cells, known as hemocytes (Ferrandon 
et al., 2007).
Recognition of pathogens is the first step in a cascade of events that lead 
to immune response.  Microbial products, often cell surface components, are 
detected by recognition receptors, which in turn stimulate signaling pathways that 
culminate in the induction of antimicrobial peptide gene expression.  There are at 
least two different pathways that regulate the expression of AMP genes in 
Drosophila, the Toll and IMD pathways.  The Toll pathway is stimulated by fungal 
and many Gram-positive bacterial pathogens, while the IMD pathway is triggered 
by the DAP-type peptidoglycan common to most Gram-negative bacteria 
(Kaneko et al., 2004; Michel et al., 2001; Levitin and Whiteway, 2008).  Once 
activated, these pathways trigger an intracellular cascade, culminating in the 
rapid and robust production of antimicrobial peptides. 
The signaling pathways of mammalian and insect innate immune 
responses show a great deal of overall similarity.  After binding and activation of 
receptors, various adaptor proteins stimulate downstream kinases.  These 
kinases in turn activate NF-κB proteins, leading to their nuclear localization and 
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transcription of immune genes.  Of particular interest is the ubiquitination of 
signaling proteins, a step which play a critical role in mammalian innate immunity.  
Although ubiquitination has been implicated in signaling within the insect innate 
immune response no ubiquitinated target proteins have thus far been identified.  
Ubiquitination
Polyubiquitination of target proteins plays an important role in many 
mammalian innate immune signaling pathways, and is also implicated in insect 
immunity.  Ubiquitin is an evolutionarily conserved 76 amino acid polypeptide, 
found in all eukaryotic organisms.  Originally identified as a cellular label of 
proteins designated for destruction, ubiquitination has also been shown to play 
an additional regulatory role.  In order to covalently bind a ubiquitin moiety to a 
target protein, a multi-step enzymatic cascade must first occur (Figure 1.1) 
(Hershko, 1983).  Initially ubiquitin is produced as a poly-protein which is 
recognized by endogenous ubiquitin specific protease (USP) (Varshavsky, 2000).  
USP cleaves the polypeptide just after the double glycine residues present at the 
C-terminal of each individual ubiquitin sequence, releasing mono-ubiquitin 
polypeptides.  This liberated ubiquitin then binds to the ubiquitin activating 
enzyme (E1) via a thioester bond between the active cysteine of the E1 and the 
C-terminal glycine of the ubiquitin moiety.  This ‘activated’ ubiquitin is then 
transferred to a ubiquitin conjugating enzyme (E2) via the formation of an 
additional thioester bond.  Lastly the C-terminal glycine of the ubiquitin is 
7
Figure 1.1
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Figure 1.1 Protein ubiquitination
Ubiquitination of a target substrate protein is a multistep enzymatic process.  In 
the first setup free ubiquitin is conjugated to a ubiquitin activating enzyme (E1) in 
an ATP-dependent process.  The ubiquitin is then passed to a ubiquitin-
conjugating enzyme (E2).  Utilizing a ubiquitin ligase (E3) the ubiquitin is then 
bound to a lysine on the substrate protein via a isopeptide bond.  Mono-
ubiquitinated substrate proteins can then be degraded by the proteosome or 
marked for cellular trafficking.  Alternatively, lysine 48 or lysine 63 of the 
conjugated ubiquitin can act as sites for binding further ubiquitin moieties 
resulting in K48- or K63-polyubiquitination respectively.  While K48-polyubiquitin 
chains have been shown to play a role in protein degradation via the 
proteosome, K63-polyubiquitin chains appear to act as scaffolds to recruit 
downstream singling components.  The N-terminal amino group of an initial 
conjugated ubiquitin protein can also bind further ubiquitin moieties resulting in 
linear (or head to tail) polyubiquitin chains.  The physiological relevance of linear 
polyubiquitin chains remains unclear. 
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covalently bound to the ε-amino group of a lysine on the target protein via an 
isopeptide bond with the assistance of a ubiquitin protein ligase (E3).  Two 
classes of E3 enzymes have currently been identified.  Those containing a 
HECT domain mediate the transfer of ubiquitin via the formation of a ubiquitin-E3 
intermediate (Bernassola et al., 2008).  While E3 enzymes containing a RING 
domain catalyze the attachment of ubiquitin directly from the E2 conjugating 
enzyme to the target protein (Petroski and Deshaies, 2005). 
Currently a number of ubiquitin modification types have been identified, all 
of which play different regulatory roles.  The binding of a single ubiquitin moiety 
to a target protein can serve as a flag for protein destruction via the proteosome, 
while also marking proteins for cellular localization or transport (Hicke, 2001).  
The ubiquitin protein also carries seven lysine residues which can themselves be 
the target of further ubiquitination, resulting in the formation of polyubiquitin 
chains.  Two types of lysine-mediated polyubiquitin chains have been widely 
described, lysine 48 (K48) and lysine 63 (K63).  K48-mediated polyubiquitin 
chains play a major role in targeting proteins for destruction via the 26S-
proteasome (Glickman and Ciechanover, 2002).  K63-mediated chains do not 
target proteins for destruction however, and instead seem to play an alternative 
role (Chiu et al., 2009; Mukhopadhyay and Riezman, 2007).  Implicated in a 
number of intracellular pathways K63-polyubiquitin chains are thought to act as 
scaffolds, recruiting downstream proteins together via ubiquitin binding domains.  
Once in proximity, these proteins (which are often kinases) are activated, 
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initiating downstream signaling.  It is currently unclear if the remaining five lysine 
residues present in ubiquitin also mediate the production of polyubiquitin chains.  
It also remains to be resolved what functions polyubiquitin chains mediated from 
these lysines serve. 
The most recently discovered type of polyubiquitin chains are linear (or 
head-to-tail) chains (Kirisako et al., 2006; Rahighi et al., 2009; Komander et al., 
2009; Tokunaga et al., 2009).  Unlike K48- and K63-polyubiquitin chains which 
require binding of a lysine residue, linear ubiquitin chains result from the binding 
of the C-terminal glycine of a free ubiquitin protein to the N-terminal amino group 
of a previous conjugated ubiquitin.  Little is known about the functional relevance 
of these linear polyubiquitin chains, however; there is some evidence that they 
may play a role in immune signaling (Tokunaga et al., 2009; Rahighi et al., 2009; 
Komander et al., 2009).  
Evidence has come to light indicating that the substrate proteins to which 
polyubiquitin chains are conjugated may not be as critical as once thought.  Work 
done by Xia and colleagues (2009), shows that unanchored polyubiquitin chains 
(i.e. polyubiquitin chains which are not conjugated to a target protein) are able to 
recruit and activate downstream kinases.  In at least one case, these unachored 
polyubiquitin chains have been shown to form after stimulation of mammalian 
HEK cells (Xia et al., 2009).  These data strongly indicate that the presence or 
absence of polyubiquitin chains is in some cases more important than the 
substrate protein to which they are conjugated.
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Protein ubiquitination is a reversible reaction.  Deubiquitinating enzymes 
(DUBs) catalyze the removal of ubiquitin from target proteins via protease or 
metalloprotease activity (Amerik and Hochstrasser, 2004).  Deubiquitination is a 
critical step in many signal transduction pathways.  In particular at least 2 DUBs 
have been described as playing integral roles in mammalian immunity 
(Kovalenko et al., 2003; Trompouki et al., 2003; Krikos et al., 1992). Recently a 
Drosophila DUB, USP36, was identified as playing a role in the IMD innate 
immune signaling pathway (discussed further in Chapter 2).  This protein is 
shown to remove K63-polyubiquitin chains in order to down regulate signaling 
(Thevenon et al., 2009). 
Drosophila Toll signaling
The Drosophila Toll pathway responds to Gram-positive bacterial and 
fungal infections (Lemaitre et al., 1996).  Unlike human Toll-like receptors (TLRs), 
Drosophila Toll does not directly bind pathogens or microbe-derived compounds.  
Instead Toll is activated by the serum protein Spätzle.  Spätzle is secreted into 
the extracellular environment as a pro-protein, with a disulfide-linked dimeric 
structure.  In order to activate the Toll pathway, pathogens activate serine 
protease cascades that culminate in the cleavage of Spätzle, liberating the 
mature Toll ligand (C-terminal 106 amino acids) (Hu et al., 2004; Weber et al., 
2003). 
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Recognition of Gram-positive bacteria involves the receptors PGRP-SA 
and PGRP-SD (Bischoff et al., 2004; Gobert et al., 2003; Michel et al., 2001; Pili-
Floury et al., 2004).  These receptors can function individually, or in the case of 
PGRP-SA as part of a complex with Gram-Negative Binding Protein 1 (GNBP-1), 
which is a peptidoglycan (PGN) processing enzyme.  Both the PGRP-SA and 
PGRP-SD receptors recognize lysine-type PGN, found in the cell wall of most 
Gram-positive bacteria, although their specificities probably differ slightly (Michel 
et al., 2001; Bischoff et al., 2004).  Once activated, the receptors and associated 
proteins lead to Spätzle cleavage by activating serine protease cascades 
(Lemaitre et al., 1996; Ligoxygakis et al., 2002; Kambris et al., 2006; Jang et al., 
2006).
Once cleaved, Spätzle binding induces dimerization of the Toll receptor.  
Although the ligand is a symmetric dimer, biophysical studies indicate that the 
Spätzle-induced Toll dimer is asymmetrical (Weber et al., 2003).  It is not yet 
clear if this asymmetric aspect of the ligand-induced Toll dimer is critical for the 
activation of intracellular signaling.  Dimerization of the Toll receptor is believed to 
recruit a pre-existing MyD88/Tube complex (Figure 1.2 ) and also associates with 
the kinase Pelle (the homolog of mammalian IRAK).  The assembly of the 
resulting receptor complex occurs via two distinct functional domains on each 
protein.  While the interaction between Toll and MyD88 occurs via their Toll/IL-1R 
(TIR) domains, Myd88, Tube, and Pelle interact in a trimeric complex via Death 
Domains (DD) found in each protein (Sun et al., 2002a; Sun et al., 2002b; 
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Figure 1.2
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Figure 1.2 Drosophila NF-κB signaling 
(Left) In the presence of Gram-negative bacteria, the receptor PGRP-LC binds 
DAP type peptidoglycan (PGN).  Binding of PGN to the receptor recruits the 
adaptor proteins IMD, FADD, and the caspase DREDD.  Through an undefined 
mechanism requiring Uev1A and Bendless (Ubc13 homologue), the MAP3 
kinase TAK1 is then activated.  The protein DIAP2 is also thought to play a role in 
this activation.  TAK1 then phosphorylates and activates the IKK complex leading 
to the phosphoryation of the NF-κB protein Relish.  In a separate arm of the 
pathway, Relish is cleaved in a DREDD dependent manner.  Cleaved/
phosphorylated Relish translocates into the nucleus activating antimicrobial 
peptide production.  TAK1 also phosphorylates the JNK kinase Hemipterous 
leading to the phosphorylation of the JNK protein Basket and activation of AP1 
dependent immune genes.  (Right) In the presence of Gram-positive bacteria and 
fungus, the secreted cytokine Spätzle is proteolytically cleaved.  Cleaved Spätzle 
then acts as the Toll receptor ligand inducing dimerization.  Activated Toll recruits 
the adaptor proteins MyD88, Tube and Pelle.  Activation of Pelle leads to the 
phosphorylation of the IκB protein Cactus.  Phosphorylation of Cactus promotes 
its K48-polyubiquitination and proteosomal degradation allowing the NF-κB 
homologue Dif (or Dorsal) to translocate into the nucleus and activate AMP 
production.
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Tauszig-Delamasure et al., 2002; Towb et al., 1998).  Although the DDs of these 
proteins are necessary for their interactions, Myd88 and Pelle do not interact 
directly; Tube acts as the core of the trimeric complex.  The mammalian homolog 
IRAK displays similar recruitment via an adapter complex in the mammalian 
Myd88-dependent TLR signaling.
Insect infections by Gram-positive bacteria and fungi culminate in the 
nuclear translocation of the NF-κB proteins DIF and/or Dorsal.  DIF is the main 
regulator of Toll signaling in both adults and larvae, whereas Dorsal is specifically 
required for the immune response in larvae.  Dorsal was first identified for its role 
in dorso-ventral patterning of the developing embryo (Santamaria and Nusslein-
Volhard, 1983).  The intracellular signaling components that lead to the activation 
of Dorsal are the same in both early embryo development and the immune 
response (Drier and Steward, 1997).  In the absence of stimulation, DIF/Dorsal 
are sequestered in the cytoplasm by their interaction with the IκB protein Cactus 
via six-ankyrin repeats.  Upon signaling, Cactus is degraded and DIF/Dorsal then 
translocates to the nucleus (Belvin et al., 1995; Bergmann et al., 1996; Gillespie 
and Wasserman, 1994; Reach et al., 1996; Wu and Anderson, 1998).  The 
degradation of Cactus, like that of IκBs, is controlled by phosphorylation and 
K48-polyubiquitination with subsequent protesome-mediated degradation.  Unlike 
mammalian IκBα which contains a single phosphorylation site responsible for its 
eventual degradation, Cactus contains two sites.  Phosphorylation of the PEST 
domain, found at the C-terminus of Cactus, is also implicated in its signal-
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independent degradation (Liu et al., 1997).  
Unlike mammalian TLR signaling, neither of the two Drosophila IKK-
related kinases (IKKε and IKKβ) are required for Toll-mediated Cactus 
phosphorylation and degradation.  Although Drosophila IKKβ can phosphorylate 
Cactus in vitro (Kim et al., 2000), it is not required for drosomycin expression in 
cultured cells or flies (Lu et al., 2001; Rutschmann et al., 2000b; Silverman et al., 
2000).  The sequence motifs that are phosphorylated in Cactus show a high level 
of similarity to those critical for IκBα phosphorylation in human cells.  It remains 
to be determined if Pelle or some other kinase is responsible for Cactus 
phosphorylation.  Once phosphorylated Cactus is likely ubiquitinated via the 
Slimb-SCF E3-ligase complex, as Drosophila embryos mutant for slimb (βTrCP 
homolog), are unable to activate the Dorsal target genes twist and snail (Spencer 
et al., 1999).
Degradation of Cactus and nuclear translocation of DIF (and Dorsal) leads 
directly to the transcriptional induction of many immune-responsive genes (De 
Gregorio et al., 2002; De Gregorio et al., 2001; Irving et al., 2001).  For example, 
the well-characterized AMP genes Defensin, Drosomycin, Cecropin and 
Metchnikowin are all activated as a consequence of Toll signaling, with DIF or 
Dorsal binding the κB-sites within the promoter/enhancer regions of these AMP 
genes (Senger et al., 2004).  Toll signaling leads to the activation of other less-
well characterized genes as well, some of which might be AMPs while others 
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may control different facets of the immune response such as the activation of the 
cellular immune response and the proliferation of hemocytes (Qiu et al., 1998; 
Zettervall et al., 2004). In addition, many components of the Toll pathway are 
regulated by Toll signaling (De Gregorio et al., 2002; Lemaitre et al., 1996).  Most 
notable is the upregulation of Cactus in response to an immune challenge, which 
generates a negative feedback loop to down-modulate the cascade (Nicolas et 
al., 1998). 
The Toll and IMD pathways are thought to be activated independently and 
initiate specific responses to different microorganisms.  However, some AMPs 
are activated by both the Toll and IMD pathways.  Tanji et al. (2007) have 
demonstrated that some antimicrobial peptide genes have distinct κB elements in 
their enhancer region (e.g. Drosomycin).  These elements respond to either 
Relish or DIF, with optimal gene induction occurring only when both the Toll (DIF) 
and IMD (Relish) pathways are activated, suggesting synergistic regulation of 
AMPs by two pathways (Tanji et al., 2007).
Drosophila IMD signaling
The IMD pathway is activated by DAP-type PGN derived from Gram-
negative and certain Gram-positive bacteria, such as E. coli and Bacillus spp.  
Initially, it was believed that the IMD pathway was activated by lipopolysaccharide 
(LPS) (Silverman et al., 2000; Werner et al., 2003).  However, this did not 
account for the activation of the IMD pathway by certain Gram-positive bacteria 
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(Kaneko et al., 2004; Lemaitre et al., 1997; Leulier et al., 2003).  It was 
subsequently demonstrated that the commercial LPS preparations often used to 
experimentally stimulate the IMD pathway are contaminated with PGN, and it is 
this PGN that activates the IMD pathway (Kaneko et al., 2004; Leulier et al., 
2003; Werner et al., 2003).
Recognition of DAP-type PGN involves the receptors PGRP-LC and 
PGRP-LE (Choe et al., 2002; Gottar et al., 2002; Leulier et al., 2003; Ramet et 
al., 2002; Takehana et al., 2002).  PGRP-LC encodes three alternatively spliced 
transcripts PGRP-LCa, -LCx and –LCy, which produce single pass 
transmembrane cell surface receptors.  Each have a distinct extracellular PGRP 
domain anchored to identical transmembrane and cytoplasmic domains (Werner 
et al., 2003).  PGRP-LE encodes a single protein which lacks both a signal 
sequence and a transmembrane domain.  Although PGRP-LC null flies, which 
lack all three isoforms, induce dramatically reduced levels of antimicrobial 
peptide following infection with Gram-negative bacteria, such as E. coli and 
Agrobacterium tumefaciens, they are not particularly susceptible to infection with 
all Gram-negative bacteria.  For example, PGRP-LC mutants are sensitive to A. 
tumefaciens, Erwinia carotovora carotovora, and Enterobacter cloacae but not E. 
coli and B. megaterium. (Choe et al., 2002; Gottar et al., 2002; Takehana et al., 
2004).  Mutants that abolish signaling through the IMD pathway, such as null 
alleles in IKK genes, are highly susceptible to all Gram-negative bacteria.  It was 
therefore hypothesized that another receptor must also recognize and respond to 
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Gram-negative bacteria.  Moreover, it suggests that relatively low levels of 
antimicrobial peptide gene induction, as observed in PGRP-LC mutants, are 
sufficient to protect against infection from many Gram-negative bacteria.  Genetic 
experiments suggest that PGRP-LE is the alternate receptor for the IMD 
pathway.  Double PGRP-LC, PGRP-LE mutants are hyper-susceptible to most 
Gram-negative bacteria, similar to other null mutants in the IMD pathway, and 
these double mutants do not induce detectable levels of antimicrobial peptide 
genes following infection (Takehana et al., 2004).  Over expression of either 
PGRP-LC or PGRP-LE, in flies or in cell culture, is sufficient to drive AMP 
expression through the IMD pathway.  
It has been shown that PGRP-LC and PGRP-LE serve to recognize 
different forms (monomeric and polymeric) of DAP-type PGN and to protect 
distinct niches.  In cell culture and in flies, only the PGRP-LCx isform is required 
for recognizing polymeric PGN (isolated from E. coli).  However, both PGRP-LCx 
and -LCa are required in cultured cells for the recognition of the monomeric 
fragment of DAP-type PGN known as TCT (Trachael Cyto-Toxin) (Kaneko et al., 
2004; Stenbak et al., 2004).  The role of PGRP-LCy in microbial recognition is 
still unknown.
The molecular mechanism by which PGN binding to either PGRP-LC or 
PGRP-LE leads to activation of the IMD pathway is still unclear.  However, it is 
known that the cytoplasmic domain of PGRP-LC is responsible for initiating this 
signal transduction cascade (Choe et al., 2005).  Epistatic experiments suggest 
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that the imd protein functions immediately downstream of PGRP-LC and 
upstream of all other known members of the pathway.  IMD is a death domain 
protein similar to mammalian Receptor Interacting Protein 1 (RIP1) (Georgel et 
al., 2001) and immunoprecipitation experiments have shown that PGRP-LC and 
IMD interact (Aggarwal et al., 2008; Choe et al., 2005; Kaneko et al., 2006).  
Kaneko et al. (2006) identified a RIP Homotypic Interaction Motif (RHIM)-like 
domain that is crucial for signaling by PGRP-LC when over expressed or 
following infection.  The RHIM domain, a motif of approximately 35 amino acids, 
was first identified in mammalian proteins RIP1, RIP3 and in the adaptor protein 
TRIF (Meylan et al., 2004; Sun et al., 2002b).  The RHIM domain of TRIF 
interacts with RIP1 and RIP3, while RIP1 and RIP3 also interact with each other 
through their RHIM domains.  The TRIF-RIP1 interaction is implicated in TLR3-
induced NF-κB activation (Meylan et al., 2004).  Likewise, the RHIM-like domain 
of PGRP-LC is critical for signaling, however it is not necessary for the interaction 
between PGRP-LC and IMD.  Instead, PGRP-LC interacts with IMD via a region 
that is not required for signaling , and thus, the PGRP-LC/IMD interaction 
appears be superfluous for the activation of the pathway (Kaneko et al., 2006).  
Although the N-terminal signaling domains of PGRP-LC and PGRP-LE are not 
homologous, a RHIM-like motif was also identified in PGRP-LE.  Mutation of the 
PGRP-LE RHIM-like motif blocks signaling induced by forced expression of this 
intracellular receptor.  However it remains unclear exactly how the RHIM-like 
domains of PGRP-LC and -LE function to transduce IMD signaling, but it can be 
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speculated that the RHIM-like domain might interact with some unidentified 
component of the pathway.  
Downstream of PGRP-LC and the imd protein, signal transduction through 
the IMD pathway leads to the Drosophila MAP3 kinase TAK1 and activation of 
the Drosophila IKK complex (Figure 1.2) (Silverman and Maniatis, 2001; 
Silverman et al., 2003; Vidal et al., 2001).  RNAi-based experiments suggest that 
ubiquitination may play a key role in the activation of TAK1.  Work by Zhou and 
colleagues has indicated that the E2 ubiquitin conjugating enzyme complex of 
UEV1A and Bendless (the Drosophila Ubc13 homolog) functions downstream of 
IMD yet upstream of TAK1 in the IMD pathway (Zhou et al., 2005).  The 
mammalian homologs of this E2 complex, Uev1A and Ubc13, are responsible for 
the K63-polyubiquitination of many immune proteins, such as RIP1, TRAF2 and 
TRAF6.  Unlike K48-polyubiquitination, which leads to proteasomal degradation, 
K63-polyubiquitin chains often have a regulatory function and are used to recruit 
and activate other signaling components.  It is highly probable that K63-
polyubiquitination plays an important role in the IMD signaling pathway between 
IMD and TAK1.  
The Drosophila Inhibitor of Apoptosis Protein 2 (DIAP2) has also been 
identified as a member of the IMD signaling pathway (Gesellchen et al., 2005; 
Kleino et al., 2005; Leulier et al., 2006; Valanne et al., 2007).  Similar to other E3 
IAP proteins, DIAP2 contains 3 baculovirus IAP repeat (BIR) domains as well as 
a RING motif that is required for IMD signaling (Huh et al., 2007).  Thus, although 
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DIAP2 has not yet been epistatically placed in the IMD signaling cascade, it is a 
good candidate for the missing IMD pathway E3 ligase, perhaps functioning 
along with the dUEV1A/Bendless E2 complex.  Analysis of these proteins and 
their roles in IMD pathway ubiquitination can be found in Chapter 2.  A 
deubiquitinating enzyme, USP36 has also been identified as playing a role in 
IMD pathway signaling.  Functioning as a K63-polyubiquitin protease, USP36 
acts to down regulate IMD pathway signaling, further implicating the importance 
of K63-polyubiquitination for IMD pathway activation (Thevenon et al., 2009). 
The apical caspase DREDD has been shown to play a role in the pathway 
between IMD and TAK1, perhaps functioning as an E3-ligase accessory factor 
(Zhou et al., 2005).  The mammalian homologue of DREDD, caspase-8, has 
been implicated NF-κB signaling pathways, many of which are thought to involve 
ubiquitination.  Taken together, it becomes an attractive hypothesis that the E2/
E3 complex of UEV1A, Bendless, DIAP2 and perhaps DREDD may mediate the 
K63-poly-ubiquitination of some member of the IMD pathway.  This ubiquitinated 
protein is likely to be critical for signaling to TAK1, the next component in the 
pathway.
TAK1 is believed to function in a complex with the Drosophila TAB2 
homolog (Zhuang et al., 2006).  Similar to mammalian TAB2, which was originally 
identified as a TAK1 binding protein, Drosophila TAB2 contains a conserved C-
terminal K63-polyubiquitin binding domain (Wang et al., 2001; Zhou et al., 2005), 
again suggesting that ubiquitination may play a crucial role in IMD signaling.  
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Signaling by the TAK1/TAB2 complex leads to the simultaneous induction of two 
downstream branches of the IMD pathway, which culminate in JNK and NF-κB/
Relish activation (Silverman et al., 2003). 
The JNK arm of the IMD pathway is activated by TAK1-mediated signaling 
to Hemipterous, the Drosophila MKK7/JNKK homolog (Chen et al., 2002; Holland 
et al., 1997; Sluss et al., 1996).  Hemipterous then phosphorylates the basket 
protein (JNK), which activates the Drosophila AP-1 transcription factor.  Signaling 
through the IMD/JNK pathway has been linked to the up-regulation of wound 
repair and stress response genes (Boutros et al., 2002; Silverman et al., 2003), 
yet the precise role that JNK signaling plays in the IMD pathway remains 
controversial.  Several reports have concluded that JNK signaling is not involved 
in AMP gene induction, instead it is suggested that AMP gene expression relies 
entirely on the NF-κB/Relish branch of the IMD pathway (Boutros et al., 2002; 
Silverman et al., 2003).  In fact, an unidentified product of the Relish branch of 
the IMD pathway was proposed to inhibit JNK signaling (Park et al., 2004), while 
the JNK pathway was proposed to directly inhibit AMP gene expression by 
recruiting histone deacetylases (Kim et al., 2005).  Alternatively, Delaney and 
colleagues (2006) concluded that the TAK1/JNK branch of the IMD pathway is 
critical for AMP gene induction, at least in clones of JNK-deficient cells within the 
larval fat body (Delaney and Mlodzik, 2006).  The role of the JNK pathway in 
antimicrobial gene expression remains controversial and further work will be 
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necessary to clarify whether JNK has positive and/or negative role in this 
process. 
In parallel to JNK activation, TAK1 is also required for induction of the NF-
κB/Relish branch of the IMD pathway, through activation of the Drosophila IKK 
complex (Silverman et al., 2003; Vidal et al., 2001).  The Drosophila IKK complex 
contains two subunits, a catalytic kinase subunit encoded by ird5 (IKKβ) and a 
regulatory subunit encoded by kenny (IKKγ) (Rutschmann et al., 2000a; 
Silverman et al., 2000).  In the Drosophila S2* cell line, it was demonstrated that 
the IKK complex is activated rapidly following immune stimulation and this 
activation requires TAK1 (Silverman et al., 2000; Silverman et al., 2003).  
Activated IKK complex can then directly phosphorylate Relish. 
Relish is a bipartite protein similar to mammalian NF-κB precursors p100 
and p105.  It contains an N-terminal Rel homology domain (RHD) and an 
inhibitory IκB domain with six ankyrin repeats that retain the protein in the 
cytoplasm.  Upon infection with Gram-negative bacteria, Relish expression is 
strongly induced in adult flies (Dushay et al., 1996).  Relish mutant flies show 
extreme sensitivity to infections and fail to induce antimicrobial genes after 
bacterial infection (Hedengren et al., 1999).  Although the Relish locus encodes 
an embryo specific isoform, Relish does not appear to have a role in 
development as homozygous Relish mutants continue to be viable and fertile.  
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In mammals, the NF-κB precursors p100 and p105 are processed by the 
proteasome and their C-terminal region is degraded to produce p50 and p52, 
respectively.  This processing is regulated by phosphorylation of C-terminal 
serine residues, which leads to ubiquitination and partial proteasome degradation 
of the C-terminus (Perkins et al., 1997).  In contrast, Relish processing does not 
depend on proteasomal degradation.  Relish is instead endo-proteolytically 
cleaved by a caspase, producing an N-terminal RHD transcription factor module 
that translocates to the nucleus to activate immune genes, while the stable C-
terminal domain remains in the cytoplasm (Stöven et al., 2000).  Relish cleavage 
occurs after residue D545, within a typical caspase target motif, 542LQHD545.  
DREDD, in addition to its previously mentioned role upstream in the pathway, 
also appears to function downstream and is a likely candidate for the caspase 
responsible for cleavage of Relish.  DREDD and Relish physically interact under 
cell culture conditions and Dredd RNAi prevents antimicrobial peptide gene 
expression induced by an activated allele of TAK1 (Zhou et al., 2005).  Dredd 
mutants also fail to cleave Relish, are unable to induce AMP gene expression 
and are highly sensitive to Gram-negative bacterial infections (Leulier et al., 
2000; Stöven et al., 2003).  Furthermore, over expression of DREDD is sufficient 
to cause Relish cleavage and purified DREDD cleaves Relish in vitro (Erturk-
Hasdemir et al., 2009).
Phosphorylation of Relish occurs in a signal dependent manner by the 
Drosophila IKK complex and the C-terminus of Relish is required for both its 
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phosphorylation and cleavage (Stöven et al., 2003).  Recently, studies have 
identified 2 serine residues, 528 and 529, in the N-terminal transcription factor 
module of Relish that are phosphorylated by Drosophila IKKβ yet are 
dispensable for the Relish cleavage.  Instead, phosphorylation appears critical for 
the proper transcriptional activation of Relish targets via efficient recruitment of 
RNA polymerase II to the promoters of antimicrobial peptide genes.  Apart from 
its role in phosphorylation, the IKK complex also functions noncatalytically in the 
cleavage of Relish (Erturk-Hasdemir et al., 2009).  In total, Relish activity is 
coordinately regulated by 2 distinct mechanisms; cleavage by DREDD and 
phosphorylation by the IKK complex. 
While Relish is activated by caspase-dependent cleavage, the ubiquitin-
proteasome pathway may target Relish for destruction.  It was established that 
inhibiting the SCF E3-ubiquitin-ligase complex caused the constitutive expression 
of antimicrobial peptide genes and increased levels of Relish (Khush et al., 
2002).  Thus, the ubiquitin proteosome pathway may be important for down-
regulating the IMD pathway. 
Mammalian NF-κB signaling
Mammals rely largely on an adaptive immune response, including B-cells, 
T-cells, and antibodies to provide long lasting protective immunity from 
pathogens.  However, the first line of defense against a pathogenic invasion is 
largely delegated to the innate immune response.  Unlike the adaptive immune 
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response, which tends to be slow acting, yet entail a very specific defense 
against a particular pathogen, the innate immune response is much faster yet 
less specific, activating defenses against a wide variety of pathogens.
Mammals have developed an intricate series of receptors and cell 
signaling events which respond to a range of microbial products, known as 
pathogen associated molecular patterns (PAMPs).  When these receptors bind 
their PAMP ligand a signaling cascade is triggered causing the production of both 
pro- and anti-inflammatory cytokines and chemokines which modulate the 
immune response.  This leads to the recruitment and activation of cells involved 
in both innate and adaptive immune response, the activation of complement to 
promote the removal of foreign organisms, and serves to prime the adaptive 
immune response. 
The NF-κB signaling pathway is perhaps the most well defined 
mammalian innate immune signaling pathway (Figure 1.3).  Signaling through the 
canonical NF-κB pathway can occur via a number of cellular receptors including 
tumor necrosis factor receptors (TNFR), the interleukin-1 receptor (IL-1R), or the 
toll like receptors (TLRs).  Currently eleven human and thirteen mouse TLRs 
have been identified each of which contain leucine rich repeat (LRR) motifs in 
their extracellular domains which are used bind a variety of PAMPs.  Alternatively, 
TNFR and IL-1R do not bind PAMPs but instead bind the cytokines TNF and IL-1, 
respectively, which are produced during an infection.  Although the extracellular 
domains of TLRs and IL-1R show striking differences, a cytoplasmic domain 
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Figure 1.3
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Figure 1.3 Mammalian NF-κB signaling
(Left) Upon recognition of microbial products TLR4 dimerizes and leads to the 
recruitment of the adaptor proteins MyD88 and Mal.  MyD88 interacts with IRAK 
via homeotypic death domain interactions and binds TRAF6.  Activated IRAK 
auto-phosphorylates and TRAF6 is then released into the cytoplasm.  
Phosphorylated IRAK stays near the membrane and is polyubiquitinated and 
degraded.  In the cytoplasm, TRAF6 interacts with the E2 enzymes Uev1a, 
Ubc13, and Ubc5 promoting its own K63-polyubiquitination.  In a second MyD88 
independent pathway TLR4 activation leads to the recruitment of the adapters 
TRIF and TRAM.  These adaptors then interact with the proteins RIP1 and 
TRAF6.  Via interactions with Uev1A and Ubc13, RIP1 and TRAF6 are K63-
polyubiquitinated.  (Right) Binding of the cytokine TNF to its receptor TNF-R1 
leads to recruitment of the adaptor protein TRADD which in turn interacts with 
TRAF2 and RIP1.  Activation of TNF-R1 leads to the PKCδ/ε dependent 
phosphorylation of TRAF2.  Phosphorylated TRAF2 is K63-polyubiquitinated in a 
Uev1A/Ubc13 dependent manner.  RIP1 is also K63-polyubiquitinated in an 
event which requires Uev1A/Ubc13 and cIAP1/2.  (Bottom) In all cases K63-
polyubiquitination of upstream pathway members leads to the recruitment of 
TAK1 via ubiquitin binding domains found in TAB2/3.  Activated TAK1 then 
phosphorylates and activates the IKK complex resulting in the phosphorylation 
and K48-polyubiquitin mediated degradation of IκBα, releasing NF-κB into the 
nucleus. TAK1 also phosphorylates MKK3, -4, -6 and -7 activating JNK/p38 
mediated AP1 signaling.
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found in both receptors, which is critical for downstream signaling, shows a high 
degree of similarity and has been named the Toll/IL-1 receptor (TIR) domain 
(O'Neill and Bowie, 2007; Dunne and O'Neill, 2003).  Although these receptors 
may bind different ligands they are able to activate similar downstream signaling 
pathways.  
Upon binding ligand, TLRs (in particular TLR4) oligomerize causing a 
conformational change which results in the recruitment of the downstream 
adaptor myeloid differentiation primary response protein 88 (MyD88) and MyD88 
adaptor-like protein (Mal, also known as TIRAP) (Akira et al., 2006; O'Neill and 
Bowie, 2007; Kawai et al., 1999; Fitzgerald et al., 2001; Horng et al., 2002; Kim 
et al., 2007; Park et al., 2009).  MyD88 recruits IL-1 receptor-associated kinase 
(IRAK) and tumor necrosis factor receptor associated factor 6 (TRAF6) via 
interactions in the death domains of MyD88 and IRAK (Burns et al., 1998; 
Wesche et al., 1997; Cao et al., 1996).  Four members of the IRAK family have 
been identified (IRAK-1, IRAK-2, IRAK-M, IRAK-4), two of which, IRAK-1 and 
IRAK-4, show serine/threonine kinase activity (Suzuki et al., 2002; Kawagoe et 
al., 2008; Keating et al., 2007; Qin et al., 2004; Cheng et al., 2007).  MyD88 
recruited IRAK4 and IRAK1/2 are phosphorylated and along with TRAF6 
disassociate from the receptor complex (Cheng et al., 2007; Kollewe et al., 2004; 
Li et al., 1999).  IRAK remains on the membrane becoming polyubiquitinated and 
degraded, whereas TRAF6 migrates into the cytoplasm (Li et al., 1999; Yamin 
and Miller, 1997).  Varying reports have indicated the formation of both K48- and 
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K63-polyubiquitin chains on IRAK however multiple groups have concluded that 
IRAK degradation does not appear proteasome-dependent (Ordureau et al., 
2008; Windheim et al., 2008; Yamin and Miller, 1997). 
Once disassociated from the receptor, TRAF6 interacts with the ubiquitin 
E2 complex of Uev1A and Ubc13.  Using its own ring finger to act as an E3 
ligase, TRAF6 promotes its own K63-polyubiquitination (Lamothe et al., 2007; 
Deng et al., 2000; Wang et al., 2001; Wooff et al., 2004).  Although the E2 
Uev1A/Ubc13 complex has been shown to be sufficient for TRAF6 
polyubiquitination, a third E2, UbcH7, is also thought to be involved (Geetha et 
al., 2005). In addition, the E2 enzyme UbcH5, which is known to generate 
various types of polyubiquitin chains, is also thought to play a role in TRAF6 
polyubiquitination and subsequent downstream activation (Xia et al., 2009; Chen 
et al., 1996).  
Polyubiquitinated TRAF6 acts as a scaffold, recruiting downstream 
kinases.  The MAP3 kinase TAK1 is recruited by ubiquitin-binding motifs in its 
binding partners TAB2 and TAB3 (Kanayama et al., 2004).  Serving as adaptors 
between TRAF6 and TAK1, the TAB2 and TAB3 proteins contain two ubiquitin-
binding motifs, an N-terminal CUE domain and a C-terminal nuclear protein 
localization four zinc finger (NZF) (Ishitani et al., 2003; Takaesu et al., 2000; 
Kanayama et al., 2004; Cheung et al., 2004).  Although the NZF appears to play 
a significant role in binding TAB2/3 to ubiquitinated TRAF6, the CUE domain 
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appears to be dispensable for NF-κB signaling (Kanayama et al., 2004; Kishida 
et al., 2005).
Binding of the TAB2/3-TAK1 complex to ubiquitinated TRAF6 leads to 
activation loop auto-phosphorylation of TAK1, and initiation of downstream 
signaling pathways (Takaesu et al., 2000; Jiang et al., 2002; Wang et al., 2001; 
Sakurai et al., 2000; Kishimoto et al., 2000; Xia et al., 2009).  TAK1 
phosphorylates the multi-protein IKK complex composed of three proteins; two 
kinases, IKKα and IKKβ, and a scaffold protein IKKγ (NEMO) (Hacker and Karin, 
2006; Mercurio et al., 1997; Rothwarf et al., 1998; Zandi et al., 1997).  One main 
site of IKK phosphorylation occurs in the activation loop of IKKβ which allows the 
protein to become active and further phosphorylate downstream proteins (Wang 
et al., 2001). 
It is widely thought that the ubiquitin-binding motif found on NEMO is 
responsible for bringing the IKK complex into proximity with TAK1 by binding 
K63-polyubiquitinated TRAF6 (Wu et al., 2006; Windheim et al., 2008; Xia et al., 
2009; Laplantine et al., 2009).  A number of reports, however, have indicated that 
NEMO may instead bind linear-polyubiquitin chains (Rahighi et al., 2009).  
Surprisingly NEMO has been the only protein within the NF-κB pathway shown to 
be modified by linear polyubiquitin.  Linear polyubiquitination of NEMO occurs in 
concert with the E3 proteins HOIL-1L and HOIP in a Ubc13 dependent manner, 
and in the absence of linear polyubiqiutination of NEMO, NF-κB responses are 
severely depleted (Tokunaga et al., 2009).  It is currently unclear what 
33
physiological role, if any, linear polyubiquitin plays in NF-κB signaling, or why 
there is such a discrepancy between the reported ubiquitin binding preference of 
NEMO.  One possible explanation could be the use of NEMO protein fragments 
used in in-vitro linear ubiquitin binding assays which may show an altered binding 
specificity when compared to the full length protein. 
Evidence has been presented indicating that the mere presence or 
absence of polyubiquitin chains may be more important than the substrates to 
which they are conjugated.  Work by Xia et al. (2009), shows that unanchored 
polyubuiqitin chains are able to recruit and activate both TAK1 and IKK kinases.  
While unanchored K63-polyubiquitin chains generated by the E2 complex of 
Uev1A and Ubc13 alone were able to activate TAK1 (and to a lesser degree IKK), 
the E2 enzyme UbcH5 was required to generate polyubiquitin chains which 
activated the IKK complex robustly in a NEMO-dependent manner.  The chains 
generated by UbcH5 however appeared to be neither K48 or K63-polyubiquitin 
chains, indicating that they could be either linear, or some alternative 
polyubiquitin linkage (Xia et al., 2009).
It has also been shown that NEMO can become K63-polyubiquitinated in a 
TRAF6 dependent fashion, a step that appears to be crucial for maximal IKK 
kinase activity (Sun et al., 2004).  Once activated by phosphorylation and 
perhaps ubiquitination, the IKK complex phosphorylates the NF-κB inhibitory 
protein IκB, signaling the protein to become K48-polyubiquitinated and degraded 
by the proteosome (Chen, 2005; Hacker and Karin, 2006).  NF-κB can then freely 
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translocate into the nucleus where it binds any number of κB sites activating 
various inflammatory cytokines and cell survival genes (Hoffmann and Baltimore, 
2006).  
Aside from NF-κB signaling, activated TAK1 also phosphorylates various 
MAP2 kinase proteins, such as MKK3, -4, -6, and -7 (Chang and Karin, 2001).  
Phosphorylation of these proteins leads to the activation of both c-Jun N-terminal 
kinase (JNK) and p38.  This results in the activation and nuclear translocation of 
activator protein 1 (AP1), which promotes the induction of various pro-
inflammatory cytokines (Chang and Karin, 2001; Shim et al., 2005).
MyD88-independent signaling pathways are also present downstream of 
TLR4 (and TLR3).  In one of these pathways the adaptors TRIF and TRAM 
associate with the proteins TRAF3 and TANK to induce signaling to the IKK-like 
proteins TBK1 and IKKε (Yamamoto et al., 2003; Hacker et al., 2006; Oganesyan 
et al., 2006; Sato et al., 2003).  These kinases phosphorylate the transcription 
factors interferon regulatory factor 3 and 7 (IRF3 and IRF7), causing them to 
dimerize and translocate into the nucleus where they activate the production of 
type I interferons (Sharma et al., 2003; Fitzgerald et al., 2003).  MyD88-
independent signaling can also lead to the activation of the NF-κB pathway.  In 
this case TRIF/TRAM bind the receptor interacting protein 1 (RIP1) and in 
association with the E3 ligase TRAF6 promote the K63-polyubiquitination of 
RIP1, leading to the recruitment and activation of TAB2/3 and TAK1 and 
activation of NF-κB (Meylan et al., 2004; Sato et al., 2003). 
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Aside from acting in MyD88-independent TLR signaling, the adaptor RIP1 
also plays a significant role in the activation of NF-κB by tumor necrosis factor 
(TNF), utilizing a signaling pathway that has many overlapping components.  
TNF, binding as a trimer, forces the trimerization of the death domain containing 
TNF receptor (TNF-R1), which then interacts with the death domains of the 
adaptor protein TRADD leading to the recruitment of TRAF2 and RIP1 (Hsu et 
al., 1996a; Hsu et al., 1996b; Idriss and Naismith, 2000).  Activation of TNF-R1 
also leads to protein kinase C (PKC)δ/ε-dependent phosphorylation of TRAF2 (Li 
et al., 2009).  PKCs have traditionally been thought to be involved in T-cell and B-
cell mediated NF-κB signaling.  It is therefore unclear precisely how activation of 
TNF-R1 recruits/activates PKCδ/ε.  Phosphorylated TRAF2 then interacts with 
IKKα and IKKβ through an undetermined mechanism.  Furthermore, 
phosphorylation of TRAF2 is required for its K63-polyubiquitination, and 
subsequent recruitment of TAB2/3 and TAK1 (Li et al., 2009).  In parallel, RIP1 is 
also K63 polyubiquitinated, leading to recruitment of TAB2/3-TAK1 and NEMO/
IKK (Lee et al., 2004; Kanayama et al., 2004; Ea et al., 2006; Wu et al., 2006).  
TAK1 then goes on to activate signaling as previously discussed.
After TNF signaling has been activated TRADD, RIP1 and TRAF2 
disassociate from TNF-R1.  TRADD then utilizes its death domains to bind the 
adaptor protein FADD, recruiting caspase-8 and allowing the induction of 
apoptosis (Hsu et al., 1996a).  Although caspase-8 has traditionally been 
implicated as an activator of apoptosis, a growing body of literature indicates that 
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it also plays a role in NF-κB signaling in B-cells, T-cells and lipopolysaccharide 
(LPS) signaling.  Cells from mice or humans which lack caspase-8 show defects 
in immune activation, cytokine production and nuclear translocation of NF-κB 
(Chun et al., 2002; Sun et al., 2008; Su et al., 2005; Bidere et al., 2006; Lemmers 
et al., 2007).  However, the precise function of caspase-8 in NF-κB signaling 
remains unclear.
Polyubiquitination of RIP1 after TNF-R1 activation was largely thought to 
be the result of the E2 complex of Uev1A and Ubc13 utilizing TRAF2 as an E3 
ligase.  Recent data however shows that TRAF2 may only play a minor role as 
the E3 ligase for RIP1.  Instead the proteins cIAP1 and cIAP2 seem to play more 
significant roles in TNF induced RIP1 K63-polyubiquitination (Bertrand et al., 
2008).  Inhibitor of apoptosis (IAP) proteins have been largely thought to act in 
the inhibition of apoptosis by blocking the activity of caspases.  However, a 
number of IAP proteins have recently been implicated in signaling outside of cell 
death.  While all IAP proteins are characterized by the presence of baculovirus 
IAP repeat (BIR) domains, a number of them (including cIAP1/2) have also been 
shown to carry putative E3 ubiquitin ligase RING finger motifs strongly implicating 
them in ubiquitination.  cIAP1/2, for example, have also been associated with the 
K63-polyubiquitination of the RIP family member RIP2, following NOD signaling 
(Bertrand et al., 2009).  Although they rely on many of the same downstream 
signaling components, unlike TLR and TNF receptors which are membrane 
bound, nucleotide-binding and oligomerization (NOD)-like receptors (NLRs) act 
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as cytosolic intracellular receptors.  Upon activation of NLRs, RIP2 is K63-
polyubiquitinated by the E3 proteins cIAP1/2.  However, the precise mechanism 
by which RIP1/2 and cIAP2/3 interact remains to be resolved. 
Thesis objective
Currently a number of unanswered questions remain regarding the 
activation and regulation of innate immune signaling in both mammals and 
Drosophila.  Many homologous proteins have been shown to play roles in both 
mammalian and insect innate immunity, however, the significance, interaction 
and physiological relevance of these proteins have not been completely 
elucidated.  The work described in the following chapters was designed to utilize 
Drosophila as a model system for better understanding innate immunity of both 
vertebrates and invertebrates.  By studying Drosophila innate immune signaling I 
aim to elucidate novel mechanisms by which many of these proteins interact and 
are regulated.  It is my hope that this work can contribute to the ever growing 
body of knowledge regarding innate immunity and ultimately be used to develop 
effective and efficient treatments for pathogenic diseases.
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CHAPTER II
Caspase Mediated Cleavage, IAP Binding and Ubiquitination: Linking Three 
Mechanisms Crucial for Drosophila NF-κB Signaling.
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Abstract
Innate immune responses are critical for the immediate protection against 
microbial infection.  In Drosophila, infection leads to the rapid and robust 
production of antimicrobial peptides, through two NF-κB signaling pathways - 
IMD and Toll.  The IMD pathway is triggered by DAP-type peptidoglycan, 
common to most Gram-negative bacteria.  Signaling downstream from the 
peptidoglycan receptors is thought to involve K63-ubiquitination and caspase-
mediated cleavage, but the molecular mechanisms remain obscure.  We now 
show that PGN-stimulation causes caspase-mediated cleavage of the imd 
protein, exposing a highly conserved IAP-binding motif (IBM) at its neo-N-
terminus.  A functional IBM is required for the association of cleaved-IMD with the 
ubiquitin E3 ligase DIAP2.  Through its association with DIAP2, IMD is rapidly 
conjugated with K63-linked polyubiquitin chains.  These results mechanistically 
connect caspase-mediated cleavage and K63-ubiquitination in immune-induced 
NF-κB signaling.
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Introduction
Activation of the Drosophila IMD pathway by DAP-type peptidoglycan 
(PGN) leads to the robust and rapid production of a battery of antimicrobial 
peptides (AMPs) and other immune responsive genes (Ferrandon et al., 2007; 
Lemaitre and Hoffmann, 2007).  Two members of the peptidoglycan recognition 
protein (PGRP) family of receptors are responsible for the recognition of DAP-
type PGN, the cell surface receptor PGRP-LC and the cytosolic receptor PGRP-
LE (Kaneko et al., 2006).  DAP-type PGN binding causes these receptors to 
multimerize or cluster (Chang et al., 2006; Lim et al., 2006), and trigger signal 
transduction.  IMD signaling culminates in activation of the NF-κB precursor 
Relish and transcriptional induction of AMP genes.
Currently, the molecular mechanisms linking these PGN-binding receptors 
and activation of Relish remain unclear.  Genetic experiments suggest that the 
most receptor proximal component of the pathway is the imd protein (Georgel et 
al., 2001), while the MAP3 kinase TAK1 appears to function further downstream 
(Silverman et al., 2003; Vidal et al., 2001).  In addition to NF-κB signaling, TAK1 
also mediates immune-induced JNK signaling (Silverman et al., 2003).  The role, 
if any, that JNK signaling plays in AMP gene expression is controversial (Delaney 
et al., 2006; Kim et al., 2005).  More central to AMP gene induction, TAK1 is 
required for activation of the Drosophila IKK complex, which in turn is essential 
for the immune-induced cleavage and activation of the NF-κB precursor Relish, 
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the key transcription factor required for immune-responsive AMP gene 
expression (Silverman et al., 2000). 
Other major components in the IMD pathway include the caspase-8 like 
DREDD and its adapter FADD.  Cell-based RNAi studies suggest that these 
proteins have two distinct roles in IMD pathway signaling, one relatively early in 
the cascade and the second further downstream.  Using RNAi, DREDD and 
FADD were shown to be required for immune-induced activation of the IKK 
complex (Zhou et al., 2005).  These data further suggested that DREDD and 
FADD function downstream of IMD but upstream of TAK1, however their precise 
function remained unclear.  In its second role, DREDD is thought to play a key 
role in the endoproteolytic cleavage of Relish, the ultimate cytoplasmic event in 
IMD signaling (Stöven et al., 2003; Erturk-Hasdemir et al., 2009). 
In addition to the components outlined above, several studies have 
suggested that ubiquitination plays a critical, positive role in the IMD signaling 
cascade.  Recently, Drosophila Inhibitor of Apoptosis 2 (DIAP2) was shown to be 
a crucial component of the IMD pathway (Gesellchen et al., 2005; Huh et al., 
2007; Kleino et al., 2005; Leulier et al., 2006).  Typical of IAP proteins, DIAP2 has 
three N-terminal BIR domains, which are involved in interactions with other 
proteins carrying conserved IAP binding motifs (IBMs) (Wu et al., 2000).  In 
addition, some IAPs, including DIAP2, carry a C-terminal RING finger domain 
that provides these proteins with ubiquitin E3 ligase activity (Vaux and Silke, 
2005).  Although it is not precisely clear where in the pathway DIAP2 functions, 
43
one study showed that the RING finger is indispensable for its role in the immune 
response, suggesting it operates as an E3 ubiquitin ligase in IMD signaling (Huh 
et al., 2007).  Also, Zhou et al. (2005) showed, using RNAi-based approaches, 
that the E2 ubiquitin conjugating enzymes Uev1a and Ubc13 (bendless) are 
critical components of the IMD pathway.  Notably, Ubc13 and Uev1a function 
together in a complex to generate K63-linked polyubiquitin chains.  K63-
polyubiquitin chains are not linked to proteasomal degradation but, instead, are 
thought to play regulatory roles (Chiu et al., 2009; Mukhopadhyay and Riezman, 
2007; Xia et al., 2009).  Although no connection between DIAP2 and the Ubc13/
Uev1a E2 complex has been established, one attractive scenario is that DIAP2 
functions as an E3 together with the Ubc13-Uev1a E2 complex.
Previous work has suggested that Ubc13, Uev1a, DREDD and FADD all 
function downstream of IMD but upstream of TAK1.  In fact, it was predicted that 
DREDD may play a role as an accessory protein for K63-ubiquitination in IMD 
signaling (Zhou et al., 2005).  However, it was not established if the upstream 
role for DREDD involves its protease activity.  Moreover, no K63-ubiquitinated 
target protein(s) have been identified in the IMD pathway.  Thus, the molecular 
mechanisms that link the caspase DREDD and K63-ubiquitination to the 
activation of the IMD pathway are undefined.
The imd1 allele is a strong hypomorphic mutation that impairs innate 
immune responses.  Surprisingly, this allele encodes a conservative amino acid 
substitution, alanine (A) to valine (V) at position 31, which lies outside the death 
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domain of IMD and is positioned in a region with no obvious structural motifs 
(Georgel et al., 2001).  Thus, the reason for the strong hypomorphic phenotype 
associated with the A31V substitution remains unclear.  In this work, we 
demonstrate that imd protein is rapidly cleaved following PGN-stimulation.  
Cleavage requires the caspase DREDD and occurs at caspase recognition motif, 
27LEKD/A31, creating a neo-N-terminus at A31 that is critical for the immune-
induced association of IMD with DIAP2.  Substitution of the neo-N-terminus with 
valine, as in imd1, disrupts the IMD-DIAP2 interaction.  Moreover, once 
associated with DIAP2, cleaved-IMD is rapidly K63-polyubiquitinated.  Together, 
these data resolve a number of outstanding questions in IMD signal transduction 
and present a novel molecular mechanism linking caspase-mediated-cleavage to 
NF-κB activation.
Results
Signal-induced modification of IMD
Previous evidence suggested that the apical caspase DREDD plays a 
crucial role in the IMD pathway upstream of TAK1 activation (Zhou et al., 2005).  
To determine if proteolytic activity is required upstream in the IMD pathway, the 
caspase inhibitor zVAD-FMK was utilized.  Immune responsive Drosophila S2* 
cells were treated with zVAD-FMK (or vehicle control) prior to stimulation with E. 
coli peptidoglycan (PGN).  Treatment with caspase inhibitor suppressed the 
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activation of TAK1 kinase, as monitored by in-vitro IP-kinase assay.  zVAD-fmk 
also prevented accumulation of phospho-JNK (Figure 2.1A)
Hypothesizing that IMD signaling results in the DREDD-mediated 
cleavage of an upstream signaling component, we next examined the fate of 
endogenous imd protein.  Peptidoglycan stimulation of S2* cells resulted in the 
rapid, signal dependent modification of IMD (Figure 2.1B).  The faster migrating 
IMD product did not accumulate in the presence of caspase inhibitor (Figure 
2.1C), suggesting that it represents an IMD cleavage product.  Cleavage of IMD 
appeared very rapidly, within one minute, and peaked between 10 and 30 
minutes.  Treatment of S2* cells with RNAi targeting either DREDD and FADD, 
prior to stimulation with peptidoglycan, resulted in a noticeable decrease in IMD 
cleavage, and accumulation of full length IMD (Figure 2.1D).  Furthermore, over 
expression of wild type DREDD (WT), but not a catalytically inactive mutant (CA) 
or the the caspase DRONC, from the copper inducible metallothionein promoter 
resulted in the cleavage of IMD, independent of any immune stimulus (Figure 
2.1E).  Together these results suggest that the proteolytic activity of DREDD is 
required for the cleavage of IMD. 
A slower migrating form of IMD was also detectable following immune 
stimulation.  λ phosphatase treatment resolved this higher molecular weight 
species, indicating that it is a phosphorylated isoform of IMD (Figure 2.2).  
Interestingly, RNAi-mediated knockdown of TAK1, DIAP2 or Uev1a and Ubc13 
resulted in reduced levels of phospho-IMD (Figure 2.1D), suggesting that TAK1 
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Figure 2.1 Dredd-dependent cleavage of IMD
(A) S2* cells were treated with zVAD-FMK or vehicle control (DMSO) prior to 
stimulation with peptidoglycan for 30 minutes.  TAK1 kinase activity, assayed by 
TAK1 IP-kinase assay, was reduced in the presence of zVAD-FMK, compared to 
controls.  Similarly, a reduction of phospho-JNK was also observed, by 
immunoblotting. 
(B) S2* cells were stimulated with peptidoglycan from 0 to 120 minutes, as 
indicated, and endogenous-IMD was monitored in whole cell lysates by 
immunoblotting.
(C) Endogenous IMD was monitored in S2* cell lysates after pretreatment with 
zVAD-FMK followed by PGN stimulation.
(D) Endogenous IMD was monitored by IP-immunoblotting in lysates from S2* 
cells after treatment with RNAi against various IMD pathway components, as 
indicated.
(E) Endogenous IMD was monitored in S2* cell lysates after expression of 
DREDD-WT, DREDD-CA or DRONC.  Caspases were expressed from the 
metallothionein promoter by addition of copper sulfate for 6 hours.  DREDD-CA is 
a catalytically inactive mutant.  All 3 caspases were robustly expressed (data not 
shown).
In all cases,  marks unmodified full length IMD,  highlights phosphorylated 
IMD, and  marks the cleaved-IMD products.
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Figure 2.2
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Figure 2.2 IMD is phosphorylated
Whole cell lysates from PGN-stimulated S2* cell lysates were treated with λ-
protein phosphatase and immunoblotted with IMD antisera.
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may be responsible for phosphorylating IMD in some sort of regulatory loop.  This 
phosphorylation event may regulate signaling, but will require further study.
DIAP2 functions between IMD and TAK1
To examine how IMD cleavage might be linked to downstream signaling 
events such as K63-ubiquitination, we sought to more carefully characterize the 
role of DIAP2, a putative ubiquitin E3-ligase, in this pathway.  As previously 
shown, DIAP2 RNAi markedly inhibited the induction of the antimicrobial peptide 
gene Diptericin following immune stimulation with DAP-type peptidoglycan, 
similar to RNAi targeting PGRP-LC or IKKγ, as analyzed by Northern blotting, 
(Figure 2.3A) (Gesellchen et al., 2005; Huh et al., 2007; Kleino et al., 2005; 
Leulier et al., 2006).  Using a stable S2* cell line that expresses imd from the 
metallothionein promoter, AMP gene expression can be induced by the addition 
of copper (Zhou et al., 2005).  DIAP2 RNAi also inhibited Diptericin induction in 
this assay (Figure 2.3B), similar to RNAi targeting Uev1a and Ubc13 or TAK1, as 
shown previously (Zhou et al., 2005).  In contrast, RNAi mediated knockdown of 
PGRP-LC did not inhibit IMD-induced signaling.  These results suggest that 
DIAP2, TAK1, Ubc13 and Uev1a, but not PGRP-LC, function downstream of 
IMD.  
In addition, the activation of the two downstream kinases, TAK1 and IKK, 
was directly assayed by immunoprecipitation-kinase assays.  PGN-induced 
activation of both kinases required DIAP2 (Figure 2.3C).  Together these data 
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Figure 2.3 DIAP2 functions between IMD and TAK1
(A) S2* cells were treated with RNAi against various IMD pathway components, 
as indicated, prior to stimulation with E.coli peptidoglycan (PGN) for 6 hours.  
Induction of the AMP gene Diptericin was monitored by Northern blotting.  rp49 
levels were monitored as a loading control.
(B) S2* cells stably expressing metallothionein IMD were treated with RNAi 
against various IMD pathway components, as indicated.  Then cells were 
stimulated with copper sulfate for 6 hours to induce IMD expression.  Expression 
of the AMP gene Diptericin and rp49 were monitored by Northern blotting.
(C) The activation of TAK1 or IKK kinases was monitored by 
immunoprecipitation-in vitro kinase assays, after stimulation with E. coli PGN for 
10 minutes.  Recombinant MKK6K28A and recombinant Relish were used as 
substrates for TAK1 and IKK, respectively.  RNAi was used to target various IMD 
pathway components, as indicated
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argue that DIAP2 functions downstream of IMD but upstream of TAK1, similarly 
to Ubc13 and Uev1a (Zhou et al., 2005).
Cleaved IMD associates with DIAP2 and is ubiquitinated
As IMD is rapidly cleaved following immune stimulation and DIAP2 
appears to function immediately downstream, we hypothesized that these two 
proteins may associate.  To that end, endogenous DIAP2 was 
immunoprecipitated from PGN-stimulated and unstimulated S2* cells.  
Endogenous IMD co-precipitated with DIAP2 in a signal dependent fashion 
(Figure 2.4A).  Strikingly, DIAP2 preferentially associated with cleaved-IMD.  
Overall, the amount of IMD cleavage observed in whole cell lysates varied, 
ranging from 5% to 15% of the total, while the cleaved IMD was preferentially 
(50-70%) associated with immunoprecipitated DIAP2.  
These results, linking cleaved IMD and the E3-ligase DIAP2, suggest that 
one or both of these proteins may be conjugated with ubiquitin.  Using 
immunoprecipitation followed by immunoblotting for total ubiquitin, IMD was 
found to be ubiquitinated rapidly and robustly after PGN stimulation of S2* cells 
(Figure 2.4B).  DIAP2 was also ubiquitinated, but to a lesser extent (Figure 2.4C 
and Figure 2.5A).  This modification occurs within one minute of stimulation, 
reaching a maximum at 5-10 minutes, and is lost in approximately 30 minutes.  
IMD ubiquitination is stable after boiling in 1% SDS, further arguing that it is 
directly conjugated (Figure 2.5B).  IMD cleavage, DIAP2 association, and 
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Figure 2.4
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Figure 2.4 Association of DIAP2 and cleaved-IMD leads to IMD 
ubiquitination
(A) Endogenous DIAP2 was immunoprecipitated from whole cell lysates 
prepared from S2* cells before or after a 10 minute stimulation with E. coli PGN, 
and associated IMD was monitored by immunoblotting (left lanes).  For 
comparison, levels of full length and cleaved IMD in whole cell lysates are shown 
on the right.   marks unmodified full length IMD,  highlights phosphorylated 
IMD, and  marks the cleaved-IMD products.
(B) Ubiquitination of endogenous IMD was monitored in lysates from S2* cells 
after stimulation with E. coli PGN for various times (as indicated) by anti-IMD 
immunoprecipitation followed by immunoblotting with anti-UbPan (top).  An anti-
IMD immunoblot serves as a loading control (bottom). 
(C) Ubiquitination of endogenous DIAP2 was monitored in lysates from S2* cells 
after stimulation with E. coli PGN for various times (as indicated) by anti-DIAP2 
immunorecipitation followed by immunoblotting with anti-UbPan.  An anti-DIAP2 
immunoblot serves as a loading control (bottom). 
(D) Ubiquitination of endogenous IMD in PGN-stimulated S2* cells was 
monitored after RNAi targeting various pathway members (top).  An anti-IMD 
immunoblot serves as a loading control (bottom). 
(E) Ubiquitination of endogenous IMD after PGN-stimulation was monitored after 
treatment with RNAi targeting various E2-ubiquitin conjugating enzymes (top).  
An anti-IMD immunoblot serves as a loading control (middle).  In parallel, IMD
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Figure 2.4 Association of DIAP2 and cleaved-IMD leads to IMD 
ubiquitination (cont.)
pathway activation was also monitored by Northern blotting for the AMP gene 
Diptericin.  The ratio of Diptericin to Rp49 message was quantified by 
phosphoimager and plotted (bottom).  Y-axis is arbitrary normalized 
phosphoimager units.  
(F) Ubiquitination of endogenous IMD in S2* cells was monitored after treatment 
with zVAD-FMK, or vehicle control (DMSO) (top).  An anti-IMD immunoblot 
serves as a loading control (bottom).
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Figure 2.5 DIAP2 is ubiquitinated
(A) 200 µg or 600µg of S2* cell lysates were immunoprecipiated for endogenous 
IMD or DIAP2, respectively.  Samples were then run side-by-side and 
immunoblotted with endogenous ubiquitin antibody.  IMD and DIAP2 blots are 
also shown as a loading control, lower panels. 
(B) Endogenous IMD was immunoprecipitated from standard S2* lysate (Std.) or 
lysates that had been boiled with 1% SDS (B-SDS).  Samples were then 
immunoblotted for endogenous ubiquitin.  IMD blots are shown as a loading 
control, below. 
(C) PGN-induced ubiquitination of endogenous DIAP2 in lysates from S2* cells 
was monitored after pretreatment with zVAD-FMK, or vehicle control (DMSO).  
An anti-DIAP2 immunoblot serves as a loading control.
(D) PGN-induced ubiquitination of endogenous DIAP2 in lysates from S2* cells 
treated with RNAi to various IMD pathway. An anti-DIAP2 blot serves as a 
loading control.
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ubiquitination were also all analyzed together (Figure 2.6).  This experiment 
demonstrates that IMD ubiquitination peaks shortly after cleavage and maximal 
DIAP2 association.
In order to determine which members of the IMD pathway are required for 
PGN-induced IMD ubiquitination, S2* cells were treated with RNAi targeting 
various pathway components, and then analyzed by IMD immunoprecipitation 
and ubiquitin immunoblotting.  PGRP-LC, IMD, DREDD, FADD, and DIAP2 RNAi 
markedly reduced IMD ubiquitination. Conversely, targeting of downstream 
components, such as TAK1 or IKKγ, did not robustly affect IMD ubiquitination 
(Figure 2.4D).  Previously, the E2 complex of Ubc13, and Uev1a was implicated 
in IMD pathway ubiquitination.  RNAi treatment targeting both of these proteins 
(separately and together), reduced but did not eliminate the ubiquitination of IMD 
after stimulation (Figure 2.4E, lanes 6-8) similar to their partial effect on immune-
induced Diptericin expression (Zhou et al., 2005 and Figure 2.4E).  Recently, it 
has been suggested that another E2, Ubc5, may also form K63-ubiquitin chains 
(Xia et al., 2009).  Therefore, we determined if the Drosophila Ubc5 homologue, 
Effete, was also required for IMD ubiquitination.  RNAi targeting Effete, in concert 
with Ubc13, or Uev1a (together or separately) were able to completely inhibit 
ubiquitination of IMD (Figure 2.4E, lanes 3-5).  Similarly, when Diptericin 
induction was analyzed, RNAi targeting Uev1a, Bend or Effete alone or in pairs 
only partially inhibited IMD signaling, while treatment with all three RNAis nearly 
abolished immune-induced Diptericin expression (Figure 2.4E, bottom). 
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Figure 2.6 Coincident IMD ubiquitination, cleavage and DIAP2 association 
Lysates from S2* cells stimulated with PGN for various times (as indicated) were 
immunoprecipitated for endogenous IMD or DIAP2.  Immunoprecipiated IMD 
samples were then immunoblotted for endogenous ubiquitin and endogenous 
IMD.  Immunoprecipitated DIAP2 samples were probed with endogenous IMD 
and DIAP2.  marks unmodified full length IMD,  highlights phosphorylated 
IMD,and  marks the cleaved-IMD products.
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Moreover, pretreatment with the caspase inhibitor zVAD-FMK reduced the 
amount of ubiquitinated IMD observed (Figure 2.4F), consistent with above data.  
DIAP2 ubiquitination similarly required these same factors (Figure 2.5C and 
2.5D).  Together, these results indicate that cleaved IMD and DIAP2 associate, 
triggering their Uev1a/Bend/Ubc5 dependent ubiquitination.
DIAP2 is the E3 for IMD K63-polyubiquitination in vivo
Strikingly, infection-induced IMD ubiquitination was readily detectable 
when IMD was immunoprecipitated from lysates extracted from adult flies, 30 
minutes after septic infection with E. coli.  As expected, diap2 null flies, diap27c, 
show no IMD-ubiquitination following infection with E. coli (Figure 2.7A).  
Previously, the RING finger of DIAP2 was shown to play an important role in the 
IMD pathway (Huh et al., 2007).  Therefore, we next sought to determine if this 
domain was required for IMD-ubiquitination.  Transgenic rescue flies, expressing 
wild type DIAP2 from the daughterless-gal4/UAS system were able to rescue the 
diap27c IMD ubiquitination phenotype.  However expression of a RING finger 
mutant of DIAP2 (DIAP2C466Y) was unable to rescue this phenotype (Figure 2.7A, 
right panels).  These data demonstrate that IMD is ubiquitinated in a signal-
dependent manner in flies, and that the DIAP2 RING finger is critical for this 
ubiquitination.  These results strongly suggest that DIAP2 is the E3-ligase 
involved in for IMD modification.
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Figure 2.7
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Figure 2.7 IMD is K63-polyubiquitinated
(A) Ubiquitination of endogenous IMD from adult flies was monitored after 
infection with live E. coli (top).  An anti-IMD immunoblot serves as a control 
(middle,  marks unmodified full length IMD,  highlights phosphorylated 
IMD,and  marks the cleaved-IMD product).  IMD ubiquitination was monitored 
in wildtype (DD1), diap27c (null), and diap27c expressing transgenic wildtype (WT) 
or RING-finger mutated (RF) DIAP2.  anti-DIAP2 immunoprecipitation verifies the 
presence/absence of DIAP2 protein in the various mutant Drosophila lines, as 
indicated. 
(B) Total K63-linked (left) or K48-linked (right) polyubiquitin chains were 
immunoprecipiated from denatured cell lysates prepared from S2* cells 
stimulated with PGN for various times, as indicated.  The presence of IMD was 
then monitored by IMD immunoblotting (top).  Subsequently the same 
membranes were then probed for total ubiquitin as a control (bottom).
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The data implicating Ubc13 (bendless) and Uev1a in this pathway (Zhou 
et al., 2005), suggest that IMD may be modified with K63-linked polyubiquitin 
chains.  In order to clarify if IMD is conjugated with K48- or K63-polyubiquitin 
chains, we took advantage of two monoclonal antibodies that are specific to 
either K48- or K63-polyubiquitin chains (Mollah et al., 2007).  After denaturing 
lysis, these antibodies were used to immunoprecipitate ubiquitin conjugated 
proteins from PGN-stimulated S2 cells.  These immunoprecipitated samples were 
then analyzed by immunoblotting for IMD.  These experiments demonstrate that 
IMD is strongly K63-ubiquitinated in a PGN-inducible manner, peaking at 
approximately 10 minutes after stimulation (Figure 2.7B), while negligible IMD 
was detected in the K48-immunoprecipitated samples.  Control probing of these 
blots, with an antibody that recognizes all ubiquitin forms, showed that the K63- 
and K48-specific antibodies immunopurified similar amounts of ubiquitin-
conjugated material. These data demonstrate that IMD is conjugated with K63-
linked polyubiquitin chains.  
Non-cleavable IMD prevents signaling
We next sought to identify the IMD cleavage site and determine how IMD 
cleavage might be linked to association with DIAP2 and K63-ubiquitination.  
Based on experiments with either N- or C-terminally epitope-tagged IMD (data 
not shown) and the size of the cleaved product (~30 kDa), the site of cleavage 
was tentatively mapped to the N-terminal region of IMD.  The involvement of the 
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caspase DREDD further suggested a candidate cleavage site after residue 30, in 
the motif 27LEKD/A31.  Wild type or D30A mutant versions of IMD, with epitope 
tags at both the C- and N-termini, were expressed in S2* cells by stable 
transfection, using the constitutive actin promoter.  Double-tagged wild type IMD 
showed the expected cleavage and ubiquitination kinetics after stimulation with 
PGN, as detected with the C-terminal FLAG-tag (Figure 2.8A).  The N-terminal 
T7-tag did not detect cleaved-IMD (data not shown).  With the aspartate at the 
putative cleavage site substituted with alanine (D30A), no PGN-induced cleavage 
was observed (Figure 2.8A, lower panel, right lanes), suggesting that caspase-
mediated cleavage of IMD occurs at this position.  Furthermore, IMDD30A acted as  
a dominant negative, blocking the PGN-induced ubiquitination of endogenous 
IMD (Figure 2.8A, upper panel, right lanes), and blocking downstream IMD 
signaling as monitored by analysis of Diptericin expression (Figure 2.8B).  
Similarly, transgenic flies, over expressing IMDD30A show a marked inhibition of 
Diptericin induction following E. coli challenge (Figure 2.8C).  These data strongly 
argue that cleavage of IMD occurs between residues 30 and 31, and that this 
cleavage is required for ubiquitination and activation of downstream target genes. 
Using a series of IMD deletion mutants we also analyzed which regions of 
IMD were required for signal induced ubiquitination (Figure 2.8D).  As shown 
previously, over expression of wild type IMD drives IMD pathway signaling 
(Figure 2.3B).  Interestingly only IMD∆1 and IMD∆5 were unable to drive 
signaling after over expression (Figure 2.8E and data not shown).  The region 
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Figure 2.8 Uncleavable IMD is a dominant negative
(A) Total ubiquitinated IMD was monitored by immunoprecipitation/Ubpan 
immublotting, in cells stably expressing either WT or mutant (D30A) IMD from the 
actin promoter (top). The lower anti-FLAG blot monitors cleavage of the WT or 
D30A IMD. 
(B) Northern blot analysis of Diptericin expression was used to monitor IMD 
pathway signaling in cells over expressing WT or D30A IMD, before and after 
stimulation with E. coli PGN. 
(C) Northern blot analysis of Diptericin expression was used to monitor IMD 
pathway signaling in flies expressing a transgenic copy of UAS-IMDD30A under 
the control of ubiquitous daughterless-Gal4 driver (top).  Quantitation of these 
data is presented below.
(D) A map of IMD deletions used to analyze signaling activity is shown. The 
caspase cleavage (LEKD) and IAP binding motif (AAPV) domains are indicated.  
The C-terminal death domain is indicated in grey. 
(E) Wile type IMD or IMDΔ5 was stably expressed in S2* cells from the copper 
inducible metallothionein promoter.  Activation of immune signaling was 
monitored by Northern blotting for Diptericin. Rp49 blot serves as a loading 
control. 
(F) Ubiquitination of  wild type IMD or IMD∆5 was monitored in two conditions.  
(Left) IMD protein was expressed at high level by addition of high copper for 5 
hours, identical to that seen in panel E. (Right) IMD protein was moderately 
expressed, with lower copper for only 1 hour,  and then cells were stimulated with 
PGN.  In both cases, IMD was then immunoprecipitated with FLAG antibody, and 
ubiquitination levels were assayed by immunoblotting for ubiquitin.  FLAG blot 
(bottom) serves as a control for the levels of IMD immunoprecipitated.
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removed in the IMD∆1 construct contains the IMD cleavage site, which is critical 
for signaling, as shown above, via its involvement in DIAP2 interaction (see 
below for more details).  In order to determine if the region removed in IMD∆5 
functions in ubiquitination, imd protein was analyzed in two ways.  First, IMD was 
strongly over expressed from the metallothionein promoter, at a level strong 
enough to induce AMP expression (Figure 2.8F, left).  Second, IMD was 
expressed at lower levels, before cells were stimulated with PGN (Figure 2.8F, 
right). In both cases wild type IMD shows robust ubiquitination after activation, 
while IMD∆5 shows no ubiquitination over background. These data indicated that 
this region of IMD is crucial for signal induced ubiquitination and the induction of 
downstream target genes. 
IMD Cleavage Exposes an IAP-Binding Motif
BIR domains, such as those found in DIAP2, preferentially bind to 
unblocked N-terminal alanines, generated either by removal of the initiating 
methionine or endoproteolytic cleavage.  These exposed neo-N-terminal alanines 
are invariant components of  IAP-binding motifs (IBMs), which also include a 
strong preference for proline at position 3 (Shi, 2004).  In particular, the DIAP1 
BIR1 domain associates with the neo-N-termini IBM of the cleaved caspases 
drICE and DCP-1 (Tenev et al., 2005).  Likewise, cleavage of IMD at D30 
exposes a putative IBM sequence with an initial alanine and a proline at position 
three (AAPV).  Moreover, both the proposed caspase cleavage site and this IBM 
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are highly conserved in the imd protein from 12 Drosophila species and the 
Anopheles mosquito (Figure 2.9A, highlighted in blue and red respectively).
Interestingly, the imd1 allele substitutes alanine 31 with valine, altering the 
key residue of the IBM.  Although a fairly conservative change, this substitution 
generates a strong hypomorphic phenotype through unknown mechanisms 
(Georgel et al., 2001).  To test whether cleaved IMD exposes a bona fide IBM we 
assessed whether DIAP2 interacted with cleaved-wild type IMD (A31) or cleaved-
mutant (V31) IMD.  To this end, we used the ubiquitin-fusion technique to 
express IMD31-273 (Varshavsky, 2000), which generates IMD with an unblocked N-
terminal IBM.  In this system, ubiquitin is fused to the test proteins A31-IMD31-273 
or V31-IMD31-273.  Ubiquitin-specific proteases  co-translationally cleave these 
fusion proteins at the C-terminus of the Ub moiety (Bachmair et al., 1986; 
Hershko, 1983), yielding the test protein A31-IMD31-273 or V31-IMD31-273 (Figure 
2.10).  Wild type A31-IMD31-273 robustly interacted with DIAP2 (Figure 2.9B, lane 
marked AAPV).  However, V31-IMD31-273, equivalent to the cleavage product 
expected from the imd1 allele, showed markedly reduced binding to DIAP2 
(Figure 2.9B, lane marked VAPV).  Also, in transient transfections, full length IMD 
was spontaneously cleaved at a low level (Figure 2.9B, lower left panels), and 
only the cleaved product associated with cotransfected DIAP2, consistent with 
the data examining the endogenous proteins.  
In order to verify the importance of the neo-N-terminal alanine on IMD 
pathway signaling, we over expressed IMD-A31V in S2* cells from the actin 
71
Figure 2.9
72
50
37
25
50
37
25
IB: 
!HA-IMD
IP: !IMD
IB: !UbPan
A
B
D
E
C
IP: !IMD
IB: !IMD
IB:
!HA-IMD
GTC-DIAP2 - + + +
IMD-HA FL VA
PV
FL AA
PV
IB:
!DIAP2
IB:
!DIAP2
G
S
T-
pu
rif
ic
at
io
n
Ly
sa
te
100
75
100
75
0E.coli (m) 30 60 0 30 60 0 30 60 0 30 3060
225
150
102
76
52
31
38
im
dS
ha
d
DD1 imd1 dreddB118
PGRP-
LC!E/LE112
IB: !V5-
IMD 
IB: !V5-
IMD 
G
S
T-
pu
rif
ic
at
io
n
Lysate
IB:
!DIAP2
GTC-DIAP2
AAPV-Imd V5
FL "R
IN
G
"R
IN
G 
C1
49
G
"R
IN
G 
C2
49
G
"R
IN
G 
C1
49
/24
9G
-
                                                 Total Identity
D.mel    20 PTPVEGRLEKD AAPVDDNEPDNNNSGALALPS 51      100%
D.sim    20 PTPVEGRLEKD AAPVDDNEPANNNSGALALPF 51      97.8%
D.sec    20 PTPVEGRLEKD AAPVDDNEPANNNSGALALHF 51      96%
D.yak    20 PKPVEGRLEKD AAPVDDNESDNNNSGALALPS 51      93.8%
D.ere    20 PKTVEGRLEKD AALVDENESDNNNSGALALPS 51      91.9%
D.ana    20 ED--EGRLEKD AAPVDDSEGDNNNSGALSLPS 49      84.2%
D.pse    21 MQ-SEGRLETD AAPVHDSEADNNNSGALALPS 51      82.2%
D.per    21 MQ-SEGRLETD AAPVDDSGADNNNSGALALPS 51      81.9%
D.moj    28 MS-AEGRLETD ALPV--SEADNDNSGALSLTS 56      74%
D.vir    23 MN-SEGRLETD ALPI--SETDN-NSGALSLPS 50      71.9%  
D.wil    29 ATATEGHLETD ALPVLDEEQDNINSGALSLPS 60      69.9%
D.gri    24 MNTEEGRLETD ALPI--SEEDN-NSGALSLAS 52      71.8%
A.gam    19 ------KLETD AAPLP-PRRKADAYGDETMAH 43      28.7%
Dipt
LacZ UTR LacZ UTR LacZ UTR
IMDWT IMDD30A IMDA31V
-PGN + - + - + - + - + - +
Rp49
Figure 2.9 IMD A31 is required for DIAP2 association
(A) An alignment of IMD from 12 Drosophila species and the Anopheles mosquito 
show conservation in the caspase cleavage site (blue), and IAP-binding motif 
(red). 
(B) The binding of WT and mutant cleaved-IMD proteins was monitored using the 
ubiquitin-cleavage technique.  HA tagged full length (FL), A31-IMD31-273 (AAPV) 
or V31-IMD31-273 (VAPV) were co-expressed in cells along with GTC-DIAP2.  
GST purification and immunoblotting for anti-HA were used to monitor IMD/
DIAP2 association. 
(C) Northern blot analysis of Diptericin expression was used to monitor IMD 
signaling in cells expressing WT, D30A or A31V IMD after treatment with RNAi to 
LacZ or imd 3ʼ UTR. 
(D) Ubiquitination of endogenous IMD from WT (DD1) and various mutant adult 
flies was motioned after infection with live E. coli via IMD immunoprecipitation 
followed by UbPan immunoblotting (top).  IMD immunoblot is shown as a loading 
control (bottom).   marks unmodified full length IMD,  highlights 
phosphorylated IMD,and  marks the cleaved-IMD product. 
(E) Association of IMD and DIAP2 mutants was monitored via GST-
coprecpitation, as in panel B.
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Figure 2.10 Ubiquitin fusion technique
imd protein from residues 31-273 was expressed with the N-terminal ubiquitin 
fusion technique.  Once translated, ubiquitin-specific proteases (UBPs) remove 
the ubiquitin moiety.  The remaining target protein is left with an exposed neo-N-
terminal residue.  Two such proteins were expressed in this fashion, A31-
IMD31-273 (WT) and V31-IMD31-273 (imd1).
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promoter.  Cells were treated with RNAi against the 3’ UTR region of IMD, to 
remove the endogenous wild type protein, or LacZ (as a control) prior to 
stimulation with PGN.  As expected, expression of IMD-D30A shows a strong 
dominant negative phenotype, consistent with previous data.  On the other hand, 
cells expressing IMD-A31V and treated with the control LacZ RNAi showed a 
strong Diptericin induction.  Treatment with IMD 3’UTR RNAi, which selectively 
degrades endogenous, but not ectopically expressed IMD, resulted in a near 
complete inhibition of Diptericin induction, showing that IMD-A31V is not 
sufficient for signaling in cells, as observed in flies (Figure 2.9C).
In order to probe whether or not these same mechanisms are involved in 
immune signaling in the whole animal, IMD cleavage and ubiquitination was also 
probed in the the imd1 strain, which carries the A31V substitution.  In lysates 
prepared from these flies, cleaved IMD was readily detected following E. coli 
infection but ubiquitinated IMD was completely absent (Figure 2.9D).  In fact, the 
cleaved IMD product appears to accumulate in the imd1 animals, relative to the 
wild type control, presumably because cleaved IMD is rapidly and efficiently 
ubiquitinated in wild type but not imd1 animals.  Likewise, cleaved IMD is more 
easily detected in the diap2 mutant strain (Figure 2.7A).  On the other hand, 
neither cleaved nor ubiquitinated IMD was detectable in either dredd, or PGRP-
LE;PGRP-LC mutant animals, consistent with the results from cell culture.  
In order to determine which domains of DIAP2 are required for the binding 
of cleaved IMD, a series of DIAP2 mutations were generated.  A C149G mutation 
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of BIR2, predicted to abrogate its IBM binding (Ribeiro et al., 2007), reduced 
IMD31-273 association.  Under the same conditions, mutation of the BIR3 domain 
(C249G) did not affect the interaction with IMD31-273.  When both BIR2 and BIR3 
domains were altered (C149/249G), IMD31-273 completely failed to interact (Figure 
2.9E).  As expected, the RING finger domain did not contribute to IMD binding, 
since its deletion had no noticeable effect on IMD31-273 binding.  Together these 
results indicate that cleaved IMD carries a bona fide IBM at its neo-N-terminus, 
which preferentially binds to the BIR2 of DIAP2, and to some extent also binds 
the BIR3 domain.  The alanine at the N-terminus of the IMD cleavage product is 
critical for this binding, while valine at this position, as in imd1, weakens with the 
interaction.  
Discussion
In previous work, we demonstrated that the caspase-8 like protease 
DREDD and its binding partner FADD are required upstream in the IMD pathway, 
at a position similar to Ubc13 and Uev1a (Zhou et al., 2005).  However it was not 
clear from these studies if the protease activity of DREDD is also required in this 
role upstream in the IMD pathway.  Here, we show that upon immune stimulation 
the imd protein is rapidly cleaved in a DREDD and FADD dependent manner.  In 
fact, expression of DREDD, without immune stimulation, was sufficient to cause 
IMD cleavage.  A caspase recognition site was identified in IMD, with cleavage 
predicted to occur after aspartate 30.  Substitution of this residue with alanine 
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prevents signal-induced cleavage and creates a dominant-negative allele of imd.  
This putative cleavage site in IMD (27LEKD/A31) is similar to the Relish cleavage 
site (542LQHD/G546), consistent with the notion that both proteins are cleaved by 
the same protease.  Likewise, when IMD cleavage was blocked by caspase 
inhibitors, IMD was no longer ubiquitinated.  Alignment of imd protein sequences 
from 12 Drosophila species and the Anopheles mosquito showed that the 
cleavage site is highly conserved (LEKD or LETD in all cases).  These findings 
strongly argue that IMD cleavage after position 30 is mediated by DREDD, and 
that this cleavage is critical for further downstream signaling events.  
Cleavage of IMD exposes a highly conserved IAP-binding motif (IBM) 
(Figure 2.9A), which then binds the BIR 2/3 domains of DIAP2.  In the context of 
programmed cell death regulation, these IBM motifs are best defined by their 
neo-N-terminal alanine as well as the proline at position 3, both of which are also 
present in cleaved-IMD, supporting the notion that IMD includes an IBM starting 
at position 31.  The notion that IMD carries an IBM also provides a molecular 
explanation for the hypomorphic phenotype observed in the imd1 mutant, which 
carries a valine substitution for this alanine at position 1 of cleaved IMD.  
Although several IAP proteins have been implicated in mammalian innate 
immune/NF-κB signaling (Deveraux and Reed, 1999; Verhagen et al., 2001; 
Bertrand et al., 2008; Bertrand et al., 2009), the significance of their associated 
BIR domains, as well as their possible binding to proteins with exposed IBMs, 
has remained largely unexplored.  We show here, for the first time, that the BIR/
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IBM association plays a crucial role in innate immune NF-κB signaling in 
Drosophila.  These findings present a novel role for the BIR-IBM interaction 
module outside of the cell death arena.
Furthermore, characterization of signaling in the imd1, diap2, dredd and 
PGRP-LC/LE mutant flies provides critical in vivo verification of the cell culture 
data and leads to the model presented in Figure 2.11.  In particular, the molecular 
mechanism we propose suggests that immune stimulation leads to the DREDD-
dependent cleavage of IMD, perhaps by recruiting IMD, FADD and DREDD to a 
receptor complex.  Consistent with this aspect of the model, dredd mutants and 
receptor mutants failed to cleave (or ubiquitinate) IMD following infection.  Once 
cleaved, the exposed IBM of IMD interacts with BIRs 2 & 3 of DIAP2.  Currently, 
we do not know precisely where in the cell the IMD/DIAP2 association occurs.  In 
Figure 2.11, this interaction is diagramed as occurring away from the receptor 
proximal complex, but this is only for illustrative purposes.  Once associated with 
DIAP2, cleaved IMD is rapidly K63-ubiquitinated.  As the RING mutated version 
of diap2 failed to support IMD ubiquitination in flies, DIAP2 likely functions as the 
E3 for this reaction.  In addition, the imd1 allele, which fails to interact with DIAP2 
because of a mutation in the IBM, demonstrates the critical nature of the IMD-
DIAP2 interaction for innate immune signaling.  Consistent with the notion that 
cleavage precedes ubiquitination, mutants that fail to generate ubiquitinated IMD 
(i.e. diap2 and imd1) actually accumulate more cleaved IMD than is observed in 
wild type flies.  Presumably, in wild type animals, cleaved IMD is efficiently 
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Figure 2.11
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Figure 2.11 IMD pathway model
DAP-type PGN binding causes multimerization or clustering of PGRP receptors.  
This likely recruits the adapter proteins IMD, FADD and the caspase DREDD.  
Once in proximity, DREDD cleaves IMD, generating an exposed neo-N-terminal 
A31 residue.  This neo-N-terminus then binds the E3 ligase DIAP2 via its BIR2/3 
domains.  In conjuction with the E2-ubiquitin conjugating enzymes UEV1a, 
Bendless (Ubc13) and Effete (Ubc5), IMD (and to a lesser degree DIAP2) are 
then K63-polyubiquitinated.  This polyubiquitin chain then leads to the activation 
of downstream kinases ultimately leading to the phosphorylation and activation of 
Relish and induction of downstream targets, like the AMP genes.
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ubiquitinated, and thus is difficult to detect in our assays.  On the other hand, 
dredd mutants or mutants lacking the key immunoreceptors (PGRP-LC/LE) failed 
to cleave and ubiquitinate IMD, consistent with our cell culture data. 
Previous work has suggested that ubiquitination plays a critical role in IMD 
signaling in the Drosophila immune response (Gesellchen et al., 2005; Huh et al., 
2007; Kleino et al., 2005; Leulier et al., 2006; Zhou et al., 2005).  However, the 
molecular target(s) of ubiquitination and the mechanisms of its activation have 
remained elusive.  As discussed above, the data presented here indicate that 
DIAP2 functions as the E3-ligase in the IMD pathway, a function usually 
attributed to the TRAF or, more recently, cIAP proteins in mammalian NF-κB 
signaling pathways (Bertrand et al., 2009).  The E2 complex of Ubc13 and Uev1a 
also appears to be involved in IMD ubiquitination.  RNAi targeting of these K63-
ubiquitinating enzymes reproducibly decreases IMD ubiquitination and the 
induction of target genes, however the degree of inhibition is variable and never 
complete (data herein and Zhou et al., 2005).  We now show that a third E2 
enzyme, Effete, the Drosophila Ubc5 homologue, also plays a vital role in 
ubiquitination of IMD.  RNAi treatment targeting Effete, in concert with Uev1a 
and/or Bendless reproducibly eliminated IMD ubiquitination and the induction of 
Diptericin.  
Several lines of evidence argue that IMD is the critical target for K63-
ubiqutination in this pathway.  First, IMD is by far, the most robustly modified 
component that we have identified, and the only one in which modifications can 
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be detected in whole animals.  Second, the protein produced as a result of the 
imd1 mutation, which does not signal, is also not ubiquitinated.  Third, we present 
a deletion mutant, IMD∆5, that is not ubiquitinated and fails to signal.  Finally, 
Thevenon et al. (2009) recently identified the Drosophila ubiquitin specific 
protease, USP36, as a negative regulator of IMD ubiquitination.  Functionally, 
USP36 is able to remove K63-polyubiquitin chains from IMD, promoting K48-
mediated polyubiquitination and degradation of IMD.  Consistent with our model, 
animals which over express USP36 show decreased levels of IMD ubiquitination, 
reduced IMD pathway activation as monitored by Diptericin RNA expression, and 
are susceptible to bacterial infection.  Together, these data strongly argue that 
IMD is the critical substrate for K63-polyubiqutination in IMD pathway signaling, 
although other proteins may also be conjugated to lesser degree (as shown here 
for DIAP2) and could potentially substitute for IMD as the platform for ubiquitin 
conjugation.  Interestingly, Xia and colleagues, recently showed that unanchored 
K63-polyubiquitin chains (i.e. ubiquitin chains which are not conjugated to a 
target substrate) are sufficient to activate the mammalian TAK1 and IKK kinase 
complexes.  Furthermore they show that unanchored polyubiquitin chains are 
produced after stimulation of HEK cells with IL-1β (Xia et al., 2009).  Thus, the 
presence (or absence) of K63-polyubiquitin chains may be more important than 
their conjugation substrate.
K63-polyubiquitin chains are likely to serve as scaffolds to recruit the key 
kinases TAK1 and IKK, in the IMD pathway.  Both of these kinases include 
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regulatory subunits with highly conserved K63-polyubiquitin binding domains.  
Drosophila TAB2, which complexes with TAK1, and the IKKγ subunit are 
predicted to contain conserved K63-polyubiquitin binding domains (Ea et al., 
2006; Kleino et al., 2005; Zhou et al., 2005; Zhuang et al., 2006).  Thus, we 
hypothesize that K63-polyubiquitin chains will recruit both the TAB2/TAK1 
complex and the IKK complex, creating a local environment for optimal kinase 
activation and signal transduction, however this aspect of our model is still 
speculative. 
Although mammalian caspase-8 and FADD are best known for their role in 
apoptosis, a growing body of literature indicates that these factors, along with 
RIP1 (which has some homology to IMD), also function in RIG-I signaling to NF-
κB (Balachandran et al., 2004; Takahashi et al., 2006).  In addition, caspase-8 
has been implicated in NF-κB signaling in B-cell, T-cell and LPS signaling (Bidere 
et al., 2006; Chun et al., 2002; Lemmers et al., 2007; Salmena et al., 2003; Su et 
al., 2005; Sun et al., 2008).  Cells, from mice or humans, lacking caspase-8 have 
defects in immune activation, cytokine production and nuclear translocation of 
NF-κB p50/p65 (Chun et al., 2002; Lemmers et al., 2007).  Furthermore, recent 
evidence also shows that during mammalian NOD signaling the RIP2 protein is 
ubiquitinated in a cIAP1/2 dependent manner (Bertrand et al., 2009).  Given that 
Drosophila homologs of RIP1, FADD and capase-8 also function in the IMD 
pathway, the results presented here may help elucidate the mechanism by which 
these factors function in these mammalian immune signaling pathways.
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Material and Methods
Fly Stocks
 The following fly strains were used in this work.  DD1 (labeled as WT in 
most cases) (Gottar et al., 2002; Rutschmann et al., 2000), diap27c (Leulier et al., 
2006), diap27c; UAS-DIAP2C466Y/UAS-DIAP2C466Y or TM6-Tb (Leulier et al., 
2006), imd1 (Georgel et al., 2001), imdshadok (Kaneko et al., 2006), daughterless-
GAL4/UAS-IMDD30A , dreddB118 (Leulier et al., 2000), and double PGRP-LC, 
PGRP-LE mutant flies (pgrp-le112;+;pgrp-lcΔE) (Takehana et al., 2004).
RNAi
RNAi to IMD pathway components, and LacZ as a control, were produced 
using T7 RiboMAX Express Large Scale RNA Production System (Promega).  
S2* cells were split to 0.5x106 cells per ml and allowed to incubate for ~24 hours 
at 27°C.  2µg/ml RNAi was then delivered by calcium phosphate transfection and 
cells were allowed to recover for ~24 hours at 27°C.  1µM 20-hydroxyecdysone 
was then added to the cells for ~24 hours.  Finally cells were stimulated with 
either E.coli peptidoglycan (100ng/ml) or induced with copper, for 6 hours, before 
being isolation of RNA or whole cell lysate for Northern blotting or 
immunoprecipitation/immunoblot/kinase assays as described below.  
RNA Analysis
Total RNA was isolated with the TRIzol reagent (Invitrogen) as previously 
described (Silverman et al., 2000) and expression of Dpt and Rp49 was analyzed 
by Northern blot analysis followed by autoradiography.  
85
IMD Antibody
For the production of anti-IMD polyclonal antibodies, the full-length imd 
coding sequence was cloned in the E. coli expression vector pDS56/RBII, 6xhis.  
His-tagged-IMD was expressed in M15 E. coli (strain M15) and purified by nickel 
chelate chromatography.  Purified proteins were used to immunize rabbits.  
Nucleotide sequence of all constructs was confirmed by sequencing.
TAK1 Antibody
For the production of the anti-TAK1 polyclonal antibody, the peptide 
KSDGRERLTVTDTKP was generated an used to immunize rabbits (Open 
Biosystems, Inc.).  Serum was then pooled and purified via affinity purification. 
Protein and Immunoprecipitation Assays
Following stimulation with PGN (100ng/ml) or CuSO4 (500µM), S2* cells 
were lysed in buffer (10% glycerol, 1% Triton X-100, 20mM Tris, 150mM NaCl, 
25mM β-glycerolphosphate, 2mM EDTA, 1mM DTT, 1mM Sodium 
Orthovanadate, 1X Protease Inhibitor Cocktail).  For total protein analysis, 
50-100µg of total protein were prepared as previously described (Kaneko et al., 
2006) and immunoblotted with anti-IMD, anti-pJNK (Santa Cruz), or anti-JNK(FL) 
(Santa Cruz).  For immunoprecipitations, 200-600µg of total protein extract was 
immunoprecipitated as previously described (Kaneko et al., 2006) with anti-
DIAP2 (Leulier et al., 2006) , anti-IMD or anti-FLAG-M5 (Sigma), before 
immunoblotting with anti-DIAP2, anti-Ubiquitin (Santa Cruz), or anti-IMD.  For 
adult flies,  a 4mL culture of E. coli 1106 was grown up to an approximate OD595 
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of 1.  Bacteria were then pelleted, washed once with PBS and pelleted a second 
time.  A stainless steel needle was then dipped into the bacterial pellet and used 
to infect flies by pricking their abdomen.  Post infection, 10-15 frozen adult male 
flies were ground in 500µL of 2X lysis buffer.  400-600µg of total protein were 
then immunoprecipitated in 2X lysis buffer overnight at 4°C with anti-IMD.  
Immunoprecipitated IMD was then washed 2 times 500µL with lysis buffer and 
analysed as described above.  
K48- and K63-polyubiquitin Immunoprecipitation Assays
Following stimulation with PGN (100ng/ml), S2* cells were lysed in buffer 
(10% glycerol, 1% Triton X-100, 20mM Tris, 150mM NaCl, 25mM β-
glycerolphosphate, 2mM EDTA, 1mM DTT, 1mM Sodium Orthovanadate, 1X 
Protease Inhibitor Cocktail) containing 6M UREA and 2mM NEM.  900µg of total 
protein extract was then diluted to 3M UREA (using lysis buffer) and 
immunoprecipitated overnight at room temperature with K48- or K63-
polyubiquitin antibody.  Samples were then spun at ~14000xg to remove any 
possible UREA precipitate.  Protein A sepharose was added to each sample and 
samples were allowed to roll at room temperature for 8 hours to overnight.  
Finally samples were washed 3x 500µl in lysis buffer containing 3M UREA and 
2mM NEM before running on SDS-PAGE and immunoblotting for IMD (as 
above).
Kinase Assays
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Activity of kinases was assayed as previously described (Silverman et al., 
2000; Wang et al., 2001).  Briefly, cultured S2* cells or S2* cells stability 
transfected with inducible metallothionein FLAG-TAK1 were pretreated with 1µM 
20-hydroxyecdysone for 24-48 hours.  For FLAG-TAK1 assays, cells were 
pretreated with low copper (100µM CuSO4 for 1 hour).  Cells were then 
pretreated as appropriate and stimulated with E.coli peptidoglycan (100ng/ml) for 
10 minutes or not.  Cells were lysed in 100µl/ml of lysis buffer (10% glycerol, 1% 
Triton X-100, 20mM Tris, 150mM NaCl, 25mM β-glycerolphosphate, 2mM EDTA, 
1mM DTT, 1mM Sodium Orthovanadate, 1X Protease Inhibitor Cocktail), and 
kinases were immunoprecipitated with appropriate antibodies for 2-3 hours at 
4°C; 75µg of total protein for FLAG-TAK1 with anti-FLAG M2 Agarose (Sigma), 
75µg of total protein for endogenous TAK1 with anti-TAK1 antisera and 50µg of 
total protein for IKK with anti-IKKγ.  Immunoprecipitated kinases were washed 2 
times with 500µL of lysis buffer and 2 times 500µL with kinase reaction buffer 
(200mM HEPES, 200mM β-glycerolphosphate, 100mM MgCl2, 500mM NaCl, 
10mM DTT, 1mM Sodium Orthovanadate).  Kinases were then added to 10µL of 
kinase reaction buffer containing 200µM cold ATP, 1µL 32gP*-ATP, and substrate 
(1ug rMKK6-K28A for TAK1 KA, or 50ng rRelish for IKK KA).  Kinase reactions 
were incubated at 30°C for 30 minutes and run on SDS-PAGE.  SDS-PAGE gels 
were then fixed, dried, and autoradiographed.  
Cloning
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T7/FLAG Double tagged IMD was constructed in the pPAC-PL vector at 
KpnI and NotI using standard cloning techniques.  Subsequently, Act-T7-IMD 
D30A-FLAG and Act-T7-IMD A31V-FLAG were produced using QuikChange Site 
Directed Mutagenesis (Stratagene).  AAPV-Imd (31-273) or the mutated form 
VAPV-Imd (31-273) were expressed using the Ubiquitin-fusion technique 
(Varshavsky, 2000).
Caspase Inhibitor Treatment
S2* cells were split 0.5x106 cells per ml and allowed to incubate for ~20 
hours at 27°C.  1µM 20-hydroxyecdysone was then added for and additional 24 
hours.  100µM caspase inhibitor zVAD-FMK, dissolved in DMSO, was then 
added to cells for 30 minutes or 4 hours at 27°C before stimulation with E.coli 
peptidoglycan.  Proteins were analyzed as described above.  
IMD/DIAP2 Pull Down
S2 cells were transfected with pAc myc-Imd-HA or the pMT DHFR-HA-Ub-
Imd (31-273) constructs with or without pMT-DIAP2-GTC.  Expression was 
induced with 350µM CuSO4 for 15 h and cells lysed in lysis buffer (50mM Tris, pH 
7.5, 150mM NaCl, 1% TX-100, 10% glycerol, 1mM EDTA, Complete Protease 
Inhibitor Cocktail (Roche), 1 mM DTT).  DIAP2-GTC was purified using GSH-
Sepharose (GE Healthcare) and complexes eluted with 10mM Glutathione 
solution (in 50mM Tris-HCl pH 8.0).  DIAP2 and interacting IMD proteins were 
analysed by Western Blot using antibodies against HA (myc-Imd-HA) (Roche), 
V5 (Imd (31-273) (AbD Serotec) and DIAP2 (Leulier et al., 2006).
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Boiling SDS Immunoprecipitations
After stimulation with PGN S2* cells were harvested and spit. Half of the 
total cell pellet was lysed in lysis buffer as described above.  The second half of 
the pellet was lysed in lysis buffer containing 1% SDS and immediately boiled for 
10 minutes.  Lysates from both treatments were then immunoprecipiated for IMD 
using anti-IMD sera as above.  In the case of the boiled SDS lysis, the total SDS 
in the sample was diluted to below 0.05% before immunoprecipitation. 
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CHAPTER III
Serine/Threonine Acetylation of Drosophila TAK1 by the Y. pestis Effector 
YopJ
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Abstract
The Gram-negative bacteria Yersinia pestis, causative agent of plague, is both 
lethal and extremely virulent.  One mechanism contributing to Y. pestis virulence 
is the presence of a type-three secretion system which injects effectors proteins, 
Yops, directly into the immune cells of the infected host.  One of these Yop 
proteins, YopJ, has been shown to be highly pro-apoptotic and play a role in 
attenuation of mammalian NF-κB, p38 and JNK signal transduction pathways.  
Although the precise function of the protein remained elusive for some time, 
recent work has shown that YopJ acts as a serine/threonine acetyl-transferase 
targeting mitogen-activated protein (MAP) 2 kinases.  Utilizing Drosophila cell 
culture and whole animals as a model system, we demonstrate YopJ mediated 
inhibition of one NF-κB signaling pathway (IMD), but not the other (Toll) .  In fact, 
we show that TAK1, the critical MAP3K in the IMD pathway, is, targeted for YopJ-
mediated serine/threonine acetylation.  Acetylation of critical serine/threonine 
residues in the activation loop of Drosophila TAK1 blocks phosphorylation of the 
protein and subsequent kinase activation.  These data present the first evidence 
that TAK1 is a target for YopJ mediated inhibition.  
93
Introduction
The gram-negative bacteria Yersinia pestis is perhaps best known for its 
role as the causative agent of plague, responsible for millions of deaths 
throughout history.  Although not often thought of as a 21st century disease, Y. 
pestis is endemic in rodents throughout the world, including a number of areas of 
the United States, particularly the southwest region where it can be found in 
prairie dogs and other mammals.  Y. pestis is transmitted between hosts in two 
ways.  The most common route of infection is through the bite of the flea , which 
causes a subcutaneous infection.  The bacteria then travel to the lymph nodes of 
the infected host causing blisters (also known as bubos), the defining symptom of 
bubonic plague.  The second route of infection occurs in pneumonic plague, 
when the bacteria are transmitted person-to-person by coughing, after the 
bacteria colonize the lungs of an infected individual. 
One aspect which makes Y. pestis so virulent is the presence of a type 
three secretion system (T3SS) and a number of effector proteins known as 
Yersinia outer proteins (Yops) on the pCD1 plasmid (Iriarte and Cornelis, 1996). 
These bacterial effector proteins are injected by the T3SS directly into host 
immune cells (typically macrophages and dendritic cells) where they interfere 
with number of intracellular functions, such as cytoskeleton stability and various 
signal transduction pathways, greatly limiting the innate immune response 
(Marketon et al., 2005).
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YopJ is one of six Yops that is injected into the immune cell cytoplasm and 
may play a large role in the down regulation of the innate immune response.  
YopJ has been shown to be both pro-apoptotic and to inhibit MAPK, TNF and 
NF-κB signaling pathways (Monack et al., 1997; Monack et al., 1998; Palmer et 
al., 1998; Schesser et al., 1998; Palmer et al., 1999).  Although functionally 
identified to inhibit these pathways, the precise targets and mechanism employed 
by YopJ remained controversial for some time.  Initially YopJ was proposed to act 
as a ubiquitin-like protein protease, cleaving the ubiquitin-like protein SUMO from 
its conjugated targets (Yoon et al., 2003).  Subsequent evidence however 
suggested that YopJ acts as a deubiquitinase, removing critical polyubiquitin 
chains from the NF-κB/innate immune signaling pathway protein TRAF6, which is  
essential for downstream signaling (Sweet et al., 2007; Zhou et al., 2005).  
However, recent biochemical evidence from two groups, strongly argues that 
YopJ has a completely novel and unpredicted function; that of an serine/
threonine acetyltransferase.  In this role YopJ acetylates serines and threonines 
of a family of mitogen-activated protein 2 (MAP2) kinases critical to mammalian 
innate immune signaling.  This acetylation blocks their phosphorylation and 
subsequent activation of the kinases, thus neutralizing their innate immune 
signaling pathways (Mittal et al., 2006; Mukherjee et al., 2006).  
It is clearly difficult to reconcile the drastically different functions attributed 
to YopJ.  On the one hand, YopJ seems to act upstream during signaling blocking 
ubiquitination and pathway activation.  While on the other hand YopJ appears to 
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block activation of downstream MAP2 kinases by acetylation.  In either case the 
inhibitory activity would be sufficient to block immune signaling, consistent with 
previous literature (Monack et al., 1997; Monack et al., 1998; Palmer et al., 1998; 
Schesser et al., 1998; Palmer et al., 1999).  A number of hypotheses therefore 
present themselves which could explain the discrepancy regarding the function of 
YopJ.  First, YopJ could have two separate and distinct functions, working both as 
a ubiquitin protease and a serine/threonine acetyl-transferase.  Secondly, YopJ 
mediated inhibition of kinases could disengage some feedback loop which is 
required for ubiquitination of upstream pathway components.  Finally, these 
purported activities could be an artifact. as ,much of the published data is based 
on transient transfections or in vitro reactions.  In order to further elucidate the 
molecular functions of YopJ we utilize Drosophila cell culture and whole animals 
as a model system to analyze YopJ mediated inhibition of NF-κB signaling. 
Unlike mammals, Drosophila lack a fully developed adaptive immune 
system.  Instead they rely almost entirely on innate immune signaling to defend 
against invading pathogens.  One critical component of the Drosophila immune 
response is the rapid and robust production of a variety of antimicrobial peptides 
(AMPs) following infection.  The production of AMPs is transcriptionally regulated 
by two innate immune pathways, the Toll pathway and the IMD pathway.  The Toll 
pathway is activated by fungi and lysine type peptidoglycan (PGN), found in most 
Gram-positive bacteria which lead to the proteolytic cleavage of the cytokine 
Spätzle. Cleaved Spätzle binds the Toll receptor leading to the activation of an 
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adaptor complex containing the signaling proteins dMyD88, Tube, and the kinase 
Pelle.  As a consequence the Drosophila IκB homologue Cactus is then 
phosphorylated, ubiquitinated, and degraded by the proteosome.  The removal of 
Cactus then allows the NF-κB proteins Dif and Dorsal to translocate into the 
nucleus and activate AMP genes.  
Conversely, the IMD immune signaling pathway is activated by the 
presence of DAP-type PGN common to most Gram-negative bacteria. When 
DAP-type PGN is bound by the peptidoglycan recognition protein (PGRP) it 
initiates an intracellular cascade in which cleavage of the proximal adapter 
protein IMD by the caspase DREDD leads to the K63-mediated polyubiquitination 
of IMD.(Kaneko et al., 2004 and Chapter 2).  It is then proposed that this K63-
polyubiquitin chain recruits the downstream kinases TAK1 and IKK.  Once 
recruited to the ubiquitin scaffold TAK1 becomes activated and initiates two 
downstream arms of the IMD pathway.  In the Relish/NF-κB arm , TAK1 
phosphorylates and activates the IKK complex leading to the subsiquent 
phosphorylation of the NF-κB protein Relish (Silverman et al., 2003).  In addition, 
the caspase DREDD is also responsible for the cleavage of Relish (Stöven et al., 
2000).  Once cleaved and phosphorylated, Relish translocates into the nucleus 
and activating AMP production.  In the second arm of the IMD pathway, TAK1 
phosphorylates the JNK kinase Hemipterous, which in turn phosphorylates the 
JNK protein Basket, leading to the activation of the AP1 transcription factor and 
production of various immune genes.
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Both the Drosophila IMD and Toll pathways show a significant amount of 
homology to mammalian innate immune signaling pathways, and potentially both 
could be targets of YopJ mediated inhibition.  However, we present evidence that 
only the IMD pathway is sensitive to YopJ mediated inhibition and furthermore 
that the presence of YopJ results in the serine/threonine acetylation of the MAP3 
kinase TAK1 and subsequent inhibition of the kinase.  This inhibition is sufficient 
to block downstream signaling of both the JNK and Relish/NF-κB branches of the 
IMD pathway.  These data demonstrate that the MAP3 kinase TAK1 is a potent 
target of YopJ mediated inhibition and show YopJ mediated modification in living 
cells. 
Results
YopJ blocks the IMD innate immune signaling pathway
In order to develop Drosophila as a model system for the study of YopJ-
mediated innate immune inhibition, stable S2* cell lines inducibly expressing 
either wild type YopJ (YopJWT) or a catalytically inactive mutant (C172A, YopJCA) 
were generated.  With the metallothionein promoter, addition of copper sulfate 
directly to the culture media induces the expression of YopJWT or YopJCA proteins, 
while in the absence of copper no protein is detected by western blot analysis 
(Figure 3.1A, bottom panel).  After treatment with copper, these cells were 
stimulated with Spätzle or DAP-type PGN to activate the Toll or IMD pathways, 
respectively.  Toll signaling was monitored by Northern blotting for Drosomycin 
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Figure 3.1
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Figure 3.1 YopJ inhibits IMD but not Toll immune signaling
(A) S2* cells stably expressing YopJWT or YopJCA under control of the 
metallothionein promoter were pretreated with copper (to activate expression of 
YopJ) prior to stimulation with Spätzle (Left) or PGN (Right).  Activation of 
immune signaling was monitored by Northern blotting of Diptericin and 
Drosomycin RNA. (B) Adult flies carrying transgenic pGUS-YopJWT, yolk-Gal4 
driver, or yolk-Gal4; YopJWT, were pricked with a tungsten needle coated in either 
PBS or live E. coli. (C) Eyes of adult flies carrying transgenic pGUS-YopJWT or 
pGUS-YopJCA alone, or crossed to GMR-Gal4.  Columns one and two represent 
two individual YopJWT insertion lines.
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expression, while IMD signaling was monitored by probing for Diptericin (and to a 
lesser degree Drosomycin) (Figure 3.1A).  Expression of YopJ had no effect on 
the Spätzle-induced expression of Drosomycin, while PGN-induced Diptericin 
and Drosomycin expression were dramatically inhibited.  The failure to induced 
Diptericin was clearly linked to YopJ expression because YopJCA was not 
inhibitory, and without copper pretreament Diptericin induction was robust.  
Together, these results demonstrate that YopJ is a potent inhibitor of IMD, but not 
Toll, signaling in Drosophila cells.
For studies in whole animals, we generated YopJ transgenic flies.  Using 
the dual GMR/UAS promoter system (pGUS, Brodsky et al., 2000) we generated 
transgenic Drosophila which expressed wild type or mutant YopJ constitutively in 
the eye, and at any other location/time with appropriate Gal4 ‘drivers’.  To monitor 
the effect of YopJ on the humoral systemic immune response, the fat body-
specific yolk-Gal4 driver was used.  After infection with live E. coli, control 
animals (female yolk-gal4 driver flies or YopJWT flies containing no Gal4 driver) 
showed robust IMD pathway activation as monitored by Diptericin RNA 
production.  When the yolk-gal4 driver was used to induce YopJWT production in 
female fat bodies, IMD pathway activation was severely inhibited as seen by the 
reduction in Diptericin levels (Figure 3.1B), consistent with our cell culture data.  
Together these observations show that YopJ does not effect Toll signaling, yet 
blocks IMD signaling in both tissue culture and whole animals.
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Interestingly constitutive GMR-mediated expression of YopJWT (from the 
pGUS transgene) in the eyes of adult flies led to the formation of a rough and 
reduced eye phenotype, which was not seen in YopJCA flies (Figure 3.1C).  
Multiple transgenic insertion lines were generated for both wild type and mutant 
YopJ.  Although the penetrance of the rough eye phenotype varied between the 
YopJWT lines (as shown in Figure 3.1C, columns one and two), no phenotype was 
present in flies expressing YopJCA.  The rough/reduced eyes found in YopJWT flies  
could be further enhanced by driving the higher expression of YopJWT via an 
additional GMR-Gal4 driver.  It is unlikely that the rough and reduced eye 
phenotype seen in adult Drosophila expressing YopJWT is due to inhibition of the 
IMD pathway.  Unlike the Toll pathway, IMD pathway signaling is not involved in 
development and most IMD pathway mutants are viable to adulthood.  It 
therefore seems likely that the developmental defects seen in YopJWT flies are a 
consequence of inhibition of other MAP kinase pathways important for eye 
development.  Further work will be required in order to identify these kinases and 
determine if they are inhibited in a similar fashion to the IMD pathway. 
Having established that YopJWT expression is sufficient to inhibit the IMD 
signaling pathway, we next determined the epistatic position of YopJ-mediated 
inhibition.  Recent work by our group shows that cleavage and subsequent 
ubiquitination of IMD are crucial aspects of IMD pathway signaling (Chapter 2).  
As YopJ was proposed to act as a ubiquitin-protein protease, we examined if 
either of these IMD modifications were altered in stable cell lines expressing 
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YopJ (Sweet et al., 2007; Zhou et al., 2005).  Similarly to previous experiments, 
addition of copper sulfate to culture media induced the expression of either 
YopJWT or YopJCA (Figure 3.2A).  After stimulation with PGN comparable levels of 
IMD cleavage and ubiquitination were detected in both the YopJWT and YopJCA 
expressing cells in the presence or absence of copper treatment, indicating that 
YopJ has no effect on these upstream signaling events.  
Next we examined activation of the Drosophila JNK kinase.  Western 
blotting of lysates from cells expressing YopJWT with anti-phospho-JNK antibody 
showed no phospho-JNK in these cells when stimulated with PGN, whereas JNK 
was phosphorylated normally in response to PGN in S2* cells and cells 
expressing YopJCA (Figure 3.2B).  Together with the inhibition of AMP gene 
induction, these data indicate that YopJ acts by inhibiting the IMD pathway 
downstream of IMD but upstream of JNK phosphorylation and Relish (NF-κB) 
activation.  Orth and colleagues have argued that both NF-κB and JNK signaling 
are inhibited by YopJ by targeting different MAP2Ks for acetylation.  An alternate 
possibility is that YopJ inhibits a protein upstream in the IMD pathway, that is 
required for both NF-κB and JNK activation, such as TAK1.  This possibility is 
suggested by the reduction in the levels of phospho-IMD in cells expressing 
YopJWT (Figure 3.2A, lane 6, middle panel).  Although the function of phospho-
IMD is not yet clear, our earlier work has established that it is dependent on TAK1 
activity (Chapter 2). 
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Figure 3.2 YopJ functions between IMD and JNK
(A) Protein expression of YopJWT or YopJCA was induced in S2* cells prior to 
stimulation with PGN.  Ubiquitination of IMD was monitored by IMD/ubiquitin co-
immunoprecipitation.  Anti-IMD blotting was used as a loading control and anti-
FLAG-YopJ blot was used to verify the presence/absence of YopJ.   marks 
unmodified full length IMD,  highlights phosphorylated IMD,and  marks the 
cleaved-IMD product (B) Phospho-JNK was monitored in lysates after treatment 
with PGN.  Full length JNK blot serves as a loading control.
105
YopJ inhibits TAK1 activation
Hypothesizing that YopJ may be directly inhibiting the kinase TAK1, we 
next co-expressed both TAK1 and YopJ (WT or CA) in double stable S2* cells.  In 
these cells, over expressed TAK1 and IKK kinase activities were monitored with 
IP-in vitro kinase assays using recombinant MKK6K28A (a mammalian TAK1 
target) and recombinant Relish as substrates (respectively).  In S2* cells, over 
expression of TAK1 alone was sufficient to activate the activity of both TAK1 and 
the downstream IKK complex (Figure 3.3A).  When both TAK1 and YopJWT were 
co-expressed, the activity of both kinases was inhibited, while co-expression of 
YopJCA resulted in no discernible reduction in signal.  Interestingly, when TAK1 
was expressed alone, or in the presence of YopJCA it migrated as a tight doublet 
at a molecular weight of approximately 100 kDa, whereas when expressed in 
concert with YopJWT it ran slightly faster at a size of approximately 85kDa (Figure 
3.3A).  The predicted molecular for Drosophla TAK1 is 76 kDa.  These data 
strongly indicated that YopJ directly interferes with the activity of TAK1 and that 
this interference was likely the result of some kind of post-translational 
modification. 
In order to analyze the effect of YopJ on endogenous TAK1, IP-in vitro 
kinase assays were undertaken with a newly generated anti-TAK1 antibody.  
Cells expressing YopJWT showed little TAK1 kinase activity above background, 
while cells expressing YopJCA showed activity comparable to S2* cells (Figure 
3.3B).  These data support the results obtained with over expression of TAK1.  
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Figure 3.3 YopJ inhibits TAK1 kinase activity 
(A) Activity of TAK1 and IKK was monitored by in-vitro kinase assay in S2* cells 
expressing metallothionein driven TAK1 with or without YopJWT or YopJCA.  Anti-
FLAG (TAK1 and YopJ) and IKKγ blots serve as controls.  (B) Activation of 
endogenous TAK1 was monitored in S2* cells expressing either YopJWT or 
YopJCA.  Anti-FLAG immunoblot serves as a control for the presence of YopJ  (C) 
IKK kinase activity was monitored in S2* cells expressing YopJWT or YopJCA after 
stimulation with PGN.  IKKγ blot serves as a kinase control. 
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Although our anti-TAK1 antibody is effective for immunopreciptiation, as 
monitored by endogenous TAK1 IP-kinase assays, it is not very useful for 
immunoblotting (data not shown) we have thus far been unable to detect 
endogenous TAK1 via immunoprecipitation/immunoblotting using this antibody.  
Therefore, we used an RNAi approach to demonstrate that the TAK1 IP-kinase 
assay is monitoring TAK1 acitivity.  RNAi treatment targeting TAK1 was able to 
completely inhibit endogenous TAK1 kinase activity and accumulation of 
phospho-JNK after immune induction (Figure 3.4).
Consistent with YopJ mediated inhibition of endogenous TAK1 kinase 
activity, downstream IKK kinase activity is also absent in the presence of YopJWT 
(Figure 3.3C).  S2* cells treated with PGN show activation of IKK as monitored 
by and IP-in vitro kinase assay, with IKKγ antibody and recombinant Relish as a 
substrate, while expression of YopJWT inhibits this activity.  As expected 
expression of YopJCA does not block the activity of IKK.  Together these data 
show that wild type YopJ is able to inhibit the kinase activity of TAK1 and IKK 
after over expression of TAK1 as well as PGN induced activation.  These results 
support the hypothesis that inhibition of TAK1, by YopJ, results in a reduction of 
downstream IKK activity.  
TAK1 is post-translationally modified
In order to assess if the difference in TAK1 migration seen in the presence 
of YopJWT was related to its lack of activity, we further analyzed the over 
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Figure 3.4 Endogenous TAK1 kinase assay
Endogenous TAK1 kinase activity was monitored after treatment with RNAi to 
IMD pathway kinases prior to PGN stimulation. Anti-IKKγ blot serves as a control 
for IKKγ RNAi efficiency.  Anti-phospho-JNK and FL-JNK blots serves as a 
control for TAK1 activity. 
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expressed FLAG-TAK1 protein.  When optimized for higher resolution, 
immunoblot analysis showed that over expressed TAK1 alone, or TAK1 in the 
presence of YopJCA actually migrates as a doublet at approximately 95 and 
105kDa while in the presence of YopJWT TAK1 runs faster at a lower molecular 
weight of approximately 85kDa (Figure 3.5A).  When activated, mammalian TAK1 
is auto-phosphorylated at three phospho-acceptor sites in its activation loop 
(Sakurai et al., 2000; Kishimoto et al., 2000).  In order to determine if the 
observed Drosophila TAK1 bands represented phosphorylation events, we 
treated lysates expressing TAK1 in the presence or absence of YopJ with λ-
protein phosphatase.  When treated with λ-protein phosphatase the doublets 
observed in the TAK1 alone and TAK1 with YopJCA samples changed from 
approximately 95/105kDa to approximately 85/93kDa.  In the presence of YopJWT 
however we found no change in the migration of TAK1 was detected (Figure 
3.5B).  These data indicate that active TAK1, (when expressed alone or with the 
inactive YopJCA) is phosphorylated, however no phosphorylation is present on 
TAK1 when co-expressed with YopJWT.
An alignment of Drosophila and mammalian TAK1 shows that three 
phospho-acceptor sites found in the activation loop of mammalian TAK1 (T184, 
T187, and S192) as well as the surrounding residues are all highly conserved in 
Drosophila TAK1 (Figure 3.5C).  In mammals, mutations to any of these three 
residues to alanine is sufficient to ablate the activity of the protein and block 
downstream signaling (Yu et al., 2008; Prickett et al., 2008; Qiao et al., 2005).  In
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Figure 3.5
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Figure 3.5 YopJ acetylates TAK1
(A) High resolution anti-FLAG immunoblot of S2* cells over expressing FLAG-
TAK1 in the presence of YopJWT or YopJCA.  (B) Anti-FLAG (TAK1) immunoblot of 
lysates from S2* cells expressing FLAG-TAK1 alone or in the presence of YopJWT 
or YopJCA, were treated (or not) with λ-phosphatase.  (C) Alignment of human 
and Drosophila TAK1 activation loops.  Residues of mammalian TAK1 known to 
be phosphorylated are indicated (P).  Conserved residues are boxed in grey.  (D) 
Summary of MS/MS peptide analysis of Drosophila TAK1 activation loop.  
Phosphorylated (P) and acetylated (Ac) residues are indicated. A table containing 
all phospho-peptide and acetyl-peptide residues can be found in Supplemental 
Table 3.1.  In both (C) and (D) conserved residues are boxed in grey.
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 order to confirm the phosphorylation of Drosophila TAK1 and determine which 
residues where phosphorylated, FLAG-TAK1 was isolated and prepared from 
samples containing over expressed TAK1 alone, with YopJWT or with YopJCA.  
These samples were then subjected to microcapillary reverse-phase HPLC nano-
electrospray tandem mass spectrometry (MS/MS). 
YopJ acetylates TAK1. 
MS/MS peptide analysis identified a single phosphorylation in the 
activation loop of Drosophila TAK1, at S176 which aligns to S192 of the 
mammalian protein, when TAK1 was expressed alone or in the presence of 
YopJCA, (Figure 3.5D).  A number of other phosphorylation sites were found 
outside the activation loop (see Table 3.6 for the full list of phospho-residues).  
Interestingly, no phosphorylation was seen in the activation loop of TAK1 when 
co-expressed with YopJWT and overall, phosphorylation as a whole was greatly 
reduced.  Given that YopJ is thought to act as a serine/threonine acetyl 
transferase, TAK1 samples were then analyzed for acetylation.  In the presence 
or absence of YopJCA, TAK1 displayed no detectible acetylation (see Table 3.6 for 
full list of acetyl-residues).  However, in the presence of YopJWT, TAK1 showed 
remarkably heavy acetylation of both T168 and T171, which align to the critical 
threonines of the mammalian TAK1 activation loop, with minor acetylation of 
S167 and S176.  
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Table 3.6
MS/MS TAK1 Phospho-Residues
TAK Alone TAK + YopJWT TAK +YopJCA
S176 T149* S65
S314 Y262* S110
T321 S639* S116
S390 T149
T394** S176
S395** S208
S396** S307
S433* S314
T321
Y369*
T372*
S390
T394**
S395**
S396**
S433
MS/MS TAK1 Acetyl-Residues
TAK Alone TAK + YopJWT TAK +YopJCA
None detected S167* None detected
T168
T171
S176*
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Table 3.6 MS/MS TAK1 phospho- and acetyl-residues
A complete list of all phospo- (Top) and acetyl- (Bottom) residues identified in 
Drosophila TAK1. Complete data set is available upon request. 
* Residues that require validation to determine modification
** Proximal serines and threonines of which one or more is phosphorylated but 
the data needs to be validated to distinguish the exact position
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Predicting that phosphorylation of serine 176 of Drosophila TAK1 is critical 
for kinase activation we generated a TAK1S176A mutant under the control of the 
metallothionein promoter.  As shown previously, over expression of wild type 
TAK1 is sufficient to activate TAK1 kinase activity as monitored by IP-in vitro 
kinase activity.  Over expression of TAK1S176A however was unable to drive 
kinase activity (Figure 3.7A).  Immuno-blotting showed that TAK1S176A migrated 
slightly faster than wild type TAK1 at a molecular weight of approximately 
~85kDa.  To determine if this shift was the result of lack of phosphorylation, 
lysates expressing wild type TAK1 or TAK1S176A were subjected to λ-protein 
phosphatase treatment.  Wild type TAK1 samples migrated as a smear at 
approximately 95-105kDa, consistent with previous data (Figure 3.7B and 3.5A).  
When treated with λ-phosphatase this band collapsed to approximately 85kDa as 
seen previously (Figure 3.5B).  Strikingly, TAK1S176A, migrated at approximately 
85kDa with and without λ phosphatase treatment indicating that the protein is not 
phosphorylated.  These data demonstrate that phosphorylation of Drosophila 
TAK1 at serine 176 is required for kinase activation and acetylation of threonines 
168 and T171 (and to a lesser degree serines 176 and 192) by YopJ block this 
phosphorylation rendering the kinase inactive.
Discussion
Data obtained from mammalian systems and a number of in vitro 
experiments, have identified the MAP2 kinase family, particularly the IKK 
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Figure 3.7 TAK1 S176A is required for kinase activation 
(A) TAK1 Kinase activity was monitored in S2* cells over expressing wild type 
TAK1 or TAK1S176A by in-vitro kinase assay.  Anti-FLAG (TAK1) blot serves as a 
control. (B) Lysates from cells over expressing either wild type TAK1 or 
TAK1S176A were treated with λ-phosphatase prior to SDS-PAGE.
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complex, as the major target for YopJ mediated inhibition of NF-κB signaling via 
serine/threonine acetylation (Mittal et al., 2006; Mukherjee et al., 2006).  The 
data presented here however shows that and additional target, the Drosophila 
MAP3 kinase TAK1, is also a potent target of the YopJ protein.  We show that 
expression of YopJ is able to inhibit IMD, but not Toll, innate immune signaling.  
Inhibition of IMD pathway signaling by YopJ inhibits the activity of both TAK1 and 
IKK kinases after activation by both PGN stimulation or over expression of TAK1, 
while upstream events, such as IMD cleavage and ubiquitination, remain 
unaffected.  YopJ also acetylates multiple serine and threonine residues in the 
TAK1 activation loop.  This acetylation prevents the phosphorylation of TAK1 at 
serine 176, an event which is vital for activity of the kinase.  We therefore 
conclude that TAK1 is a target of YopJ mediated inhibition by acetylation of 
critical activation-loop phosphorylation sites.  Since TAK1 belongs to the broader 
class of MAP3 kinases, this work raises the possibility that YopJ may target other 
MAP3 kinases as well. 
Consistent with the notion that YopJ may target other MAP2/3 kinases 
(perhaps outside the realm of immune signaling) transgenic flies expressing 
YopJWT in the eye show a rough and reduced eye phenotype.  IMD signaling is 
not implicated in development, thus this phenotype can not be attributed to 
interfering with immune signaling pathways.  Instead, one or more 
developmentally relevant MAP2/3 kinases are also likely to be inhibited by YopJ 
and account for the eye phenotype.  Further work will be required to determine 
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the precise identity of these proteins and the mechanism of YopJ’s action upon 
them.
We believe that our data utilizing the Drosophila model system has three 
advantages over that previously described.  First this work was undertaken 
exclusively in live cells or animals, an approach that because of the pro-apoptotic 
nature of YopJ has proven difficult within the context of a mammalian model.  
Utilizing the strong on/off Drosophila metallothionein promoter system, we have 
developed stable YopJ inducible cell lines, which provide better protein 
expression and greater overall consistency.  Secondly, in order to study the 
function of YopJ, previous groups were forced to purify proteins separately and 
examine artificial interactions in vitro in the presence of massive amounts of 
acetyl-CoA.  This method is subject to non-physiologically relevant artifacts, that 
may obscure accurate biochemical analysis.  In our work, the proteins analyzed 
by MS/MS were produced and isolated from live cells, and represent a more 
physiologically relevant context.  Lastly, the identity of TAK1 as the target for 
YopJ mediated inhibition seems more in line with the observations regarding the 
activity of YopJ (Mittal et al., 2006; Mukherjee et al., 2006).  Targeted inactivation 
of TAK1/MAP3 kinases would allow for a much broader and more efficient 
method of immune pathway inhibition.  Perhaps in concert with inhibition of 
MAP2 kinases, YopJ is able to effectively inhibit immune pathways in both 
mammals and insects.  
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Materials and methods
RNA analysis
Total RNA was isolated with the TRIzol reagent (Invitrogen) as previously 
described (Silverman et al., 2000) and expression of Diptericin and Rp49 was 
analyzed by Northern blot analysis followed by autoradiography.  
Protein and immunoprecipitation assays
S2* cells were lysed in buffer (10% glycerol, 1% Triton X-100, 20mM Tris, 
150mM NaCl, 25mM β-glycerolphosphate, 2mM EDTA, 1mM DTT, 1mM Sodium 
Orthovanadate, 1X Protease Inhibitor Cocktail).  For total protein analysis, 
50-100µg of total protein were prepared as previously described (Kaneko et al., 
2006) and immunoblotted with anti-FLAG-M5 (Sigma), anti-pJNK (Santa Cruz), 
anti-JNK(FL) or anti-IKKγ or anti-IMD.  In order to optimize visualization of TAK1 
10ug of total protein were run on an 8% SDS-PAGE minigel for 90 minutes at 
140v.  For immunoprecipitations, 600µg of total protein were precipitated with 
anti-IMD antisera in the presence of protein A agarose overnight at 4°C.  Pellets 
were then washed twice in lysis buffer and prepared for SDS-PAGE. Samples 
were then analyized by SDS-PAGE.  1/10 of the reaction use for blotted with anti-
IMD antisera (as a loading control), while the remaining sample used for blotting 
with anti-Ubiquitin antibody (Santa Cruz). 
Kinase assays
Activity of kinases was assayed as previously described (Silverman et al., 
2000; Wang et al., 2001).  Briefly, cultured S2* cells or S2* cells stably 
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transfected with inducible metallothionein FLAG-TAK1 were pretreated with 1µM 
20-hydroxyecdysone for 24-48 hours.  For FLAG-TAK1 assays, cells were 
pretreated with copper (500µM CuSO4 for 4 hour).  For endogenous TAK1 
assays, cells were stimulated with E. coli peptidoglycan (100ng/ml) (or not) for 10 
minutes.  Cells were lysed in 100µl/ml of lysis buffer (10% glycerol, 1% Triton 
X-100, 20mM Tris, 150mM NaCl, 25mM β-glycerolphosphate, 2mM EDTA, 1mM 
DTT, 1mM Sodium Orthovanadate, 1X Protease Inhibitor Cocktail), and kinases 
were immunoprecipitated with appropriate antibodies for 2-3 hours at 4°C; 75µg 
of total protein was used to precipitate FLAG-TAK1 with anti-FLAG M2 Agarose 
(Sigma), 75µg of total protein for endogenous TAK1 with anti-TAK1 antisera and 
50µg of total protein for IKK with anti-IKKγ.  Immunoprecipitated kinases were 
washed 2 times with 500µL of lysis buffer and 2 times 500µL with kinase reaction 
buffer (200mM HEPES, 200mM β-glycerolphosphate, 100mM MgCl2, 500mM 
NaCl, 10mM DTT, 1mM Sodium Orthovanadate).  Kinases were then added to 
10µL of kinase reaction buffer containing 200µM cold ATP, 1µL 32γP*-ATP, and 
substrate (1ug rMKK6-K28A for TAK1 KA, or 50ng rRelish for IKK KA).  Kinase 
reactions were incubated at 30°C for 30 minutes and run on SDS-PAGE.  SDS-
PAGE gels were then fixed, dried, and autoradiographed.  
MS/MS peptide analysis
FLAG-TAK1 was immunoprecipitated from S2* cell via anti-FLAG (Sigma) as 
previously described.  Samples were washed, run on SDS-PAGE and gels were 
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fixed and stained with coomassie brilliant blue.  FLAG-TAK1 bands were isolated 
from these gels and sequence analysis was performed at the Harvard 
Microchemistry and Proteomics Analysis Facility by microcapillary reverse-phase 
HPLC nano-electrospray tandem mass spectrometry (µLC/MS/MS) on a Thermo 
LTQ-Orbitrap mass spectrometer.
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CHAPTER IV
Analysis of Drosophila TAB2 mutants reveals that IKK, but not JNK 
pathway activation, is essential in the host defense against Escherichia coli 
infections.
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Abstract
We show that the Drosophila TAK1 binding protein 2 (DmelTAB2) gene is 
required for the host defense against Gram-negative bacteria. In the IMD 
pathway, DmelTAB2 functions as an adaptor for TAK1, which activates both the 
JNK and the IKK/NF-κB pathways. Multiple mRNAs are transcribed from 
DmelTAB2. The longer isoform, which encodes the predicted full length protein, 
is dispensable for IKK/NF-κB signaling but is essential for JNK pathway 
activation. In contrast, mutations that disrupt all predicted DmelTAB2 isoforms 
affect both JNK and IKK signaling. Mutant flies that express only the shorter 
DmelTAB2 isoform are resistant to an E. coli challenge despite defective JNK 
pathway activation, whereas mutants that affect all forms of TAB2 are susceptible 
to infection. We conclude that the activation of the JNK pathway does not play an 
essential role in the Drosophila host defense against E. coli infections, while 
DmelTAB2 is critical for NF-κB activation and antimicrobial peptide gene 
induction.
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Introduction
Drosophila melanogaster is a strong model to study the role of innate 
immunity in the host defense.  In addition to its powerful genetics, Drosophila 
lack an adaptive immune response.  Thus, a phenotype of sensitivity to infections 
can be directly correlated with a reduced immune response.  Once invading 
microorganisms are detected by appropriate Pattern Recognition Receptors 
(PRRs), two distinct NF-κB pathways are activated in the fat body, a functional 
equivalent of the mammalian liver (Hoffmann, 2003).  The Toll pathway is 
required in the host defense against fungal and Gram-positive bacterial 
infections.  It controls the activation of the NF-κB factor Dorsal-Related Immune 
Factor (DIF) through the destruction of its inhibitor, the IκB-like Cactus.  This 
allows for DIF nuclear translocation, and the transcription of hundreds of genes, 
including those encoding the potent antifungal peptides Drosomycin and 
Metchnikowin.  A second pathway, the Immune Deficiency (IMD) pathway, plays 
a major role in the response to Gram-negative infections.  Following the 
stimulation of its microbial receptors PGRP-LC and PGRP-LE, the IMD pathway 
activates another NF-κB transcription factor, Relish, whose composite structure is  
evocative of that of mammalian p100 and p105 Rel precursors (Choe et al., 
2002; Gottar et al., 2002; Hedengren et al., 1999; Kaneko et al., 2006; Leulier et 
al., 2003; Ramet et al., 2002).  Relish is processed by a signal-dependent 
cleavage event, followed by the nuclear translocation of the N-terminal Rel 
domain, while the ankyrin repeat containing domain remains cytoplasmic (Stöven 
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et al., 2000).  Relish activates the transcription of many target genes including 
those encoding the antibacterial peptides Diptericin and Drosocin, as well as 
Defensin, Cecropin, and Attacin.  The Toll and IMD pathways jointly control the 
expression of the latter genes.  
Downstream of the receptor proximal adaptor IMD two signaling pathways 
appear to converge on Relish and are both required for its full cleavage and 
activation. One pathway leads to phosphorylation of Relish via the DmelIKK 
complex.  The second pathway, requiring the caspase DREDD, is required for 
Relish cleavage.  DREDD is recruited into a complex with IMD through the 
adaptor protein FADD (Elrod-Erickson et al., 2000; Georgel et al., 2001; Hu and 
Yang, 2000; Leulier et al., 2000; Leulier et al., 2002; Naitza et al., 2002).  Yet, it 
remains to be established whether DREDD directly cleaves Relish (Stöven et al., 
2003).  IKK complex activation is dependent on the Mitogen-activated Protein 
Kinase kinase kinase (MAP3K) TAK1, which also functions downstream of IMD 
(Silverman et al., 2003; Vidal et al., 2001; Zhou et al., 2005).  Interestingly, cell-
based experiments have revealed a second distinct function of the DREDD/
FADD complex in that it is also required for the activation of the IKK complex 
upstream of TAK1 and downstream of IMD (Zhou et al., 2005, Chapter 2).  
Stimulation of the IMD pathway, either in flies or in S2 cell culture, also 
leads to the immediate and short-lived activation of the Jun kinase pathway 
(JNK) (Boutros et al., 2002; Park et al., 2004).  The bifurcation takes place at the 
level of TAK1, which thus plays a dual role in JNK and IKK activation (Boutros et 
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al., 2002; Silverman et al., 2003).  Interestingly, the TNF-like molecule Eiger 
induces the JNK pathway through TAK1 and possibly the MAP4K Misshapen and 
TRAF1 (Geuking et al., 2005).  Thus, TAK1 appears to be at the intersection of 
these pathways, although it is not clear whether they function in the same tissues 
since Eiger is predominantly expressed in the nervous system (Igaki et al., 2002), 
whereas IMD activation essentially takes place in the fat body during a systemic 
infection.  
We have undertaken a large scale genetic analysis of the Drosophila 
humoral immune response through Ethyl Methane Sulfonate (EMS) saturation 
mutagenesis of the second chromosome of Drosophila melanogaster, which 
represents 40% of the fly genome.  We have previously reported the mutant 
phenotypes of Dif and kenny (Rutschmann et al., 2000a; Rutschmann et al., 
2000b).  Here, we report the isolation and characterization of null alleles of galere 
(glr), which maps to the TAB2 locus.  We find that mutant alleles of this locus can 
be grouped in two categories with strikingly distinct phenotypic properties 
depending on which TAB2 isoform is affected.
Results
Phenotype of galere mutant flies
We generated 27000 mutant fly lines by EMS mutagenesis and screened 
for those that failed to induce a Diptericin-LacZ reporter gene in response to an 
immune challenge with a mix of Gram-negative (Escherichia coli) and Gram-
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positive (Micrococcus luteus) bacteria (Jung et al., 2001).  Complementation 
analysis ascribed three lines to a new locus that we named galere (glr).  Northern 
blot analysis confirmed that Diptericin expression was strongly decreased in glr 
flies after infection (Figure 4.1A).  In addition, the expression level of other 
antibacterial peptide genes were either strongly (Cecropin, Defensin, Figure 
4.1D&G) or partially decreased (Drosocin, Attacin Figure 4.1 B&C).  Induction of 
the antifungal peptide gene Drosomycin, which is mostly dependent on the Toll 
pathway, was not altered in glr mutants (Figure 4.1F).  Finally, Metchnikowin 
expression levels were not affected six hours after challenge, but we observed a 
mild decrease of its expression in glr mutants after 48 hours (Figure 4.1E), which 
is reminiscent of results obtained with kenny mutants (Rutschmann et al., 
2000b).  A noticeably dissimilar induction of Diptericin and Drosocin was 
observed in the glr mutants, which is not the case in other mutants affecting the 
IMD pathway.  
We next examined the survival of wild-type and glr flies following infections 
with selected microorganisms.  As illustrated in Figure 4.2A and B, the three glr 
mutant lines resisted fungal (Beauveria bassiana) and Gram-positive bacterial 
(Enterococcus faecalis) challenges like wildtype flies, indicating that the glr gene 
is not required for the host defense against these infections.  In contrast, all three 
lines were sensitive to infection with E. coli (Figure 4.2C-E), less so than kenny 
flies.  Furthermore, they died at the same intermediate rate as hypomorphic imd1 
mutants, whereas null imd mutants succumbed more rapidly to this challenge 
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Figure 4.1 The expression of antibacterial peptide genes is reduced in 
galere mutants
Quantification of Northern blot analysis of galere (glr) and wild-type cn bw flies, 0, 
6 or 48 hours after challenge with a mix of Gram-positive (M. luteus) and Gram-
negative (E. coli) bacteria.  cn bw samples were used as 100% references at 6 or 
48 hours, according to the kinetics of antimicrobial peptide gene expression.  
Each bar in a series corresponds to one independent Northern blot. (A, D, G) 
Diptericin, Cecropin and Defensin genes expression is drastically reduced in a glr 
background.  Note that in some experiments, Diptericin mRNA levels in the glr 
mutants were higher at 48 hours than at six hours after infection, an observation 
that we had consistently made with the imd1 hypomorphic mutant (AJ, SR, 
unpublished observations).  (B, C) Significant Drosocin and Attacin expression 
can be detected in glr flies.  (F) Drosomycin expression is normal, whereas a 
mild decrease of Metchnikowin expression was observed 48 hours after induction 
(E), as previously reported for kenny mutants.
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Figure 4.2 galere mutants are sensitive to Gram-negative bacterial 
infections
(A, B) glr mutants resist like wild-type to natural fungal (Beauveria bassiana) or 
Gram-positive bacterial (Enterococcus faecalis) infections ; Dif mutant flies 
succumb to these infections as expected.  (C-E) Mutants for the three glr alleles 
are susceptible to Gram-negative bacterial infections, both in homo- or 
hemizygous conditions.  (F) Although genetically null, glr mutant alleles display 
an intermediate sensitivity to Gram-negative bacterial infections, similar to that of 
the hypomorphic allele imd1. cn bw : wild-type background control for the glr, Dif 
and kenny (key) mutants ; GC8 : Df(2R)GC8, deficiency that uncovers the glr 
locus.
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(Figure 4.2F).  This intermediate sensitivity phenotype may be the consequence 
of the partial decrease of the induction of antimicrobial peptide (AMP) genes 
(Figure 4.1).  An hypomorphic (non null) effect of the glr alleles may account for 
this mild phenotype.  If this were the case, one would expect that hemizygous 
flies carrying one copy of the mutant allele and one deficiency chromosome 
devoid of the entire glr locus would display an increased sensitivity to infection 
compared to homozygous glr flies.  However, the survival rates of homozygous 
(glr/glr) and hemizygous (glr/Deficiency) flies were nearly indistinguishable (Fig 
4.2 C-E), indicating that the three glr alleles are genetic nulls.  
galere is required in the IMD signal transduction pathway
Relish binds and activates the Diptericin promoter.  Incubation of extracts 
from wild-type immune-challenged flies with a radiolabeled Diptericin promoter 
probe revealed a major retarded band that is absent when a mutant κB-site 
probe was used (Figure 4.3A).  As for imd1, kenny, and Relish mutants, this band 
is drastically reduced in extracts from challenged glr mutant flies.  These data 
indicate that GLR is required in the IMD pathway to activate the Relish 
transcription factor.  Moreover, the over expression of the imd gene using the 
Gal4-UAS system, which leads to the challenge-independent induction of 
Diptericin expression as previously reported (Figure 4.3B) (Georgel et al., 2001) 
was abolished in a glr mutant background.  Similar results were obtained when
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Figure 4.3 galere is acting downstream of imd in the Gram-negative 
bacteria response signaling pathway
(A) glr is required for the binding of Relish to the Diptericin gene promoter.  Fly 
extracts were incubated with a wild-type or a mutant (Dipt*) radiolabeled probe.  
The genotypes of the flies as well as the incubation time after immune challenge 
are indicated on top. Rel+E23 : background control for the Rel E20 null allele of 
Relish.
(B) Epistatic analysis between the imd and glr genes.  Quantitative PCR was 
used to measure the steady-state levels of Diptericin and imd mRNAs.  Flies in 
samples (a), (b), and (d) have been challenged for 6 hours with E. coli (I : 
induced, NI : noninduced); sample (a) flies are used as a 100% reference for 
Diptericin mRNA. imd over expression was obtained by heat-shocking flies (HS) 
that contain both an hsp-gal4 and a UAS-imd transgenes (c), (e).
(C) glr is not involved in the Toll signaling pathway.  In the fly on the left, the 
Toll10b gain-of function allele of the Toll receptor gene induces the challenge-
independent of a Drosomycin-GFP reporter gene (DD1).  GFP fluorescence is 
still observed in a glr mutant background (fly on the right).
(D) glr is not required for DIF nuclear uptake.  After a septic injury, DIF 
translocates in the nucleus in wild-type (cn bw) and glr flies, whereas it is no 
longer the case in a Toll null background.  The immunostaining of DIF appears in 
red ; in green, DAPI indicate the position of cell nuclei.  The overlap of the two 
fluorescent signals yields a yellow color.
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 imd was over expressed in glr RNAi-treated S2 cells (Figure 4.4 and see below).  
We conclude that glr acts downstream of imd in this signaling pathway.
As shown above, glr flies were resistant to fungal and Gram-positive 
bacterial infections, suggesting that glr is not involved in the Toll pathway.  This is 
further corroborated by the finding that DIF nuclear uptake was normal in glr 
mutant flies, but was abolished in a Toll null mutant background (Figure 4.3D).  
Furthermore, the constitutive expression of a Drosomycin-GFP reporter gene 
triggered by the Tl10b gain-of-function allele of the Toll receptor gene was not 
abolished in a glr background (Figure 4.3C), whereas it is blocked in a Dif mutant 
background (Rutschmann et al., 2000b).
galere encodes a Drosophila TAB2/TAB3 homolog
We identified the glr locus by positional cloning (Figure 4.5).  The three 
mutations affect the CG7417 gene (Figure 4.6A), which encodes the Drosophila 
TAB2/TAB3 homologue since the predicted protein contains its three 
characteristic domains (Figure 4.7).  The expression of a transgenic full-length 
CG7417 cDNA rescued the glr3 Diptericin inducibility phenotype (Figure 4.6B), 
thus demonstrating that the defect in IMD pathway activation is indeed due to the 
mutation in TAB2.
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Figure 4.4
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Figure 4.4 Galere/TAB2 functions downstream of IMD in S2 cells
IMD stable cells were transfected with various dsRNAs, then treated with various 
combinations of peptidoglycan and copper.  Northern blotting analysis was 
performed to examine the expression of the antibacterial gene Diptericin.
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Figure 4.5 Positional cloning of the glr locus
We first mapped the position of glr to the 55A-56E interval by 
recombination mapping between the 2R loci cn and bw.  This approximate 
position was confirmed by Single Nucleotide Polymorphism mapping.  glr 
complemented all the deficiencies of the second chromosome deficiency kit that 
uncover this region.  However, one 835 kbp interval, namely the 56C-56E region, 
was not covered by the deficiency kit and contains 75 predicted genes with no 
obvious similarity to known components of the NF-κB signaling cascade. We 
further restrained this interval by using the Df(2R)GC8 deficiency which 
proximally overlaps the Df(2R)P34 deficiency and removes an additional region 
distal to the CG7229 gene (Konsolaki and Schupbach, 1998).  glr complements 
only the latter deficiency ; this places the glr locus in the region uncovered only 
by Df(2R)GC8. We mapped by quantitative PCR the breakpoints of these two 
deficiencies (Chiang et al., 1999).  The Df(2R)P34 distal breakpoint mapped 
distal to CG7230 while that of Df(2R)GC8 was distal to CG10073.  However, we 
found that Df(2R)GC8 was unlikely to uncover the hu-li-tai-shao (hts) gene since 
it complemented two lethal P-alleles of hts. We further subdivided the 120,000 bp 
region comprised between CG7230 and hts by generating flippasemediated 
deficiencies using FRT-site-containing P-elements in this region (Parks et al., 
2004).  glr complemented the ΔC-ΔE, but not the ΔA and ΔB deficiencies, thus 
restraining the position of glr to a 45.000 bp interval delimited by the CG7230 and 
CG9811 genes that contains 11 predicted genes.  We noticed that one of these 
genes, CG7417, displayed very weak sequence similarity to mammalian TAB2.  
Indeed, the sequence conservation was mainly restricted to the Cterminal end of 
the protein and corresponds to a conserved motif known as little finger (NCBI : 
LOAD_little_fing.7.little-fing) or ZnF_RBZ (SMART : 00547.10 ; Zinc finger 
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Figure 4.5 Positional cloning of the glr locus (cont.)
domain in Ranbinding proteins).  Recently, this motif was shown to interact 
specifically with K63-polyubiquitin chains (Kanayama et al., 2004).  We therefore 
sequenced the CG7417 coding sequence both in wild-type and in the three 
mutant alleles.  We found in each mutant allele a single point mutation that 
introduces a premature STOP codon in the gene : T to A at nucleotide 2681 
(Cys786 of the 831-residue protein) for glr1, C to T at nucleotide 2496 (Gln725) for 
glr2, and C to T at nucleotide 2326 (Gln669) for glr3.  The finding that three 
independent mutations affect the coding sequence of one of the 11 candidate 
genes in the region which we delimited shows that glr mutations affect the 
CG7417 gene, a conclusion further supported by the rescue of the glr mutant 
phenotype by a transgene that expresses the wild-type gene (Figure 4.6B).
The figure shows the genetic map of the glr locus containing region. 
Scale : thousands bp, numbering according to Flybase.  Genes in the region are 
drawn as boxes or vertical bars.  Orange arrows and purple triangles represent 
respectively the Q-PCR probes and the lethal P element insertions used to map 
the distal breakpoints of the Df(2R)P34 and Df(2R)GC8 deficiencies (in green).  
Plain green lines correspond to the regions uncovered by those deficiencies, 
whereas dotted lines represent the interval containing their distal breakpoint.  
Deficiencies that were generated using the FRT-flippase system for further 
mapping are shown in blue ; blue triangles represent the modified P element 
insertions that were used to build those deficiencies.  In red, the CG7417 
candidate gene presents a weak overall sequence similarity to the TAB2 and 
TAB3 genes of vertebrates.
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Figure 4.6 galere encodes the Drosophila homolog of TAK1 Binding 
Proteins 2 and 3
(A) The Drosophila TAB2/3 homolog is mutated in glr flies.  Structural 
representation of the TAB2 and TAB3 proteins in vertebrates and invertebrates.  
Three canonical domains define this family of proteins : a CUE domain (in blue), 
a split coiled-coil domain (in purple) and a little Zn finger (in green).  Drosophila 
proteins have additional coiled-coil regions. Sequencing of the CG7417 
candidate gene from the three glr mutants revealed three independent point 
mutations in the coding sequence, that correspond to the premature introduction 
of a STOP codon and subsequent truncation of the mutant proteins, as indicated.
(B) Rescue of the glr mutant phenotype by a wild-type glr transgene.  All flies 
have been challenged with E. coli.  The genotypes of the flies are indicated in the 
legend. glr mutant flies that carry a wild-type cDNA under the control of UAS 
regulatory sequences express the glr gene at moderate levels, driven by the low 
constitutive expression provided by the hsp-Gal4 transgene in the absence of 
heat-shock (c).  glr sibling flies obtained in the same cross that carry either the 
driver or the UAS transgene fail to express Diptericin (d), like glr mutant flies (b).  
Heterozygous sibling flies behave as wild-type (e, f).
(C) TAK1;glr double mutants display the same intermediate phenotype to Gram-
negative bacterial infections as compared to either single mutant.  ywDD1 ; cn 
bw : genetic background control in which the kenny (key) mutants have been 
generated ; the TAK1 mutants have been generated in a yw context.  To compare 
the TAK1 and glr phenotypes, the genetic backgrounds of the first (yw) and 
second chromosomes (cn bw) have been homogenized using standard crosses.  
The slightly increased sensitivity of the glr simple mutants as compared to the 
TAK1 and TAK1; glr mutants is not significant.
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Figure 4.7 Alignments of the CUE, coiled-coil, and little Zn Finger domains 
that characterize the TAB2/TAB3 family
The CUE domain has been reported to bind to proteins that are mono- or 
polyubiquitinated (reviewed in (Di Fiore et al., 2003)).  Indeed, the structures of 
two proteins that bind to ubiquitin have been published (Kang et al., 2003; Prag 
et al., 2003).  The generic sequence of the PFAM CUE domain is shown.  
Residues from the Cue2-1 domain (*) and the Vps9 CUE domain (*: monomer; 
§ : dimer) that interact directly with ubiquitin are indicated on top.  Conserved 
residues of the TAB2/3 family are displayed in red (residues conserved in six 
sequences) and in orange (residues conserved in five out of six sequences).  
The apolar backbone of the domain is conserved (blue : conserved leucine or 
isoleucine residues present in the generic sequence; cyan : hydrophobic 
residues present at the same position).  It is unlikely that the TAB2/3 CUE 
domains are able to bind to ubiquitin with high affinity since a key apolar residue 
(methionine shown in green in the generic sequence) that is involved in the 
interaction with an hydrophobic pocket defined by L8, I44, H68, and V70 of 
ubiquitin is replaced by charged residues.  The same observation can be made 
about the distal di-leucine repeat where the leucine that binds to ubiquitin is 
replaced by polar or charged amino acids.  However, the mouse TAB2 CUE 
domain has recently been shown to be able to bind to monoubiquitin and to be 
required for IL-1-induced TRAF6 ubiquitination and NF-κB pathway activation 
(Kanayama et al., 2004; Kishida et al., 2005).
The split coiled-coil domain has been shown to mediate the interaction of 
TAB2/3 with TAK1 (Geuking et al., 2005; Ishitani et al., 2003).  Conserved leucine 
residues are shown in blue whereas apolar amino acids are indicated in cyan.  
Conserved charged or polar residues are displayed in light green (perfect 
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Figure 4.7 Alignments of the CUE, coiled-coil, and little Zn Finger domains 
that characterize the TAB2/TAB3 family (cont.)
conservation in darker green).  There is no significant sequence conservation of 
this domain between insects and vertebrates (19% identity between GLR and 
human TAB3), whereas the domain is well conserved within vertebrates and 
within Drosophila.  However, the Anopheles gambiae coiled-coil domain is highly 
divergent at the sequence level, both with Drosophila and vertebrates.  Coiled-
coil regions were predicted using the ISREC coils server (Lupas et al., 1991).
The Zn finger is highly conserved between members of the TAB2/3 family 
and together these domains may define a subfamily within the NCBI little finger 
family.  Conserved cysteins are shown in bold.  Red and orange colors are used 
as above.  The glr1 mutation affects this domain, and thus underscores its 
importance.  However, since this mutation introduces a STOP codon, we cannot 
formally exclude that the truncation of the 44 residues that form the C-terminal 
domain distal to the Zn finger contributes to the mutant phenotype.  
Nevertheless, this possibility appears to be remote since this C-terminal 
extension is absent in vertebrates, is not conserved in the predicted mosquito 
sequences, and is less preserved between D. melanogaster and D. 
pseudoobscura (60% sequence identity) than the 95 % and 88% identity 
conservation for the CUE and coiled-coil domains respectively.  TAB2 has been 
reported to be part of a N-CoR/TAB2/HDAC3 repressor complex on the 
chromatin that is exported out of the nucleus upon IL-1ß signaling (Baek et al., 
2002).  However, the nuclear export sequence and the MEKK phosphorylation 
sites of TAB2 that are required for export are not conserved in DmelTAB2.  We 
conclude that this aspect of TAB2 biology is unlikely to occur also in Drosophila.
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galere and TAK1 belong to the same branch downstream of imd 
Two peculiar features of the glr phenotype are its moderate sensitivity to 
E. coli infection and the intermediate levels of induction for certain AMP genes.  
By comparison null mutants of imd and kenny are highly susceptible to E. coli 
infection (Figure 4.2F) and exhibit almost no AMP gene induction.  The 
intermediate glr phenotype is reminiscent of mutants carrying a null allele of 
Drosophila TAK1, the MAPKKK involved in the IMD pathway (Vidal et al., 2001) 
and (Figure 4.6C).  This intermediate susceptibility to Gram-negative infections of 
TAK1 and glr mutants suggests that an alternative secondary path functions 
downstream of IMD for the activation of the IKK complex.  To determine whether 
glr and TAK1 function in the same or distinct branches downstream of IMD, we 
generated TAK1;glr double mutants.  If the two genes are required in distinct 
branches, the double-mutant combination should display a higher, additive, 
sensitivity to E. coli than either single mutant.  In contrast, if the two gene 
products are involved in the same arm of the bifurcation, the phenotype of the 
double mutant should be similar to that of each single mutant.  As shown in 
Figure 4.6C, we found that the latter hypothesis is correct and conclude that 
TAK1 and glr function in the same branch.  To further support this inference, we 
performed a yeast two-hybrid assay using DmelTAK1 as a bait and GLR as a 
prey and found a strong interaction, thus establishing that like in vertebrates 
Drosophila TAB2 and TAK1 bind directly to each other (Table 4.8, (Shibuya et al., 
1996)).  This interaction had been previously reported in a genome-wide yeast 
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Table 4.8
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Table 4.8 TAK1 and Galere/TAB2 interact in yeast two-hybrid assays
The strength of potential interactions was qualitatively presented as “+”s, using 
the expression of the Ade2 reporter gene as criteria.
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two-hybrid screen and confirmed recently in co-immunoprecipitation experiments 
(Geuking et al., 2005; Giot et al., 2003).  To further define the role of glr in the 
imd pathway, we analyzed its role in a S2* cell culture system (Zhou et al., 2005).
galere/TAB2 functions as an adaptor required for TAK1 activation
In the S2* embryonic macrophage cell line, IMD pathway stimulation by 
diaminopimelic acid-type peptidoglycan (DAP-PGN) induces the expression of 
Diptericin (Kaneko et al., 2004).  As previously reported, treatment of S2* cells 
with dsRNA targeted at known members of the IMD pathway led to a strong 
decrease in the induction of Diptericin by PGN (Figure 4.9A).  As expected, this 
was also the case when cells were treated with TAB2 dsRNA (Gesellchen et al., 
2005; Kleino et al., 2005; Zhuang et al., 2006).  The induction of Drosomycin 
expression by the Toll pathway was not impaired by TAB2 RNAi, consistent with 
the in vivo data (Figure 4.9B and Figures 4.1, 4.3).  To establish that TAB2 
function is required in IKK activation, we monitored the challenge induced 
phosphorylation of Relish by immunoprecipitated IKK complex (Zhou et al., 
2005).  This phosphorylation is strongly reduced in S2 cells exposed to TAB2 
dsRNA, as for other mutants of the imd pathway (Figure 4.9C).  This result 
indicates that like TAK1, TAB2 is required for the activation of the IKK complex by 
an immune challenge in Drosophila S2* cells.  To define the function of TAB2 
relative to TAK1, we asked whether glr was required for the induction of Diptericin
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Figure 4.9 Galere/TAB2 functions upstream of the IKK complex in the IMD 
pathway
(A) galere is required for the antibacterial immune response. Various dsRNAs 
were transfected into S2 cells.  Peptidoglycan-induced Diptericin gene activation 
was examined by Northern blotting.  Rp49 serves as loading control. 
(B) galere is not required for the antifungal immune response.  DsRNA-
transfected cells were treated with Spätzle-containing conditioned medium.  
Drosomycin gene expression was analyzed by Northern blotting.
(C) galere is required for peptidoglycan-induced IKK activation. DsRNA-
transfected cells were treated with peptidoglycan for 15 minutes.  The 
endogenous IKK complex was immunoprecipitated using antibody raised against 
DmelIKKγ.  The immunoprecipitates were subsequently subjected to in vitro 
kinase assays using Relish as substrate. 
(D) galere is not required for TAK1Δ-mediated antibacterial peptide gene 
activation.  TAK1Δ stable cells were transfected with various dsRNAs, then 
treated with various combinations of peptidoglycan and copper.  Northern blotting 
analysis was performed to examine the expression of the antibacterial gene 
Diptericin.
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 expression observed when an activated form of TAK1 is overexpressed in S2 
cells (Figure 4.9D).  The induction of Diptericin was not altered by TAB2 RNAi 
and was similar to that observed after RNAi targeting PGRP-LC or imd (data not 
shown), two molecules that function upstream of TAK1 in the IMD pathway.  In 
contrast, FADD and DREDD RNAi strongly reduced the induction of Diptericin in 
this system, consistent with their proposed role in Relish cleavage (Zhou et al., 
2005).  To more precisely define the role of TAB2, we assayed its role in TAK1 
activation.  To this end, we developed a TAK1 kinase activity assay in which we 
assessed the incorporation of radiolabeled ATP by epitope-tagged 
immunoprecipitated DmelTAK1 using as a substrate recombinant, kinase-dead, 
MKK6, a known target of human TAK1 (Wang et al., 2001).  PGN-stimulation of 
S2* cells led to a significant and reproducible increase in the levels of DmelTAK1 
activity, as monitored by this assay (Figure 4.10B).  As expected, this level of 
TAK1 activity decreased to background level when cells were treated with 
dsRNA against the IMD pathway receptor gene PGRP-LC or with TAK1 dsRNA, 
but LacZ dsRNA had little effect.  In contrast, a significant phospho MKK6 signal 
was observed in cells treated with IKKγ dsRNA, consistent with the position of 
kenny downstream of TAK1 in the IMD pathway.  We found no significant 
activation of TAK1 in cells treated with TAB2 exon4 dsRNA.  Taken together, 
these data establish that TAB2 is an adaptor required for the activation of TAK1 
by immune stimuli.  A similar conclusion has been reached as regards the role of 
TAB2 in TAK1 activation by the Eiger pathway (Geuking et al., 2005).
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Figure 4.10 JNK pathway activation is dispensable in the Drosophila host 
defense against E. coli
(A) Scheme of the TAB2 locus.  The location of the STOP mutations used in this 
study are represented.  The glr category of alleles is represented in blue while 
the other category, which affects the full-length protein isoform and only blocks 
JNK signaling, is represented in red. Two transcripts from the locus are shown, 
with the predicted protein product. The short isoform has been detected by 
Northern blot analysis (Inset left) and by 5’ Race PCR (Inset right, M : size 
markers).  Three ESTs (not shown : GH18828, GH24638, GH24933) further 
confirm its existence.  The putative exon 1.2 is used as an alternative 5’ exon in 
some ESTs.  However, we could not detect any phenotypic consequence when 
its expression was targeted by RNAi in S2 cells (B, F).
(B) TAK1 activation assay.  S2 cells expressing FLAG-tagged TAK1 were 
immunoprecipitated and incubated with human MKK6 and radiolabeled ATP.  
Kinase activity was monitored by autoradiography.  The quantity of 
immunoprecipitated FLAG-tagged TAK1 was revealed by Western blot with a 
FLAG antibody.  Finally, a fraction of the cell extract was used for Northern blot 
analysis and hybridized with a Diptericin and a Rp49 probe.
(C) Survival experiments with a set of TAB2 allelic combinations.  The deficiency 
used in these studies was Df(2R)EXEL6069.
(D) Genetic characterization of TAB2 alleles to map the distinct functions of the 
locus using Diptericin induction as a read-out.  The Dipt mRNA levels were
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Figure 4.10 JNK pathway activation is dispensable in the Drosophila host 
defense against E. coli (cont) 
monitored 6 hours after an E. coli challenge using quantitative RT-PCR. The 
deficiency used in this panel and in E and G was ΔB (Figure 4.5).
(E) Analysis of IKK and JNK pathway activation.  Punch and Dipt mRNA levels 
were monitored 3 hours after an E. coli challenge.  Punch expression is 
dependent both on IKK and JNK pathway activation.  Note that Dipt expression is 
moderately affected in the G666 allele, whereas Punch mRNA levels are 
decreased almost as severely as in the G734 TAB2 allele or key.
(F) JNK pathway activation is blocked when the long TAB2 isoform is targeted by 
dsRNA interference.  RNAi-treated extracts of PGN-stimulated S2 cells were 
analyzed by Western blot analysis with a P-JNK specific antibody or analyzed by 
Northern blot analysis.  Targeting the long TAB2 isoform, exon 1 dsRNA, did not 
affect Diptericin induction (see also lower panels of 6B).
(G) Survival experiments to an E. coli challenge. TAB2G734 and not TAB2G666 flies 
succumb to the infection.
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JNK pathway activation is dispensable for host defense against E. coli
The TAK1-TAB2 complex is required both for IKK complex activation and 
for JNK pathway activation.  In flies, 39 mutant alleles for TAB2 have been 
recovered in a suppressor screen for a JNK and TAK1-dependent eye phenotype 
induced by Eiger over expression in this tissue (Geuking et al., 2005).  
Interestingly, most of these mutations correspond to STOP codons distributed 
regularly along the putative TAB2 ORF (Figure 4.10A), while all three glr alleles 
encode nonsense mutations clustering in the C-terminus of the gene.  Therefore, 
we examined the susceptibility to E. coli infection of flies carrying nonsense 
mutations G71 and G576 that stop translation of TAB2 at residues 40 and 66 of 
the predicted protein, respectively.  Strikingly, we found that TAB2G71 and 
TAB2G576 hemizygous or transheterozygous flies resisted infection, in contrast to 
TAB2glr3 hemizygous flies (Figure 4.10C).  In keeping with these unexpected 
results, TAB2G71 and TAB2G576 flies induced Diptericin expression normally (data 
not shown).  We reasoned that shorter protein isoforms might originate from 
alternative start sites of transcription of the TAB2 locus, thus bypassing the early 
STOP codons.  Indeed, many TAB2 ESTs have been isolated, some of which 
contain a 5’ end starting within exon 2, past the initial AUG of the predicted full 
length protein ( Figure 4.10A).  We detected by Northern blot analysis the 
existence of three transcripts in adults, of approximate lengths 1.8 , 3.1 , and 5.2 
kbp (Figure 4.10A).  A full length sequenced cDNA (AJ277497) is 3.2 kbp and 
corresponds to the longest cDNA in the EST database.  Two transcripts were 
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mapped in detail by 5’ RACE RT-PCR in adult flies and S2 cells (Figure 4.10A).  
Interestingly, the shorter of these transcripts begins in the middle of exon 2 and 
lacks the first start codon (AUG1, Figure 4.10A).  Instead, this alternative 
transcript is predicted to utilize a later start codon (AUG2 in Figure 4.10A) and to 
encode a shorter protein product of 355 C-terminal residues (Figure 4.10A).  We 
hypothesized that this short transcript is sufficient for IMD signaling, while the 
results of Geuking et al. indicate that the longer product is required for the Eiger/
TAK/JNK pathway.  We therefore decided to test several additional nonsense 
TAB2 mutants to map the portions of this locus required for the IMD pathway.  
We found that TAB2G683 (Gln330STOP) and TAB2G666 (Gln458STOP) mutant flies 
are still able to induce Diptericin normally following E. coli infection, while the 
TAB2G734 (Gln 486STOP), TAB2G788 (Gln542STOP) and TAB2G824 (Trp767STOP) 
flies induce negligible Diptericin induction (Figure 4.10D and 4.10A for allele 
map : red alleles functional, blue alleles nonfunctional IMD signaling). This 
mapping strategy thus delineates the aa458-486 interval in which a shorter ORF 
is expected to initiate translation.  Interestingly, this 28-residue interval contains a 
ATG at position 476 (AUG2 Figure 4.10A) that is the predicted initiation codon in 
the correct reading frame of the shortest transcript isolated by 5’ RACE PCR.  
We compared in more detail the phenotypes of the TAB2G666 
(Gln458STOP) and of the TAB2G734 (Gln486STOP) mutants as regards JNK 
pathway and IKK complex activation using respectively Punch and Diptericin 
induction as known read-outs of these pathways (Silverman et al., 2003).  We 
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determined that Punch maximum induction occurs 3 hours after an E. coli 
challenge and was markedly decreased in either the TAB2G666 (Gln458STOP) or 
the TAB2G734 (Gln486STOP) alleles, while Diptericin level was drastically reduced 
only in the latter (Figure 4.10E).  Punch expression is also decreased in kenny 
mutants, thus showing that in adults Punch induction is controlled both by the 
IKK complex and the JNK pathway. These data indicate that the TAB2G666 allele 
strongly affects only JNK activation induced by a septic injury while the TAB2G734 
mutant blocks the induction of both the JNK and the IKK pathways.  Consistent 
with these interpretations, Punch expression is not reduced to background levels 
until both the JNK and NF-κB pathways are crippled, in the G734 and glr alleles.  
To confirm this interpretation, we differentially inactivated TAB2 isoforms in S2* 
cells by using dsRNA that target either exon 1 or 4.  Exon1 dsRNA is expected to 
mimic the TAB2G666 phenotype, since only the long isoform is targeted whereas 
exon4 dsRNA is expected to target both isoforms, thus recapitulating the effect
of TAB2G734.  Only exon 4 dsRNA treatment abolished Diptericin induction (Figure 
4.10B and 4.10F).  In contrast, either exon 1 or exon 4 dsRNAs prevented TAK1 
activation (Figure 4.10B) and JNK phosphorylation (Figure 4.10F).  In conclusion, 
the full-length transcript is required only for JNK pathway activation, whereas IKK 
complex activation can be mediated by the short isoform alone.  
The TAB2G666 allele allows the uncoupling of JNK pathway activation from 
IKK complex activation and thus provides the means to assess the relevance of 
JNK pathway activation to host defense.  We therefore monitored the resistance 
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of TAB2G666 and TAB2G734 mutant flies to an E.coli infection.  Figure 4.10G shows 
that only the latter are susceptible to this challenge while the former resist like 
wild-type flies.  We conclude that JNK pathway activation does not play an 
essential role in host defense against E. coli infections. 
Discussion
An important issue for understanding the NF-κB pathway in mammals is 
the role of TAB2 in TLR signaling and in the response to proinflammatory 
cytokines such as IL-1, TNFα.  While data obtained in a cell culture system 
clearly implicate TAB2/3 in the response to cytokines (Ishitani et al., 2003), no 
evidence for a similar role has been obtained so far from the analysis of TAB2 
knock-out mutant mice (Shim et al., 2005; Sanjo et al., 2003).  Given the 
evolutionary conservation of the NF-κB pathway, our data in Drosophila suggest 
that the lack of phenotype in mice is indeed due to the redundancy of TAB2 and 
TAB3 (Ishitani et al., 2003).  
The alleles of TAB2 with nonsense mutations in the first half of the gene 
(G71, G576, G683, and G666) are resistant to bacterial infection and induce 
fairly normal levels of AMP genes.  These flies express an isoform of TAB2 
lacking the CUE domain via the shorter transcript characterized above.  Thus, as 
in mammals, the N-terminal CUE domain, one of three characteristic domains of 
TAB2 that have been conserved during evolution (Figure 4.6 and Figure 4.7), is 
dispensable for NF-κB signaling and host defense against infections (Kanayama 
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et al., 2004).  In contrast, the “little Zn-finger” domain appears to be critical for 
NF-κB signaling, because a truncation removing this domain prevents immune 
activation (glr1 allele).  
In mammals, several components of the NF-κB pathway are 
posttranslationally modified by conjugation with K63-linked polyubiquitin chains 
via the E3 ubiquitin ligase TRAF6 and the E2 ubiquitin conjugating enzyme 
complex Ubc13-Uev1A (Chen, 2005).  In TNF signaling, for instance, RIP1, 
TRAF2, and NEMO (IKKγ) are polyubiquitinated and it has been proposed that 
polyubiquitinated RIP1 serves as a platform to recruit both TAK1 and IKK 
complexes (Ea et al., 2006).  Other ubiquitination complexes may also be 
involved in this pathway, because knockdown of Ubc13 leads to a moderate 
reduction of NF-κB signaling (Yamamoto et al., 2006), while JNK signaling is 
abolished. Importantly, binding of both NEMO and TAB2/TAB3 to polyubiquitin 
chains is required for IKK complex activation in vitro (Ea et al., 2006; Wu et al., 
2006). The binding of TAB2/TAB3 to K63-linked ubiquitin chains is mediated by 
their C-terminal “little Zn finger” (Kanayama et al., 2004).  K63-polyubiquitination 
is also believed to play a role in the IMD pathway in Drosophila since the 
Bendless (Ubc13)/Uev1a E2 ubiquitin conjugating enzyme complex is required 
for IKK complex activation in S2*cells (Yamamoto et al., 2006; Zhou et al., 2005, 
Chapter 2).  Our data further support the hypothesis that K63-polyubiquitin 
binding is critical for IMD signaling because the TAB2glr1 allele lacks an intact 
“little Zn finger” domain, and displays a phenotype equivalent to null.  
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We conclude that Drosophila TAB2 functions as an adaptor molecule for 
TAK1 function as : (i) TAK1 and TAB2 have the same non-additive phenotype, (ii) 
TAK1 and TAB2 interact directly (Geuking et al., 2005; Giot et al., 2003, this 
work), (iii) both TAK1 and TAB2 are required for the activation of the Drosophila 
IKK signaling complex and for that of the JNK pathway (Boutros et al., 2002; 
Silverman et al., 2003, this work), (iv) TAB2 is not required for Diptericin induction 
by an activated form of TAK1 but is required for TAK1 activation (Figure 4.10B).  
Finally, a similar conclusion has been reached in a study that addressed the role 
of the TAB2/TAK1 complex in JNK pathway activation by the eiger/wengen 
signaling cascade, which potentially intersects the imd pathway at the level of the 
TAK1/TAB2 complex (Geuking et al., 2005).  The exact physiological role of this 
pathway triggered by the TNF-like molecule Eiger remains undefined, although it 
has been implicated in the production of a shock response to Salmonella 
infection (Brandt et al., 2004).  
The genetic ablation of both TAK1 and TAB2 together leads to a strikingly 
mild phenotype, even though null alleles of genes acting either upstream (imd) or 
downstream (kenny) of TAK1 display a more severe phenotype (Figures 4.2F 
and 4.6C).  These data suggest that two alternative paths occur downstream of 
imd and that these two branches re-converge on IKK.  TAK1 and TAB2 belong to 
the same branch.  Presumably, UBC13 and UEV1A also belong to this branch in 
which regulatory ubiquitination is likely to play a cardinal role.  Relish can still be 
activated to some degree in the absence of a functional TAK1/TAB2 complex 
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since Attacin and Drosocin are still partially induced in TAB2 mutants, but are not 
detectable in Relish mutants (Hedengren et al., 1999).  This limited activation 
may partly account for the presence of Relish observed in the nuclei of TAK1 null 
mutant larvae (Delaney and Mlodzik, 2006).  We predict that one or several 
genes constitute a second, partially redundant, branch that also converges on 
IKK.  This second branch might then be responsible for the persistent activation 
of the IMD pathway.  It has been shown in cell culture experiments that over 
expressed tagged TAK1 is degraded rapidly following Relish activation (Park et 
al., 2004).  Yet, Diptericin and Drosocin are still expressed in wild-type flies at 
significant levels up to 48 hours after immune challenge (Figure 4.1), suggesting 
an alternative, longer-lived signaling pathway that functions independently of the 
TAK1/TAB2 complex.  Candidates for this second sub-branch include the five 
other Drosophila MAP3K genes (Stronach, 2005), as may be the case in 
mammals.  Indeed, the genetic ablation of TAK1 in mice does not lead to a total 
block of NF-κB signaling (Sato et al., 2006; Shim et al., 2005). In addition to 
TAK1, several MAP3K kinases such as NIK, MEKK1 and MEKK3 have been 
shown to activate the IKK signaling complex in mammalian cells (Schmidt et al., 
2003).  A potential alternative to the existence of a second branch downstream of 
RIP1 is that the IKK complexes that bind to polyubiquitinated RIP1 be sufficiently 
concentrated to allow for low level activation of the IKK complex independently of 
any MAP3K.  This explanation may also hold in flies since several essential 
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residues in the NEMO Ub binding site are conserved in its fly homologue, Kenny 
(Ea et al., 2006).  
The JNK pathway is activated briefly in response to immune stimuli both in 
flies and in cell culture systems (Boutros et al., 2002; Park et al., 2004).  Its 
targets include structural and regulatory cytoskeletal genes.  However, its 
physiological importance in the immune response remains unresolved.  
Conflicting reports concluded that the JNK pathway either down- regulates (Kim 
et al., 2005; Park et al., 2004), up-regulates (Delaney and Mlodzik, 2006; Kleino 
et al., 2005), or has no effect (Boutros et al., 2002; Silverman et al., 2003) on 
AMP gene induction in S2 cells.  Following an in vivo study, it was recently 
proposed that the JNK pathway substantially controls the expression of AMP 
genes (Delaney and Mlodzik, 2006).  However, this analysis was based on the 
experimental activation of the JNK pathway over a long time period, which did 
not recapitulate the brief activation of the JNK pathway observed in the septic 
injury model.  Thus, the expression of AMP genes in this context may not 
represent a physiological situation.  Moreover, the JNK loss-of-function clonal 
analysis, which reported a loss of AMP gene inducibility, was performed in larval 
fat body which is distinct from adult fat body.  Finally, it cannot be excluded that 
the phenotype observed may be the indirect consequence of developmental 
effects of JNK loss-of function.  
In our present report, we have analyzed several TAB2 mutant alleles and 
grouped them in two categories. The first category consists of mutations that 
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introduce STOP codons in the N-terminal half of the predicted full-length protein 
(JNK phenotype), affecting only the product of the long transcript and preventing 
JNK signaling.  These mutants display only a slight reduction in AMP gene 
induction as opposed to a strong decrease of JNK pathway activation.  In 
contrast, the second category of alleles (glr) introduces STOP codons in the C-
terminal half, affecting all isoforms of the protein and strongly inhibiting Diptericin 
induction.  For example, the TAB2G734 allele inserts a STOP codon near the 
predicted translation start of the short form and fails to support AMP genes 
induction.  In this second category of mutant alleles, we observed that both JNK 
and IKK activation are strongly reduced.  Thus, the difference between the first 
and second category of alleles is that IKK activation is prevented only in the latter 
while both groups of mutants display a severely decreased activation of the JNK 
pathway.  The key observation is that only mutant alleles of the glr category 
succumb to an E. coli challenge.  Since the mutants of the first category survive 
this infection even though JNK activation is prevented, we conclude that JNK 
pathway activation in Drosophila does not play an essential role in the host 
defense against E. coli infections.
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Figure 4.11
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Figure 4.11 Schematic representation of IKK signaling complex activation 
in the IMD pathway of Drosophila.
The proposed model of IMD pathway activation presented in the text
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Materials and methods
Fly strains
Fly stocks were grown on standard cornmeal-agar medium at 25°C. The different 
genetics combinations used in this study were obtained using standard crosses 
with the following lines : 
ywDD1 ; cn, bw : wild-type stock used for the mutagenesis in which glr3 was 
generated (Jung et al., 2001). It carries on the X chromosome a Diptericin-LacZ, 
Drosomycin-GFP (DD1) reporter genes system. The glr1 and glr2 alleles have 
been generated in a ywDD1 ; cn, bw, sp context. 
imd1 : hypomorphic allele of the imd gene. imd null alleles will be described 
elsewhere.
Tl9QRE1/Df(3R)ro-XB3 : null Tl combination.
Df(2R)P34 : deficiency from the Bloomington public stock center,
Df(2R)GC8 : deficiency that distally overlaps Df(2R)P34 (Konsolaki and 
Schupbach, 1998).
Toll10b, e/TM3, e, Ser, Sb : dominant female sterile gain-of-function allele of the 
Toll receptor gene, that constitutively signals to the nucleus.
Rel+E23 : background control for the Rel E20 null allele of Relish, (Hedengren et 
al., 1999)
yw : original stock used for the mutagenesis that generated the yw, DmelTAK1 
mutants (Vidal et al., 2001).
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P(LacW)corak08713, P(PZ)hts01103, P(LacW)htsk06121, 
P(LacW)RpL11k16914 : lethal P element insertions from the Bloomington stock 
center,
d07723, d01135, d09246, d08830, d03378 and d07259 : Flippase Recognition 
Target sequences containing P elements (Exelixis, Inc).
The G series of TAB2 alleles as well as the Df(2R)EXEL6069 deficiency are 
described in Geuking. et al. (2005).
The UAS-glr transgene was obtained by cloning a BglII-XhoI fragment from EST 
LD40663 into the same sites in the pUAS-T vector.
Microbial challenge and survival assays
Infections were performed as previously described (Rutschmann et al., 2000a).  
In this study we used the following microbial strains : Escherichia coli 1106 
(Gram-negative bacteria) alone or mixed with Micrococcus luteus (Gram-positive 
bacteria in the mix), Enterococcus faecalis (Gram-positive bacteria), and natural 
infections with Beauveria bassiana (entomopathogenic fungus).  Each survival 
experiment was performed at least three times.  For the double-mutants survival 
assay, backgrounds of the first and second chromosomes were homogenized, so 
as to be able to compare the phenotypes
Northern blots analysis
Northern blot analysis was carried out as previously described (Rutschmann et 
al., 2000a).  Quantification was done with a BAS 2000 Bioimager and all results 
were standardized against the immune independent RP49 signal.
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Immunolocalizations
One hour after infection with the mix of bacteria, flies were dissected and the fat 
body was stained with a specific rabbit anti-DIF antibody, as previously described 
(Rutschmann et al., 2000a).
Gel-shift experiments
These experiments were performed as described (Rutschmann et al., 2000a).
Real-Time Quantitative PCR
Quantification of transcripts : batches of 5 flies were frozen in liquid 
nitrogen.  Total RNA extraction, R transcription and Real-Time PCR were 
performed as previously described (Gottar et al., 2002).  Signals were 
standardized against the relevant RP49 signal, then the appropriate samples 
were given the value of 100%.
Deficiency mapping : Real-Time PCR experiments were run on genomic 
DNA
preparations of Df(2R)P34 and Df(2R)GC8 flies, using a Light Cycler (Roche). 
PCR reactions were set up according to the manufacturer’s instructions in a 20 
µL total volume. PCR steps : polymerase activation - 8 min, 45 cycles with : 
denaturation – 5 s at 95°C, annealing – 5 s at 60°C or 62°C (depending on the 
primers), elongation – 5 s at 72°C. Diptericin primers were used as a « 2 copies » 
positive control. Primers sequences are as follows :
Probe A :  Forward (F) : 5’-CGTCGCCTTTATGGCATTAT-3’
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  Reverse (R) : 5’-TCGAGCAGGTAAGCGATTTT-3’
Probe B :  F : 5’-ATTTGGGGGTTTCCTTGAAT-3’
  R : 5’-AACAATTGCAGCACAATGGA-3’
Probe C :  F : 5’-GCCAGACAAACGACACTTGA-3’
  R : 5’-ACAAATTTGGCAACGAAAGC-3’
Probe F :  F : 5’-TTGCCCTGGTCCTGAGTACA-3’
  R : 5’-GCGAATTTCGATTTCTCACA-3’
Probe D :  F : 5’-TGAAATAGGGCTGGCAAATC-3’
  R : 5’-TGACTGCTATCGAATGTTTTGG-3’
Diptericin probe :  F : 5’-GCTGCGCAATCGCTTCTACT-3’
   R : 5’-TGGTGGAGTGGGCTTCATG-3’
Sequencing
Two different fragments of DNA were amplified by regular PCR reaction on cn bw 
and glr flies’ genomic DNA preparations.  The first one corresponded to the 
second exon of CG7417, that contains the predicted ATG start codon ; we 
therefore used primers flanking this exon ; their sequence is as follows : 
F : 5’-ATGGGAGGCGTTAGACAGAAAAAC-3’ and 
R : 5’-ATGTATGTCCTCACGGCTCAGAAC-3’. 
The second fragment corresponded to exons 3/4/5 genomic region. Primers 
were : 
F : 5’-CCGAATGGGTGAACCGAGAAATC-3’ and 
R : 5’-TGAACCCATCCCCAGCAATCC-3’. 
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The amplicons were then sequenced on an automated DNA sequencer
S2 cell culture, dsRNA analysis, kinase assays
These experiments have been performed as previously described (Zhou et al., 
2005). The yeast two-hybrid experiment was performed following established 
protocol (Silverman et al., 2000).
5’ RACE PCR
These experiments were performed using the SmartTM RACE cDNA amplification 
kit from BD Biosystem.  The 3’ primer was : 5’ 
GTAAAGGGGCATGGTGGGACTACTGTC 3’ and the 3’ nested primer was 5’ 
CTGCTCCTGCGTGGGATATGGGAAAAC 3’:.  This yielded bands of 520 bp 
(short transcript, Figure 4.10A) and 1750 bp (full-length transcript).
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CHAPTER V
DISCUSSION
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Overview
This thesis research has focused on understanding the molecular 
mechanisms of innate immune signal transduction in the Drosophila IMD 
pathway.  In particular, the roles of ubiquitination and the MAP3 kinase TAK1 are 
central themes.  The data shown elucidates the critical role that ubiquitination 
plays in Drosophila IMD innate immune signaling (Chapter 2).  Furthermore, two 
novel mechanisms by which the kinase TAK1 can be regulated have also been 
described (Chapters 3 and 4).
As a whole the work presented in this thesis enables restructuring of the 
Drosophila IMD innate immune signaling pathway (Figure 5.1).  Upon binding 
PGN, the PGRP-LC receptor sets in motion a series of events in which the 
adaptor protein IMD is cleaved by the caspase DREDD.  Cleavage of IMD 
exposes an IAP binding motif containing a neo-N-terminal alanine at position 31, 
allowing IMD to interact with the BIR 2 & 3 domains of the ubiquitin E3 ligase 
DIAP2.  In concert with the E2 conjugating enzymes, Uev1a, Bendless and 
Effete, IMD is then K63-polyubiquitinated.  In a similar manner to that seen in 
mammalian NF-κB signaling, it is then proposed that this K63-polyubiquitin chain 
acts as a scaffold to recruit downstream TAK1 and IKK kinases.  Containing a 
highly conserved K63-polyubiquitin binding domain, two isoforms of the TAK1 
binding protein TAB2 have been demonstrated to be required for the differential 
activation of the downstream JNK and Relish/NF-κB arms of the IMD pathway.  
While both arms can utilize the long (full length) TAB2 isoform, the short isoform 
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Figure 5.1 Comprehensive IMD signaling pathway model
A comprehensive model of IMD pathway signaling as described in the text.
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is only able to promote activation of the Relish/NF-κB pathway.  In addition, auto-
phosphorylation of S176, within the activation loop of TAK1, is also required for 
activation of the kinase.  In concert with TAB2, activated TAK1 can then initiate 
signaling to one or both downstream arms of the IMD pathway leading to the 
production of antimicrobial peptides and the activation of other immune regulated 
genes. 
Regulation of IMD modification
As described in Chapter 2, within moments after stimulation with 
peptidoglycan (PGN), IMD becomes heavily modified, displaying cleaved, 
phosphorylated and ubiquitinated forms.  However, mechanisms involved in 
regulation of these events remain unclear.  Published work indicates that after 
activation, PGRP-LC receptor proteins come into proximity with one another 
(Chang et al., 2006).  Furthermore, the intracellular domain of PGRP-LC is 
known to associate with the IMD (Aggarwal et al., 2008; Choe et al., 2005; 
Kaneko et al., 2006).  In addition, unpublished work from our group indicates that 
DREDD (and FADD) also associates with the receptor complex.  It can be 
proposed that activation of PGRP-LC, perhaps prebound to either IMD and/or 
DREDD, allows these proteins to come into close proximity facilitating the 
DREDD-mediated cleavage of IMD (Figure 5.2).  Currently the protein domains 
required for these interactions are under active study. 
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Figure 5.2 Down regulation of IMD signaling by phosphorylation
In an unstimulated state, PGRP-LC receptors may be bound to DREDD and/or 
IMD (top).  Once stimulated the receptors co-localize inducing the DREDD 
mediated cleavage of IMD, activating signaling (bottom left).  Once activated, 
TAK1 phosphorylates IMD in a negative feedback loop (bottom right).  
Phosphorylation of IMD may block cleavage and ubiquitination of the protein. 
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After cleavage, IMD binds DIAP2 and is K63-polyubiquitinated.  As shown 
in Chapter 2, the kinetics behind this modification are rapid with 
polyubiquitination of IMD occurring within less than a minute after stimulation in 
S2* cells. Ubiquitination of IMD peaks at approximately 5 to 10 minutes and is 
largely dissipated by 30 minutes (Figure 2.6).  The initial kinetics of IMD cleavage 
are nearly identical with cleavage occurring within one minute and peaking 
between 5 to 10 minutes.  However, unlike ubiquitination, cleaved IMD is present 
for as long as 120 minutes after stimulation, long past the presence of 
ubiquitinated IMD (Figures 2.1B and 2.6).  Interestingly, the association of IMD 
with DIAP2 shows a markedly different temporal pattern.  This association occurs 
notably faster, peaking at 3 minutes, and begins to decrease immediately 
thereafter, in direct correlation with reduced levels of IMD ubiquitination (Figure 
2.6).  It is important to note that as levels of DIAP2/IMD association and IMD 
ubiquitination decrease, detectible phosphorylation of IMD increases.  Occurring 
slightly slower, phosphorylation of IMD peaks at approximately 30 minutes post 
stimulation (Figure 2.1B and 2.6).  As the presence of phosphorylated IMD 
seems to be inversely proportional to IMD ubiquitination an argument can be 
made that perhaps phosphorylation of IMD negatively regulates ubiquitination.  
Preliminary evidence indicates that this hypothesis may be correct.  RNAi 
knocking down all IMD pathway kinases (TAK1, IKK, Hemipterous and Basket) 
indicates that only TAK1 appears to play a role in IMD phosphorylation.  In 
addition, S2* cells which over express TAK1 show spontaneous phosphorylation 
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of IMD, yet fail to activate the IMD pathway.  If these same cells, containing 
phosphorylated IMD, are then stimulated with PGN, the amount of cleaved and 
ubiquitinated IMD is greatly reduced compared to control cells not over 
expressing the kinase.
This preliminary data indicates that phosphorylation of IMD by TAK1 may 
play a negative regulatory role in regards to IMD ubiquitination, possibly by 
inhibiting the cleavage of IMD.  However two lines of evidence complicate this 
issue.  Firstly, is the presence of cleaved and phosphorylated IMD after 
stimulation (Figure 2.1B and 2.2).  If phosphorylation of IMD blocks cleavage 
then how would a cleaved/phosphorylated form of IMD appear?  One possible 
explanation is that TAK1 may be able to phosphorylate both full length and 
cleaved IMD.  Therefore, while phosphorylation of the full length IMD may 
interfere with cleavage of the protein, phosphorylation of cleaved IMD may 
abrogate association with DIAP2 or the E2 conjugation proteins.  Thus 
phosphorylation of IMD may play a dual role inhibiting pathway activation (Figure 
5.2).  Secondly, cleaved IMD is present in cell lysates after more than 120 
minutes of stimulation with PGN, while ubiquitination is largely gone by 30 
minutes (Figure 2.6).  If cleavage of IMD is sufficient to initiate DIAP2 binding and 
ubiquitination, it remains unclear why this cleaved IMD is not ubiquitinated.  
Perhaps by 30 minutes after stimulation in S2* cells DIAP2 is saturated with 
cleaved IMD and although more IMD protein is cleaved it is unable to associate 
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with available DIAP2.  Alternatively, another as of yet unidentified regulatory 
mechanism may play a role in the ‘late’ inhibition of IMD ubiquitination.  
Ubiquitination of IMD
In Chapter 2, the Drosophila E2 ubiquitin conjugating enzyme Effete, 
homologous to mammalian Ubc5, is demonstrated to play an important role in 
the ubiquitination of IMD.  In these experiments, RNAi knocking down expression 
of Effete, in concert with the E2 enzymes Uev1a and Bendless is able to block 
both IMD ubiquitination and pathway signaling as a whole.  However, RNAi 
targeting these enzymes individually, or Uev1a and Bendless, show only partial 
phenotypes.  While Uev1a and Bendless are known to associate in-vivo, it has 
not been determined if Effete also directly associates with this E2 complex (Zhou 
et al., 2005).  These data indicate that these three E2 enzymes play a redundant 
or perhaps cooperative role in the ubiquitination of IMD.
In mammals, homologues to all three E2 enzymes, Uev1a, Bendless and 
Effete, have all been shown to play a role in ubiquitination during innate immune 
signaling.  For example, mammalian Uev1a and Ubc13 (homologous to 
Bendless) have been shown to be important for K63-polyubiquitination.  In 
particular, recent work illustrates that K63-polyubiquitin chains formed by 
mammalian Ubc13 after stimulation with IL-1 are required for IKK activity (Xu et 
al., 2009).  Interestingly, the same study also showed that Ubc5-mediated 
polyubiquitin of RIP1 was required for IKK activity in the TNF pathway.  In this 
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case however the polyubiquitin chains on RIP1 were not K63-mediated but some 
other unidentified linkage.  Furthermore, Ubc5 was demonstrated to interact with 
the mammalian IAP protein cIAP1.  Separately, Ubc5 has also been shown to 
produce unanchored polyubiquitin chains which are not conjugated to a target 
protein yet are sufficient to activate downstream TAK1 and IKK kinases both in 
vitro and in cell culture (Xia et al., 2009).
In light of the mammalian functions of these E2 proteins it can be 
proposed that after stimulation, IMD could be modified by the addition of multiple 
types of polyubiquitin chains.  While Uev1a and Bendless may play a role in K63-
polyubiquitination of IMD, Ubc5 (perhaps in concert with DIAP2) may promote a 
second form of polyubiquitination.  Although IMD has been demonstrated to be 
K63-polyubiquitinated, this analysis does not eliminate the possible presence of 
other ubiquitin modifications.  Multiple possibilities exist regarding the 
ubiquitination of IMD by Effete (Figure 5.3).  First, Effete could promote 
polyubiquitination of IMD mediated by lysines other than lysine 48 or 63 of 
ubiquitin.  Although K48- and K63-mediated polyubiquitination is widely 
described, ubiquitin also contains 5 other lysines (K6, K11, K27, K29, and K33) 
that could be utilized to generate polyubiquitin chains.  Secondly, Effete may help 
promote the linear ubiquitination of IMD.  Unlike lysine mediated polyubiquitin, 
linear ubiquitination occurs via the exposed N-terminus of a conjugated ubiquitin 
moiety.  Identified in mammals, the role that linear ubiquitin plays during NF-κB 
signaling remains unclear.  Lastly, Effete may promote the production of 
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Figure 5.3 Ubiquitination of IMD
After binding DIAP2, cleaved IMD becomes ubiquitinated.  The E2 enzymes 
Uev1a and Bendless are thought to mediate the production of K63-polyubiquitin 
chains.  The Ubc5 homologue Effete may also promote the generation of other 
forms of lysine mediated or linear polyubiquitin on IMD.  In concert with Effete, 
IMD may also serve as a source from which unanchored polyubiquitin chains are 
generated (Top).  At a later time, the deubiquitinating enzyme USP36 removes 
K63-polyubiquitin chains from IMD.  This promotes the production of K48-
polyubiquitination and degradation of the protein (Bottom). 
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unanchored polyubiquitin, in a similar manner to the activity of Ubc5 
observed in mammals.  Although the mechanism behind production of 
unanchored polyubiquitin remains unclear, it is possible these chains could result 
from the cleavage of a polyubiquitin chain from a conjugated substrate protein, 
for example IMD.  Further work is underway to determine if IMD is conjugated 
with any other types of polyubiquitin chains and to determine what role Effete 
plays in the additional modification.  The possible presence of multiple types of 
polyubiquitination on IMD could also help explain the difficulty in identifying 
specific lysine residues of IMD required for signal transduction. 
Deubiquitinating enzymes are also likely to play a significant role in the 
regulation of IMD pathway signaling.  As mentioned earlier, the ubiquitination of 
IMD occurs rapidly and is largely gone by 30 minutes post PGN stimulation.  
Another group has identified a ubiquitin specific protease, USP36, which is able 
to remove the K63-polyubiquitin chains from IMD (Thevenon et al., 2009).  By 
removing the IMD K63-polyubiquitin chains, USP36 is able to down regulate IMD 
signaling and appears to promote the K48-polyubiquitination and degradation of 
IMD (Figure 5.3) however the E2 and E3 enzymes involved in this event were not 
determined.  In concert with the work described herein, these data illustrate the 
importance of proper regulation of polyubiquitin for IMD signaling.
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Activation of TAK1
In Chapter 3, a single phospho-accepting-residue in the activation loop of 
TAK1, serine 176, was identified as being vital for kinase activity.  In mammals, a 
model has been proposed in which TAK1 is activated by auto-phosphorylation 
within the activation loop in trans (Xia et al., 2009).  Most likely, a similar event is 
also present in Drosophila (Figure 5.4A), however, this does not account for the 
additional phosphorylated residues identified outside the activation loop of 
Drosophila TAK1 after over expression and activation of the protein (Table 3.6).  
The manner in which these phosphorylations occur remains unclear.  These sites 
may be auto-phosphorylated, in cis or trans, after phosphorylation within the 
activation loop, and be required for proper activation of the kinase.  Alternatively, 
phosphorylation of downstream kinases by TAK1 could lead to feedback 
mediated phosphorylation of these sites.
Furthermore, data in Chapter 3 also illustrates that the acetylation of two 
highly conserved threonine residues, T168 and T171, within the activation loop of 
TAK1 is sufficient to block auto-phosphorylation and activation of the kinase. In 
mammals, but not Drosophila, these two theronines are also phosphorylated.  It 
is unclear why acetylation of these two residues in Drosophila TAK1 is able to 
block the phosphorylation and activation of this kinase.  One possible explanation 
is that these residues play a role in TAK-TAK trans-interactions required for auto-
phosphorylation and activation (Figure 5.4A).  If these threonines are modified by 
acetylation the TAK-TAK interaction may be abrogated, thus inhibiting auto-
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Figure 5.4 Activation of TAK1
(A) After binding the K63-polyubiquitin scaffold via TAB2, auto-phosphorylation 
(P) of TAK1 at serine 176 likely occurs in trans, in a similar manner to activation 
of mammalian TAK1.  (B) Acetylation (Ac) of threonines 168 and 171, may block 
this TAK-TAK interaction rendering the kinases unable to cross activate, down-
regulating the immune response.
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phosphorylation and activity.  Alternately, acetylation of these residues may force 
a conformational change in the activation loop rendering it inactive.  An in depth 
analysis will be required to determine the functional effects of the multiple 
phosphorylations found on TAK1 and the manner in which they are generated. 
Association with TAB2 
There has been much controversy as to the role, if any, that JNK signaling 
plays during Relish/NF-κB antimicrobial peptide production.  Several reports 
indicate that these two pathways may cross regulate, with each down-modulating 
the action of the other (Park et al., 2004; Kim et al., 2005).  However, Delaney et 
al., (2006) proposed a contradictory model in which TAK1/JNK activation is 
required for AMP gene induction in the larval fat body.  The work described in 
Chapter 4 demonstrates that 2 forms of TAB2 are present in Drosophila and that 
RNAi treatment targeting the long (full length) isoform is able to uncouple JNK 
and Relish/NF-κB signaling.  In these cells, JNK signaling is inhibited while AMP 
gene production proceeds as normal.  Phenotypically similar TAB2 mutant flies 
(TAB2666), also fail to robustly activate JNK signaling yet remain resistant to 
infection by E. coli.  These data are consistent with the notion that JNK signaling 
is not required for activation of AMPs by the Relish/NF-κB arm of the IMD 
pathway.  
In mammals TAB proteins have been shown to be critical components 
during NF-κB pathway activation by binding K63-polyubiquitin chains.  Mediating 
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the association and activation of TAK1, the presence of TAB proteins is essential 
for signaling in both mammals and insects.  Interestingly, in mammals, the TAB 
family protein TAB1 was shown to interact with the IAP protein XIAP.  This 
interaction takes place utilizing the BIR1 domain of XIAP and is critical for TAK1 
activation.  As both TAB and IAP family members are involved in IMD pathway 
signaling a similar precedent may hold true.  Unpublished work from our 
collaborators indicates that when co-expressed Drosophila TAB2 and DIAP2 
associate, although the domains required for this interaction remain 
undetermined.  TAB2 also appears to be critical for stabilization of IMD pathway 
components and viability of cells in culture.  Treatment of S2* cells with RNAi 
targeting TAB2 for 3 days is sufficient to inhibit IMD pathway signaling.  However, 
extended exposure (longer than 4 days) to TAB2 RNAi results in decreased 
TAK1 and DIAP2 protein levels, as well as decreased cell viability.  This 
phenotype appears to be unique to TAB2 as RNAi treatment targeting other IMD 
pathway members does not display the same effects.  These data strongly 
indicate that TAB2 associates with both TAK1 and DIAP2 prior to stimulation and 
that this association is critical for the stabilization of these two proteins.  
Defining a mammalian counterpart
Vertebrate homologues of the Drosophila proteins described in this work 
have been implicated in immune signaling yet their interactions and functions in 
many cases remain largely unclassified.  Lacking an adaptive immune response, 
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Drosophila serve as an important model system for the further understanding of 
innate immunity and host/pathogen interactions.  To that end, this research helps 
to illuminate the mechanisms by which caspase mediated cleavage, 
ubiquitination, protein/protein interactions and kinase activation play a role in 
insect NF-κB signaling, and shed light onto how similar events may occur in 
mammals.
A similar scenario could be proposed for mammalian NF-κB signaling in 
which stimulation leads to the caspase-8 mediated cleavage of RIP1 exposing an 
IAP binding motif (IBM).  This exposed IBM would then bind the BIR domains of 
cIAP1/2 promoting K63-polyubiquitination.  Although IMD is considered to be 
similar to RIP1, the two proteins share little sequence homology outside their 
death domains.  Unlike IMD, RIP1 also contains a kinase domain which is 
dispensable for NF-κB pathway activation.  Therefore, RIP1 may not be the 
functional IMD homologue involved in capase mediated cleavage during 
mammalian signaling, instead TRAFs or some alternative protein may undertake 
this role.  For such a hypothesis to hold true, these proteins must contain a 
caspase cleavage site immediately adjacent to an IBM.  Although in-silico 
analysis of both mouse and human TRAF2, TRAF6, RIP1 and RIP2 proteins 
identifies a number of possible caspase cleavage sites, no obvious IBMs are 
seen in tandem.  However, this does not eliminate the possibility that an atypical 
IBM is present or that another protein is cleaved and ubiquitinated.  Further 
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research within mammalian systems is currently underway to determine whether 
a similar paradigm holds true.
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